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“Previous generations have been absolutely convinced that their scientific theories were 
well-nigh perfect, only for it to turn out that they had missed the point entirely. Why 
should it be any different for our generation? Beware of scientific fundamentalists who try 
to tell you everything is pretty much worked out, and only a few routine details are left to 
do. It is just when the majority of scientists believe such things that the next revolution in 
our world-view creeps into being, its feeble birth-squeaks all but drowned by the 
earsplitting roar of orthodoxy.” (Pratchett et al., 2002) 
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1 Introduction  1 
1 Introduction 
1.1 Intracellular protein sorting: Vesicular traffic, secretion 
and endocytosis 
A typical mammalian cell contains up to 10,000 different proteins at a given time point. A 
yeast cell in comparison contains 5,000 different kinds of proteins, which is only slightly 
less impressive. Most proteins reside in the cytosol. However, as many as up to half of the 
proteins produced in a typical cell are delivered to a particular cellular membrane, to the 
lumen of cellular organelles, or are secreted out of the cell. The intracellular protein sorting 
can be subdivided in two major pathways (Palade, 1975; Lodish et al., 2003): the 
cytoplasmic and the secretory pathway. 
In the cytoplasmic pathway, the protein translation is initiated and completed on cytosolic 
ribosomes. Those proteins that contain no protein targeting sequence are released into the 
cytosol and remain there. Proteins with an organelle-specific targeting sequence are first 
released into the cytosol but are subsequently imported into mitochondria, peroxisomes or 
the nucleus.  
In contrast, all proteins carrying an endoplasmic reticulcum (ER)-signal sequence are 
initially targeted to the ER membrane and enter the secretory pathway. These proteins not 
only include soluble and membrane proteins of the ER, but also resident proteins of the 
Golgi apparatus, of the endosomal system, of the lysosomes/vacuoles, plasma membrane 
proteins and proteins which are secreted from the cell (for simplicity collectively referred 
to as secretory proteins). The transport of the proteins from the ER to their final 
destinations along the secretory pathway is accomplished by small vesicles that bud from 
the membrane of one organelle and fuse with the membrane of the next organelle in the 
pathway (Fig. 1). The secretory pathway is essentially conserved from yeast to man and a 
hallmark of eukaryotic cells. This process is of major significance for the cellular protein 
metabolism. For example, 70% of the proteins synthesized by hepatocytes are secreted into 
the blood. Like pancreatic cells and glandular cells, these cells are specialized for 
secretion. However, every cell uses the secretory pathway to some extent. Extracellular 
matrix proteins constitute about 5% of the protein made by most cultured cells. Moreover, 
MHC class I-peptides, although generated in the cytosol, are moving with their receptor 
along the secretory pathway to reach the cell surface. The unicellular eukaryote 
Saccharomyces cerevisiae has been used now for more than two decades to elucidate 
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Figure 1: Overview of the most important vesicular traffic routes in a cell. The protein coat of the vesicular 
trafficking steps is indicated. COPII-coated vesicles mediate anterograde ER-Golgi transport, whereas COPI-
coated vesicles mediate retrograde Golgi-ER as well as intra-Golgi transport. Clathrin/adaptor protein-coated 
vesicles travel from the trans-Golgi network to early and late endosomes as well as the vacuole/lysosome. 
Endocytosis is mediated by clathrin/AP-2-coated vesicles. The nature of the vesicle coat of secreted vesicles 
derived from the late endosome and the trans-Golgi network is not known. It has been proposed that the 
retromer complex is a vesicle coat involved in the retrieval pathway from late endosome to trans-Golgi 
network (dashed arrow; Pfeffer, 2001). Internal vesicles are depicted in the late endosome and represent 
multi-vesicular bodies. These internal vesicles are destined to the vacuole/lysosome for degradation. 
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protein and membrane traffic. Saccharomyces cerevisiae was the organism of choice 
because of its excellent genetic and biochemical amenability. It is particularly evident from 
landmark studies using Saccharomyces cerevisiae that secretion, which is protein and 
membrane flux, is an essential process to accomplish the vast expansion of the cell 
membrane surface that is needed for cell growth (Novick et al., 1980). Many bacterial 
toxins and viruses (e. g. cholera toxin, influenza virus A, simian virus 40) use the secretory 
pathway in the opposite direction to travel from the plasma membrane to the cytosol 
(Sandvig and van Deurs, 2002; Smith and Helenius, 2004).  
In most eukaryotes, secretory proteins enter the ER by co-translational translocation 
through the Sec61 translocon complex. In yeast, however, some secretory proteins enter 
the ER lumen post-translationally. Glycosylation as well as formation of disulfide bonds, 
protein folding and assembly, and proteolytic cleavages occur in the ER before proteins 
leave the ER again. Secretory proteins are transported by anterograde COPII-coated 
vesicles to the Golgi apparatus where further processing of the proteins takes place. To 
balance this forward movement of cargo, organelle homeostasis requires the retrieval of 
transport machinery components and escaped ER-resident proteins by the action of 
vesicular transport carriers. Retrograde COPI-coated vesicles retrieve proteins and lipids 
from the Golgi back the ER. All of these steps are tightly regulated and balanced so that a 
large amount of cargo can flow through the secretory pathway without compromising the 
integrity and steady-state composition of the constituent organelles.  
The secretory proteins eventually reach the trans-Golgi network by cisternal progression of 
the Golgi stacks (Pelham, 2001). The trans-Golgi network represents a major branch point 
of the secretory pathway and serves as sorting station. Thus, a protein can be loaded into 
different kinds of vesicles and thereby reach the plasma membrane, the endodomal system 
or the lysosome/vacuole. The endosomes also function in the endocytic pathway (hence the 
name) in which vesicles bud from the plasma membrane bringing membrane proteins and 
their bound ligands into the cell. Some proteins are transported to the lysosome/vacuole 
while others are recycled back to the cell surface. The membrane fluxes along these 
pathways are very large and rapid. A fibroblast kept in resting conditions in a tissue culture 
plate internalizes an amount of membrane equivalent to the whole surface area of the cell 
within one hour (Kirchhausen, 2000). Inside the cell, it often takes only seconds for a 
carrier vesicle to move from a donor membrane to an acceptor organelle. Despite these 
rapid and large fluxes, only a subset of the proteins and lipids in the donor membrane are 
taken up into the transport vesicle, effectively preventing the homogenization of the 
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membrane components and permitting membranous organelles to maintain distinct 
identities throughout the life of the cell.  
 
1.2 Molecular mechanism of vesicular traffic 
A common element of the secretory and endocytic pathway is the existence of many 
different small membrane-bounded and protein-coated vesicles that transport proteins and 
lipids from one organelle to another. These vesicles bud from the membrane of a donor 
organelle and eventually fuse with the membrane of an acceptor organelle. Despite the fact 
that most steps in the secretory and endocytic pathways employ different types of vesicles, 
the basic principles of vesicle formation and fusion are essentially conserved. Considerable 
progress has been made in understanding the molecular basis for membrane traffic 
(reviewed by Kirchhausen, 2000; Bonifacino and Glick, 2004). The best-studied vesicles 
are those that are clearly identifiable by their protein coats, namely COPII-, COPI-, and 
clathrin-coated vesicles. During the formation of a vesicle, a limited set of coat proteins 
carries out a programmed set of sequential interactions that lead to budding from the donor 
membrane, uncoating, fusion with the target membrane and recycling of the coat 
components (Fig. 2).  
Budding is initiated by recruitment of a small GTPase of the Sar1/Arf family to a patch of 
donor membrane. Coat components from the cytosol are then able to bind to the 
membrane. Polymerization of the coat protein on the membrane leads to a curved lattice 
that drives the formation of a vesicle bud by adhering to the cytosolic face of the 
membrane. At the same time, coat proteins participate directly and indirectly to recruit 
soluble and membrane cargo proteins to the forming vesicle. Vesicle budding and cargo 
selection at different stages of the exocytic and endocytic pathways are meditated by 
different coats and different sorting signals. The coat components not only recruit cargo 
but also deform the membrane to form a bud. When the bud has reached a charateristic size 
(detemined by the coat), the vesicle is released by scission of the neck connecting the 
deeply invaginated membrane to the donor surface. Finally, during uncoating, the coat 
components are released so that membrane fusion can occur between the naked vesicle and 
the target organelle. It is believed that Rab GTPases control the docking of the vesicles on 
target membranes (reviewed by Zerial and McBride, 2001). Vesicle fusion is mediated by 
a complex process involving the pairing of cognate v- and t-SNARE proteins (reviewed by 
Jahn et al., 2003). In the following sections, the formation of different vesicles is discussed 
in more detail. 
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Figure 2: The common mechanism of vesicle budding and fusion (adapted from Bonifacino and Glick, 
2004). Small GTPases of the Arf/Sar1 family become associated with a donor membrane. In turn, they are 
able to recruit soluble coat components from the cytosol. Polymerization of coat proteins leads to membrane 
deformation and cargo incorporation. After scission of the vesicle from the donor membrane and shedding of 
the protein coat, the vesicle is ready to dock and fuse with an acceptor membrane (mediated by Rab GTPases 
and SNARE proteins).  
 
1.3 Early stages of the secretory pathway 
1.3.1 COPII-coated vesicles 
COPII components and COPII-coated vesicles were originally discovered in the yeast 
Saccharomyces cerevisiae using genetic approaches coupled with cell-free assays 
(reviewed by Springer et al., 1999; Barlowe, 2000). These vesicles, which also have 
mammalian counterparts, transport newly synthesized proteins destined for secretion from 
the ER to the Golgi apparatus (Fig. 1). Although clathrin-coated vesicles have been 
discovered first, the molecular understanding of vesicle formation is most advanced for 
COPII-coated vesicles. COPII vesicles (50 – 90 nm in diameter) can be reconstituted in 
vitro using a minimal system consisting of chemically defined liposomes, GMP-PNP (a 
non-hydrolyzable GTP analog) and the purified components Sar1p, Sec23p, Sec24p, 
Sec13p and Sec31p (Matsuoka et al., 1998). Furthermore, it has been shown that some 
COPII components have the ability to self-assemble into spherical particles in solution 
(Antonny et al., 2003). For some COPII proteins, structural details are known from crystal 
structures and/or electron microscopic studies (Lederkremer et al., 2001; Bi et al., 2002).  
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Formation of COPII-coated vesicles is triggered when Sec12p, a guanine nucleotide 
exchange factor (GEF), catalyzes the exchange of bound GDP to GTP on the small 
GTPase Sar1p (Fig. 3). This exchange induces binding of Sar1p to the ER membrane 
followed by binding of the Sec23p/Sec24p complex forming a membrane-proximal layer 
(Barlowe et al., 1993; Barlowe and Schekman, 1993). ER membranes with Sec23p/Sec24p 
and Sar1p-GTP can then recruit the Sec13p/Sec31p complex to complete the coat structure 
(Barlowe et al., 1994). The large protein Sec16p which is bound to the cytosolic side of the 
ER membrane interacts with Sec13p/Sec31p and Sec23p/Sec24p and organizes the other 
coat proteins, increasing the efficiency of coat polymerization (Espenshade et al., 1995; 
Supek et al., 2002). Completing the cycle, Sec23p acts as a GTPase activating protein 
(GAP) for Sar1p (Yoshihisa et al., 1993). It is thought, that after GTP hydrolysis, Sar1p-
GDP is released, leading to uncoating of the vesicle before fusion. In this model, the 
kinetics of GTP hydrolysis would have to be slower than the kinetics of vesicle budding. 
Alternatively, the polymeric nature of the coat could provide kinetic stability even in the 
absence of Sar1p-GTP. 
 
 
 
Figure 3: The formation of COPII-coated vesicles (from Bonifacino and Glick, 2004). Sar1p is activated by 
the Sec12p and becomes membrane-associated at the ER. Sar1p-GTP is able to recruit the Sec23p/Sec24p 
complex from the cytosol. This trimeric complex binds the Sec13p/Sec31p complex. Polymerization of the 
coat induces membrane deformation. Cargo is incorporated into the vesicle by direct and indirect binding to 
the coat components.  
 
Most transmembrane cargo proteins bind directly to the COPII coat, whereas other 
transmembrane cargo proteins and most soluble cargo proteins bind indirectly via 
transmembrane export cargo receptors. The Sec23p/Sec24p complex is the component 
responsible for cargo recognition but the sorting signals recognized are quite complex 
(Springer and Schekman, 1998; Barlowe, 2003). Among the sorting signals recognized are 
1 Introduction  7 
di-acidic, di-basic and short hydrophobic sequences. Members of the p24 transmembrane 
family of export cargo receptors bind to Sec23p through a di-phenylalanine motif 
(Dominguez et al., 1998). Export cargo receptors leave the ER together with their ligands, 
unload their cargo and recycle back to the ER. The p24 family members Emp24p and 
Erv25p have been shown to recruit the GPI-anchored proteins Gas1p into COPII-coated 
vesicles (Muniz et al., 2000). There are two paralogs of Sec24p in Saccharomyces 
cerevisiae (Lst1p and Iss1p). This diversification of COPII subunits probably endows the 
coat with the ability to sort different cargo proteins and to be differentially regulated 
(Roberg et al., 1999; Shimoni et al., 2000). In addition to recruiting the Sec23p/Sec24p 
complex, the GTP-bound form of Sar1p activates Sec23p/sec24p complex to bind SNARE 
proteins involved in the specificity of targeting and in the fusion of vesicles with acceptor 
membranes (Springer and Schekman, 1998). Sec24p has three different binding sites for 
ER-Golgi SNARE proteins: the A-site, the B-site and the Arg342-site, each recognizing 
different signals on different proteins (Miller et al., 2003; Mossessova et al., 2003). 
Apparently, Sec24p cannot bind assembled SNARE complexes but instead selects for the 
uncomplexed, fusion-competent forms of the SNAREs (Mossessova et al., 2003). Thus, 
vesicle fusion is mechanistically linked with vesicle budding.  
 
1.3.2 COPI-coated vesicles 
Proteins can be recycled to the ER from the cis-Golgi via a retrograde route. Such proteins 
include ER resident proteins that have escaped the ER retention and functional components 
of anterograde COPII vesicles like ER-Golgi SNARE proteins that return to participate in 
another round of COPII vesicle formation. Retrograde vesicles are coated with the COPI 
coat, which consists of the small GTPase Arf1 and the heptameric coatomer complex 
(reviewed by Wieland and Harter, 1999; Spang, 2002). Arf1 is closely related to Sar1 but 
unlike Sar1, which functions exclusively in COPII vesicle formation, Arf1 proteins have 
many effectors, including COPI and other coats. However, currently maybe best 
understood is the role of Arf1 in the formation of COPI vesicles, which mediate retrograde 
Golgi-ER as well as intra-Golgi transport (Fig. 1). Like for COPII vesicles, COPI vesicle 
formation can be reconstituted in vitro. It has been shown that Arf1p, coatomer and GTPγS 
are sufficient to bud coated vesicles (40 – 70 nm in diameter) from chemically defined 
liposomes (Spang et al., 1998). 
Similar to all members of the Ras protein superfamily, Arf1 undergoes cycles of activation 
and inactivation mediated by GEFs and GAPs. Upon Arf1-GEF mediated nucleotide 
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exchange from GDP to GTP (Chardin et al., 1996; Morinaga et al., 1996; Peyroche et al., 
1996), Arf1 is recruited to and tightly associated with Golgi-membranes (Fig. 4). In turn, 
activated Arf1 recruits the large heptameric coatomer complex from the cytosol to the 
membrane via the β- and γ-subunit (Zhao et al., 1999). Unlike in COPII vesicle formation, 
the membrane-proximal (βγδζ) and membrane-distal (αβ’ε) subcomplexes bind 
simultaneously (Hara-Kuge et al., 1994). Binding of the coatomer complex to Arf1 and 
subsequent polymerization induces deformation of the membrane and finally vesicle 
budding.  
 
 
Figure 4: The formation of COPI-coated vesicles (from Kirchhausen, 2000). Membrane-association of 
activated Arf1 promotes recruitment of the coatomer complex from the cytosol. Polymerization of the coat 
induces membrane deformation and vesicle budding. Cargo proteins are incorporated into the vesicle by 
direct and indirect interactions with COPI components. After uncoating, the vesicle is ready to dock and fuse 
with a target membrane. 
 
In a simple model, prior to fusion of vesicles with a target membrane, the coat dissociates 
in response to the Arf1-GAP stimulated GTP hydrolysis on Arf1 (Tanigawa et al., 1993). 
In this case Arf1 would act like a timer for vesicle formation similar to Sar1. Structural 
studies extended this idea with respect to cargo recruitment (Goldberg, 1999, 2000). The 
rate of GTP hydrolysis depends on association of Arf1 with both Arf1-GAP and coatomer. 
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It was shown that the GTP hydrolsis was inhibited by a peptide derived from a p24 cargo 
receptor protein. This lead to the speculation that in the absence of cargo, the rate of GTP 
hydrolysis is too rapid to allow for vesicle formation because coatomer dissociates 
prematurely. In contrast, when bound to cargo, p24 will inhibit the GAP activity. The 
slower rate of GTP hydrolysis on Arf1 would provide time for a vesicle to be formed. In 
this way, vesicle formation would be coupled to cargo incorporation.  
Problems associated with the kinetic model and the structural data (obtained from a 
truncated version of human ARF1-GTP) provoked re-examination of the role of GTP 
hydrolysis (Szafer et al., 2000). Apparently, the GTPase cycle of controlled binding and 
hydrolysis of GTP is critical for Arf1 function. In contrast to the proposal that sorting is 
accomplished by cargo-dendent inhibition of Arf1-mediated GTP hydrolysis, some studies 
suggested that GTP is hydrolyzed in order to concentrate cargo before the vesicle is 
completely formed (Nickel et al., 1998; Lanoix et al., 1999; Malsam et al., 1999). A 
kinetic proof-reading mechanism for protein sorting has been proposed (Weiss and 
Nilsson, 2003). Support for this idea comes from two studies showing that Arf1-GAP is 
required for vesicle formation and is becoming an intrinsic part of the vesicle (Yang et al., 
2002; Lewis et al., 2004), although also a conflicting study exists (Reinhard et al., 2003). 
Furthermore, it has been shown that Arf1-GAP activity is controlled by membrane 
curvature and therefore by the size of the vesicle (Bigay et al., 2003). 
Although the precise mechanism of cargo sorting remains a matter of debate, the cargo 
sorting process happens concomitant with vesicle budding. The γ-subunit of coatomer has 
been shown to interact with membrane cargo proteins carrying the ER-retrieval motif 
K(X)KXX in their cytoplasmic domains (Cosson and Letourneur, 1994; Harter et al., 
1996). The KDEL-receptor binds to soluble cargo bearing the ER-retrieval sequence 
KDEL in the lumenal part of the forming vesicles at the Golgi and binds to ARF-GAP 
(Aoe et al., 1999). Other examples for proteins that are sorted into the COPI vesicles are v-
SNAREs, which are part of the targeting and fusion machinery. Their incorporation is 
ensured by interaction with Arf1p-GAP (Rein et al., 2002). The p24-family of cargo 
receptor proteins bind to both COPII and COPI through di-phenylalanine and di-basic 
motifs and cycle between ER and Golgi (Schimmoller et al., 1995; Stamnes et al., 1995; 
Sohn et al., 1996; reviewed by Kaiser, 2000). Whether they are essential for the vesicle 
formation itself remains to be shown (Bremser et al., 1999): At least in yeast, a knockout 
of the entire p24 family (eight members) does not have a severe consequence on the 
viability of the cell (Springer et al., 2000). Most importantly, p24 protein family members 
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form hetero- and homo-oligomeric complexes with each other (Dominguez et al., 1998; 
Fullekrug et al., 1999; Marzioch et al., 1999; Jenne et al., 2002). It has been suggested that 
the state of oligomerization regulates the interaction of the supposed cargo receptors with 
coat proteins and/or cargo proteins (Gommel et al., 1999). Multimerization of cargo 
receptors for transport seems to be a common theme: the COPI-binding putative cargo 
receptors Mst27p and Mst28p form at least dimeric complexes (Sandmann et al., 2003).  
 
1.4 Later stages of the secretory pathway, endocytosis and 
sorting of internalized proteins 
1.4.1 Clathrin-coated and related vesicles 
Clathrin-coated vesicles (50 – 150 nm in diameter) are the most prominent carrier vesicles 
and were the first to be discovered (Roth and Porter, 1964; Pearse, 1975). The low-density 
lipoprotein receptor and many other plasma membrane proteins and their ligands are 
internalized by a clathrin-dependent pathway leading to endosomes (Fig. 1). In addition, 
clathrin-coated vesicles also bud from the trans-Golgi network and fuse with endosomes or 
lysosomes (Kirchhausen, 2000).  
Clathrin coats are considerably more complex than COPII and COPI. Arf1-GTP and/or 
specific phosphoinositides (e. g. phosphatidylinositol 4,5-bisphosphate and phosphatidyl-
inositol 4-phosphate) recruit a variety of clathrin “adaptors” from the cytosol to 
membranes (Fig. 5). Examples of clathrin adaptors are the heterotetrameric AP-1, AP-2, 
AP-3, AP-4 complexes and the monomeric GGA proteins. Adaptor proteins form a 
heterogenous membrane-proximal layer onto which clathrin is subsequently deposited as 
membrane-distal layer. Clathrin and clathrin-adaptor complexes can polymerize into 
spherical, cage-like structures in vitro indicating that these proteins have an intrinsic ability 
to deform membranes (Kirchhausen and Harrison, 1981; Ungewickell and Branton, 1981). 
However, clathrin-coated vesicle formation requires the additional action of regulatory and 
accessory proteins. Clathrin vesicle scission depends on dynamins (reviewed by Sever, 
2002) and shedding of the coat requires the cytosolic chaperones Hsc70 and auxilin 
(Rothman and Schmid, 1986; Ungewickell et al., 1995). The reason for the need of a 
whole accessory machinery might be the involvement of clathrin in multiple post-Golgi 
sorting events, each requiring a specific set of adaptors and regulators.  
Although it was shown that ARF1-GTP, tyrosine-based signals and phosphatidyl-inositol 
4,5-bisphosphate constitute a minimal machinery to recruit the AP-1 complex to the 
membrane (Crottet et al., 2002), the complex process of clathrin-coated vesicle formation 
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prevented reconstitution in vitro from purified components. An exception are AP-
3/clathrin-coated vesicles which were reconstituted from liposomes in vitro using a 
minimal machinery consisting of purified AP-3 complex, clathrin, ARF1 and GTPγS 
(Drake et al., 2000). 
 
 
Figure 5: The key steps in formation of clathrin-coated vesicles (adapted from Kirchhausen, 2000). Arf1-
GTP and/or specific phosphoinositides recruit a variety of clathrin “adaptors” complexes (AP-1 or AP-2) 
from the cytosol to membranes. Clathrin and clathrin-adaptor complexes can polymerize into spherical, cage-
like structures. Cargo recruitment is accomplished by direct and indirect binding to clathrin adaptor 
complexes. Vesicle scission depends on dynamins and shedding of the coat requires the cytosolic chaperones 
Hsc70 and auxilin. 
 
AP-1 complexes and GGA proteins participate in clathrin-recruitment to the TGN and 
endosomes (reviewed by Boman, 2001; Boehm and Bonifacino, 2002; Bonifacino, 2004) 
(Fig. 1). In mammalian cells, ARF1 is required for both of these trafficking events and it 
physically interacts with AP-1 and the GGA proteins. In yeast, however, this view has 
been challenged. Although Arf1p can interact with the GGA protein, it seems not to be 
essential for GGA mediated trafficking steps (Boman et al., 2002). AP-2 complexes are 
involved in receptor-mediated endocytosis at the plasma membrane (Fig. 1). Yeast cells 
use clathrin for endocytosis but attempts to implicate AP-2 in yeast endocytosis failed so 
far (Payne et al., 1988; Tan et al., 1993; Rad et al., 1995; reviewed by Baggett and 
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Wendland, 2001). In addition, clathrin-independent endocytosis exists in yeast. Although 
ARF1 has been reported to be involved in the recruitment of AP-2 to the endosomal 
membrane (West et al., 1997), this view has recently been challenged (Jones et al., 1999a) 
and the effects reported previously were probably indirect. AP-3 complexes mediate traffic 
from the TGN directly to the lysosome/vacuole bypassing the endodomal system 
(reviewed by Robinson and Bonifacino, 2001) (Fig. 1). Whether this step is dependent on 
clathrin in yeast remains unclear (Cowles et al., 1997). AP-4 complexes, which are absent 
in organisms such as Saccharomyces cerevisiae, Caenorhabditis elegans, and Drosophila 
melanogaster have not been extensively studied so far (Dell'Angelica et al., 1999; Hirst et 
al., 1999). Indirect evidence in mammalian cells suggests that they might be involved in a 
special trafficking pathway in the endosomal/lysosomal system (Aguilar et al., 2001). 
The adaptor protein complexes bind to transmembrane cargo proteins by recognizing 
cytosolic sorting signals that contain either critical tyrosine, di-leucine residues or 
conjugated ubiquitin (Bonifacino and Traub, 2003). The tyrosine-based signal present in 
the LDL-receptor was indeed the first cytosolic sorting signal to be identified (Davis et al., 
1986). Acidic clusters present in the transmembrane mannose-6-phosphate receptor ensure 
its incorporation in a forming vesicle. The mannose-6-phophate receptor itself binds 
soluble cargo proteins modified by mannose-6-phosphate which is a sorting signal for 
proteins destined to the lysosome. Thus, clathrin/adaptor protein coats, COPII-, and COPI-
coats serve the same basic functions: cytosolic signal recognition and membrane 
deformation. 
 
1.4.2 Endocytosis and endosomal sorting 
All eukaryotic cells continually engage in endocytosis. The most well-understood 
endocytic process - receptor-mediated endocytosis – involves the internalization of 
receptors and their ligands by clathrin-coated pits. Many of the ligands are subsequently 
degraded in late endosomes or lysosomes, whereas many of the receptors are re-used up to 
several hundred times. Endosomes have a crucial role in coordinating vesicular transport 
between the TGN, the plasma membrane and the lysosomal/vacuolar organelles (Fig. 1). 
Collectively, endosomes comprise a system of heterogeneous compartments that have 
generally been characterized as ‘early’ or ‘late’ depending on the kinetics with which the 
compartments are loaded with endocytosed material. Furthermore, early endosomes and 
late endosomes can be distinguished on the basis of their morphological appearance 
(reviewed by Gruenberg, 2001; Pelham, 2002). For example, a subset of late endosomes 
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typically has a multivesicular appearance and is referred to as multi-vesicular body 
(MVB). Studies in multicellular organisms have revealed crucial roles for MVBs in 
seemingly distinct processes like growth-factor-receptor downregulation, antigen-
presentation and retroviral budding (reviewed by Katzmann et al., 2002). However, 
Saccharomyces cerevisiae has been most crucial in the discovery of molecular players in 
the MVB-sorting pathway. It has been appreciated that endocytosed receptor proteins 
targeted to the vacuole for degradation were primarily associated with membrane 
fragments and small vesicles within the interior of the vacuole rather than the vacuole 
surface membrane. These observations suggested that endocytosed membrane proteins can 
be incorporated into specialized vesicles that form at the endosomal membrane. Although 
these vesicles are similar in size and appearance to transport vesicles, they differ in their 
topology. Transport vesicles bud outward from the surface of a donor membrane (into the 
cytosol) whereas vesicles within the endosome bud inward from the surface into the lumen 
(away from the cytosol). Eventually, the surface membrane of a MVB fuses with the 
membrane of the vacuole/lysosome and delivers its internal vesicles and the membrane 
proteins they contain into the interior of the vacuole/lysosome for degradation. Thus, the 
sorting of proteins in the endosomal membranes determines which ones will remain on the 
vacuole/lysosome surface (protected from degradation) and which ones will be 
incorporated into internal vesicles (and ultimately be degraded).  
A particularly interesting example for the role of MVBs is the MHC class II-peptide 
presentation during immune response (Fig. 6). Immature dendritic cells package MHC 
class II molecules into lumenal vesicles of MVB-like compartments that are known as 
MHC class II compartments (MIICs). When the cell receives a maturation stimulus, the 
lumenal vesicles fuse with the limiting MIIC membrane, the MCH class II molecules are 
loaded with antigenic peptide and the MHC class II-peptide complexes are transported via 
secretory vesicles to the plasma membrane for presentation to naïve T cells (Kleijmeer et 
al., 2001). Surprisingly, the stimulation of dendritic cells can also cause the limiting 
membranes of MIICs to dock and fuse with the plasma membrane, which releases the 
lumenal vesicles of MIICs from the cell. These secreted vesicles, now termed exosomes, 
contain MHC molecules and co-stimulatory factors for T cells, but their precise 
physiological targets have yet to be elucidated (Zitvogel et al., 1998). 
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Figure 6: The role of multi-vesicular bodies in MHC class II-mediated immune response (adapted from 
Katzmann et al., 2002). MHC class II molecules in MIICs are loaded with antigenic peptides generated in the 
endosomal system. After fusion of internal vesicles with the MIIC membrane, traffic of MHC class II-peptide 
comlexes in secretory vesicles leads to peptide presentation at the cell surface. Alternatively, the antigenic 
stimulation of dendritic cells can cause the limiting membranes of MIICs to dock and fuse with the plasma 
membrane, which releases the lumenal vesicles of MIICs from the cell. These external vesicles are now 
termed exosomes. 
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1.5 The Arf GTPases: Structure and function 
ADP-ribosylation factors (Arfs) are well-conserved, multi-functional small GTPases found 
in all eukaryotes. They constitute a major branch of the Ras superfamily of small GTPases. 
The prototypic member, Arf1, was first identified as a co-factor for cholera toxin-catalyzed 
ADP-ribosylation of the heterotrimeric G protein Gsα (Kahn and Gilman, 1984, 1986). 
Human and yeast Arf1 proteins are 74% identical (Sewell and Kahn, 1988). This high 
degree of conservation has allowed studies on the function of Arf1 in both yeast and higher 
eukaryotes. Studies in yeast, mammalian cells and in vitro systems have implicated Arf1 
proteins as crucial regulators of membrane traffic, organelle maintenance and actin 
cytoskeleton. (reviewed by Donaldson and Jackson, 2000; Randazzo et al., 2000; Spang, 
2002; Nie et al., 2003).  
In this study, the following nomenclature of Arf proteins is used: ARF1 refers to 
mammalian ARF1, whereas Arf1p refers to yeast Arf1p. Arf1 refers to Arf1 proteins in 
general (in both yeast and higher eukaryotes). 
Mammalian ARFs are divided into three classes based on primary structure: class I (ARF1, 
ARF2, and ARF3), class II (ARF4, ARF5) and class III (ARF6). Class I ARFs are 
involved in trafficking in the Golgi-ER and endosomal systems and their functions have 
been extensively studied. The class III ARF, ARF6, functions exclusively in the 
endosomal-plasma membrane system. ARF6 is involved in processes as diverse as 
endosomal recycling to the plasma membrane, regulated secretion, coordinating actin 
cytoskeleton at the plasma membrane and Fc-mediated phagocytosis in macrophages. 
(Altschuler et al., 1999; Millar et al., 1999; Yang and Mueckler, 1999; Zhang et al., 1999). 
In contrast, virtually nothing is known about the class II ARFs. In the yeast Saccharomyces 
cerevisiae, three Arf proteins fulfill all Arf functions. The class I Arfs Arf1p and Arf2p are 
functionally interchangeable (96% protein sequence identity), and at least one these 
proteins is required for viability. Arf1p, though, constitutes 90% of Arf1 activity in yeast 
cells (Stearns et al., 1990a). Yeast Arf3p probably corresponds to mammalian ARF6.  
The effects of Arfs depend on their function as GTP-dependent switches. In analogy to 
other Ras-like proteins, the conformation of two regions of Arf, switch 1 and switch 2, 
differ between the GDP- and the GTP-bound forms (Amor et al., 1994; Greasley et al., 
1995; Goldberg, 1998; Pasqualato et al., 2002) (Fig. 7A and B). Arf has two additional 
nucleotide-sensitive regions: the myristoylated N-terminal amphiphatic helix that 
associates with a hydrophobic cleft in Arf-GDP but is free to associate with lipids and 
potentially other proteins in Arf-GTP. And lastly, the interswitch domain that is retracted 
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Figure 7: Arf as a nucleotide sensitive switch. (A) Primary structure of Arf1p from Saccharomyces 
cerevisiae. The myristoylated N-terminal helix is underlined. The consensus GTP-binding motifs conserved 
among Ras superfamily GTPases are shown in boxes. Switch 1 is shown in red, switch 2 in green and the α-
helix 3 in blue. (B) A ribbon representation of crystal structures of human full-length ARF1 bound to GDP, 
human truncated ARF1 bound to a GTP analog in comparison to GTP-analog-bound Ras (from Goldberg, 
1998). The N-terminal helix of ARF1-GDP is colored in red, bound nucleotide is colored white, with 
phosphorus atoms pink; Mg2+ ions are drawn as magenta spheres. (C) The GTPase cylce of Arf1. 
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and forms a pocket to accommodate the myristoylated N-terminal helix in Arf-GDP. These 
four surfaces on Arf presumably form the interface for nucleotide-dependent association 
with other proteins. The carboxyl-terminus and the α-helix 3 have also been implicated in 
protein-protein interactions (Goldberg, 1999; Takeya et al., 2000; Gommel et al., 2001). 
As all members of the Ras superfamily of GTPases, Arf1 proteins undergo cycles of 
activation and inactivation mediated by Arf1-GEFs and Arf1-GAPs (reviewed by Jackson 
and Casanova, 2000; Randazzo and Hirsch, 2004) (Fig. 7 C). In the GDP-bound state, Arf1 
can weakly associate with membranes via the myristoyl moiety of the N-terminus. Upon 
nucleotide exchange, Arf1 undergoes a conformational change leading to insertion of 
hydrophobic residues into the membrane and tightly associates with the membrane 
(Antonny et al., 1997). In the membrane-bound, activated form, Arf1 can interact with 
downstream effectors until it is inactivated again by GTP hydrolysis. Consistent with the 
multiple sites of action and range of effects, Arf1-GTP interacts with diverse groups of 
proteins.  
Arf1 has a number of biochemical activities that can be measured in vitro. These include 
the ability to recruit certain coat proteins to membranes (coatomer, AP-1, AP-3, AP-4, 
GGAs) (Serafini et al., 1991; Donaldson et al., 1992; Palmer et al., 1993; Stamnes and 
Rothman, 1993; Traub et al., 1993; Ooi et al., 1998; Puertollano et al., 2001). The co-
factor activity for bacterial ADP-ribosylating toxins (Kahn and Gilman, 1986; Lee et al., 
1991), the activation of phospholipase D (Brown et al., 1993) and the stimulation of 
phospholipids kinases (Godi et al., 1999; Honda et al., 1999; Jones et al., 2000; Skippen et 
al., 2002) complement the so far known biochemical activities of Arf1.  
The cellular functions of ARF1, however, which can be observed on a phenotypical level 
in mammalian cells, involve the regulation of many steps of membrane traffic and the 
regulation of the actin cytoskeleton. In the yeast Saccharomyces cerevisiae, Arf1p has been 
implicated as regulator of a large number of cellular functions including vesicular traffic, 
mitotic growth, entry into the cell-cycle, maintenance of organelle morphology, 
sporulation and actin cytoskeleton regulation (Stearns et al., 1990a; Stearns et al., 1990b; 
Ireland et al., 1994; Kahn et al., 1995; Gaynor et al., 1998; Rudge et al., 1998; Blader et 
al., 1999; Fucini et al., 2000). 
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1.6 Interactors of Arf1 
The means by which the biochemical activities of Arf1 mediate these diverse cellular 
functions are not completely understood. The guanine nucleotide-bound state of Arf1 is 
controlled by GEFs and GAPs. Many proteins regulating Arf1 activity and proteins 
presumably acting as effectors have been identified and the number is still growing 
(reviewed by Donaldson and Jackson, 2000; Randazzo et al., 2000; Spang, 2002; Nie et 
al., 2003). Consistent with the multiple sites of action, diverse groups of proteins have 
been identified. 
 
1.6.1 Arf1-regulators: Arf1-GEFs and Arf1-GAPs 
These regulatory proteins are conserved throughout evolution. Both reside in the cytosol 
and need to be recruited to the site of action on the membrane.  
All Arf-GEFs contain a Sec7 domain comprising the catalytic site (reviewed by Jackson 
and Casanova, 2000). A subclass of GEFs and GAPs contain a pleckstrin homology 
domain (PH) which interacts with phosphoinositides in the membrane. In yeast, three 
Arf1p-GEFs with established functions have been identified: Gea1p, Gea2p and Sec7p. 
Gea1p and Gea2p have overlapping functions in retrograde transport from the Golgi to the 
ER, while Sec7p has been implicated in vesicle formation from the trans-Golgi (Franzusoff 
et al., 1992; Spang et al., 2001). The cellular role of the fourth Sec7-domain containing 
protein, Syt1p, is still unclear but it might act at the post-Golgi level (Jones et al., 1999c). 
Which of the GEFs mediates the other Arf1p-dependent transport steps, remains to be 
established.  
The main characteristic of Arf-GAPs is the zinc finger domain which is involved in 
GTPase activation. Sixteen mammalian ARF-GAPs have been identified thus far as well as 
several proteins containing the Arf-GAP motif but without demonstrated Arf-GAP activity 
(reviewed by Randazzo and Hirsch, 2004). Arf-GAPs have been categorized into three 
groups: Arf-GAP1 type, Git type, and AZAP type. The diversity in domain organization in 
GAPs in higher eukaryores might allow their recruitment to different sites of action. For 
example, ARAPs (from the AZAP type) have been shown recently to represent a family of 
phosphatidylinositol 3,4,5-trisphosphate-dependent ARF-GAPs that regulate ARF-, Rho- 
and Cdc24-dependent cell activities (Krugmann et al., 2002; Miura et al., 2002). Thus, 
three small GTPases, which are thought to play roles in maintaining Golgi structure, seem 
to be regulated via the same family of effectors.  
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Arf1p-GAPs outnumber the Arf1p-GEFs in Saccharomyces cerevisiae. At least six 
putative Arf1p-GAPs are present in the yeast genome. Three of which are thus far 
characterized: Gcs1p and Glo3p have overlapping functions in retrograde transport from 
the Golgi to the ER (Poon et al., 1999). Age2p can be replaced by Gcs1p in the endocytic 
pathway (Poon et al., 2001). In addition, Gcs1p influences actin polymerization dynamics 
in yeast (Blader et al., 1999).  
 
1.6.2 Vesicle coat proteins and adaptors 
Vesicle coat proteins are central to the models explaining the regulatory role of Arfs in 
membrane traffic. Arf1-dependent coats include clathrin/AP-1, clathrin/AP-3, clathrin/AP-
4, clathrin/GGA1/2/3 and coatomer. In each case, Arf1 binds the coat directly (Donaldson 
et al., 1992; Palmer et al., 1993; Ooi et al., 1998; Zhu et al., 1999; Boehm et al., 2001). 
For coatomer, AP-1 and AP-3 binding, the switch 1 domain was mapped as the interaction 
site by cross-linking studies (Zhao et al., 1999; Austin et al., 2002). For GGA binding, 
switch 1 and switch 2 have both been implicated by mutational analysis (Puertollano et al., 
2001; Jacques et al., 2002). 
 
1.6.3 Proteins interacting with Arf1-GDP 
In addition to ARF1-GEFs, ARF1-GDP has been shown to interact with members of the 
p24 family of transmembrane cargo receptors such as p23. In biochemical studies, a 
peptide corresponding to the cytosplasmic domain of p23 bound to the carboxy-terminal 22 
amino acids of ARF1-GDP but not to ARF1-GTP (Gommel et al., 2001). This is in 
agreement with studies in live cells using fluorescence resonance energy transfer (Majoul 
et al., 2001). In one model (Gommel et al., 2001), ARF1-GDP is recruited to membranes 
by binding p23 prior to activation of ARF1 mediated by ARF1-GEF to a site of relative 
cargo enrichment. As mentioned before, however, this model cannot provide a universal 
explanation of Arf activation (Springer et al., 2000). 
 
1.6.4 Phospholipid-metabolizing enzymes 
Arf-GTP binds to and activates phosphatidyl-inositol kinases and phospholipase D (PLD), 
leading to the production of phosphatidylinositol 4,5-bisphosphate (PIP2) and phosphatidic 
acid (PA), respectively. PIP2 and PA are likely to contribute to the effects of Arfs in both 
actin and membrane remodeling. Nonetheless, the relationship between Arfs and lipids is 
first complex and second only poorly understood.  
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ARF1 can stimulate phospholipase D in vitro and in vivo in mammalian cells (Brown et 
al., 1993). PA, produced by ARF1-activated PLD, has first been implicated to be directly 
involved in the recruitment of coat proteins (Ktistakis et al., 1996; West et al., 1997). 
However, it is now firmly established that activation of PLD does not serve as the sole 
mechanism by which ARF1 regulates the recruitment of coat proteins (Stamnes et al., 
1998; Jones et al., 1999b; Kuai et al., 2000). In addition, phospholipase D is not activated 
by Arf1p in yeast (Rudge et al., 1998) and is at least not required for retrograde transport 
(Spang and Schekman, 1998). 
Although a role for PIP2 in membrane traffic is likely, its precise role remains to be 
determined. Phospholipids have long been known to regulate the actin cytoskeleton 
(Lassing and Lindberg, 1985). An intriguing concept has been proposed in which Arf1-
dependent changes in the actin cytoskeleton are linked to membrane traffic (Lorra and 
Huttner, 1999). 
 
1.6.5 Other effectors 
Arfaptin2 (and related proteins) bind to both the actin cytoskeleton regulator Rac of the 
Rho family bound to either GDP or GTP as well as to ARF1-GTP. Rac and ARF1-GTP 
binding are mutually exclusive. It has been proposed that Arfaptin2 acts to sequester Rac 
until activated ARF1 bind Arfaptin2. The displaced Rac is then free to be activated and to 
interact with Rac effectors (Tarricone et al., 2001). These results suggest that Rho family 
and Arf family protein function is coordinated within the cell. 
Arfophilin is an example of an effector binding to class II and class III ARFs at the same 
time. Thus, the same cellular event could be influenced by two different ARF isozymes 
simultaneously (Shin et al., 2001). However, the function of Arfophilin is unclear. 
Some other effectors have been identified, although their significance remains obscure. As 
mentioned above, Arfs are able to bind to cholera toxin and other bacterial toxins and are 
required as co-factor for the ADP-ribosylation of G-protein subunits (Kahn and Gilman, 
1986; Lee et al., 1991). This feature distinguishes Arf proteins from the closely related Arl 
proteins (Arf-like proteins). Arf proteins bind to mitotic kinesin-like protein 1 (MKLP1) in 
a GTP-dependent fashion (Boman et al., 1999). Furthermore, class I Arfs interact with 
PICK1 (protein interacting with C-kinase) (Takeya et al., 2000). 
Although some circumstantial evidence exists for the role of these effectors, the molecular 
function of these interaction partners is far from being clear. 
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1.7 Aim of this study 
The small GTPase Arf1p is a crucial regulator of vesicle formation in many steps of the 
secretory pathway in the yeast Saccharomyces cerevisiae. In addition, there is growing 
evidence of Arf1p being involved in actin cytoskeleton rearrangements as well as in lipid 
metabolism. The variety of already known regulators and effectors of Arf1p is, however, 
still insufficient to explain the multiple functions of the same molecule at different cellular 
locations. Furthermore, it is likely that new Arf1p-dependent pathways await discovery in 
both yeast and mammals which are not necessarily conserved.  
It is the aim of this study to identify new interactors of the small GTPase Arf1p in the yeast 
Saccharomyces cerevisiae. The subsequent characterization of the newly identified 
interactors and the elucidation of the pathways involved should lead to new insights 
concerning unexpected Arfp-dependent pathways and shed more light on vesicle formation 
and concomitant cargo protein sorting. 
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2 Materials and Methods 
2.1 Instrumentation 
Analytical balance BL310 Sartorius 
Axiocam MRm Zeiss 
Axioplan 2 epi-fluorescence microscope Zeiss 
Cooling centrifuge 5417 R Eppendorf 
Cooling centrifuge 5810 R Eppendorf 
Cooling centrifuge RC-5B Sorvall 
Developer machine Agfa 
Dissection scope Singer 
Dynal MPC-S magnetic separation rack Dynal Biotech 
Electrophoresis chamber B1A Owl 
Electrophoresis chamber SE250 Amersham Bioscience 
Electroporation Gene Pulser Biorad 
FPLC Äkta Prime Amersham Bioscience 
Fraction collector 2110  Biorad 
Gel dryer GD 2000 Amersham Bioscience 
Gel shaker 3020 GFL 
Heatable magnetic stirrer Ikamag RCT Ika Labortechnik 
Heating block Grant Boekel 
Incubators Heraeus 
Incubators Memmert 
Laboratory blender Waring 
Light microscope Axioskop 2 plus Zeiss 
PCR-machine PTC-100 MJ Research, Inc. 
pH-meter pH 330 WTW 
Power supply EPS 601 Amersham Bioscience 
Power supply Power Pac 200 Biorad 
Rotator Labquake Barnstead/Thermolyne 
Rotor 50.2 Ti Beckman 
Rotor GS3 Kendro 
Rotor SS34 Kendro 
Rotor SW28 Beckman 
Rotor SW50.1 Beckman 
Semi-dry transfer cell Biorad 
Shaking incubators Innova 4400 / 4430 New Brunswick Scientific 
Shaking incubators Unitron Infors 
Sonifier B12 Branson Sonic Power Company 
Spectrophotometer DU 640 Beckman 
Stratalinker 1800 UV Crosslinker Stratagene 
Thermomixer Compact Eppendorf 
Ultracentrifuge T-2060 Centrikon 
UV-transilluminator MWG-Biotech 
Vortexer Vortex Genie 2 Scientific Industries 
Water treatment system Milli-Q Millipore 
Waterbath Julabo Bioblock Scientific 
Wet blot tank TE22 Amersham Bioscience 
 
2.2 Chemicals 
All standard chemicals were obtained from Sigma, Roth or Merck. 
 
1 kb DNA-Ladder 15615-016 Invitrogen 
30% Acrylamide stock solution with 0.8% Bisacrylamid 3029.1 Roth 
4',6-Diamidino-2-phenylindole dihydrochloride (DAPI) D-9542 Sigma 
Alkaline phosphatase from calf intestine 713023 Roche 
Bacto-Agar granulated 214510 Difco 
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Bacto-Peptone 211830 Difco 
Bacto-Tryptone 211701 Difco 
Bacto-Yeast extract 212730 Difco 
Bacto-Yeast nitrogen base w/ amino acids and ammonium sulfate 233520 Difco 
Bacto-Yeast nitrogen base without amino acids 291920 Difco 
Benchmark Protein Ladder Prestained 10748-010 Invitrogen 
Benchmark Protein Ladder 10747-012 Invitrogen 
Brillant Blue G250 35050 Serva 
Brillant Blue R250 35051 Serva 
Calcofluor white dye F-3543 Sigma 
Citifluor R1320 Plano 
Complete mini EDTA-free protease inhibitors 1836170 Roche 
Desoxynucleosid-5‘-triphosphate (dNTPs) for PCR 1969064 Roche 
Dextrose 0155-17-4 Difco 
Digoxigenin-11-UTP 1209256 Roche 
Dimethylpimelimidate (DMP) 21667 Pierce 
DNase I, RNase-free 776785 Roche 
ECL advance kit RPN 2135 Amersham Bioscience 
ECL kit RPN 2106 Amersham Bioscience 
ECL+ kit RPN 2133 Amersham Bioscience 
Ficoll 400 17-0400-02 Amersham Bioscience 
Guanosine-5‘-diphosphat (GDP) G-7127 Sigma 
Guanosine-5‘-triphosphat (GTP) G-8877 Sigma 
Guanosine-5’-O-(3-thiotriphosphate) (GTPγS) G-8634 Sigma 
Heparin H-3393 Sigma 
Horse serum, heat-inactivated 26050-070 Invitrogen 
Leupeptin L-8511 Sigma 
Metaphor agarose 850.184 Biozym 
Non-fat dry milk powder  Frema 
Nycodenz D-2158 Sigma 
Oligonucleotide-primers  MWG-Biotech 
Oligonucleotide-primers  Qiagen 
Pellet Paint co-precipitant 69049-3 Merck 
Pepstatin A P-5318 Sigma 
Phenol/Chloroform/Isoamylalkohol (PCI) 15593-031 Invitrogen 
Protein A magnetic beads S1425S NEB 
Protein A-sepharose CL-4B 17-0780-01 Amersham Bioscience 
Protein G agarose 1243233 Roche 
Restriction enzymes  NEB 
Restriction enzymes  Roche 
Rhodamine-Phalloidine R415 MoBiTec 
RNase A 109142 Roche 
RNase 109126 Roche 
RNasin R2511 Promega 
RQ1-RNase-free DNase M6101 Promega 
Salmon sperm-DNA 85346022-39 Roche 
Seakem LE agarose 840.004 Biozym 
Taq DNA polymerase (5U/µl) 1418432 Roche 
Yeast tRNA 109495 Roche 
 
2.3 Materials 
Centriprep YM-10 4304 Amicon 
Dialysis bag Spectrapor 12 – 14.000 132 700 Spectrum 
Diethylaminoethane (DEAE) Sephacel 17-0500-01 Amersham Bioscience 
Electroporation cuvettes 24704640 Fischer 
Gel blotting paper 426 890 Schleicher & Schuell 
Hybond N+ nitrocellulose membrane RPN 203B Amersham Bioscience 
Hyperfilm ECL RPN 3114K Amersham Bioscience 
N-Hydroxysuccinimide (NHS)-activated Sepharose 4 Fast Flow 17-0906-01 Amersham Bioscience 
Nickel-Nitrilotetra-actetic acid agarose (Ni-NTA) 1000632 Qiagen 
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Nitrocellulose membrane Protran 0.45 µm 10401196 Schleicher & Schuell 
Polyvinylidenfluorid (PVDF)-membrane 0.2 µm 162-0177 Biorad 
Sephacryl S-100 High Resolution 17-0612-01 Amersham Bioscience 
Ultralink Iodacetyl resin 53155 Pierce 
 
2.4 Kits 
AlkPhos Direct labeling module RPN3680 Amersham Bioscience 
BCA protein assay kit 23227 Pierce 
Biorad DC protein assay reagents 500-0116 Biorad 
Biorad protein assay kit 500-0001 Biorad 
CDP-Star detection reagent RPN3682 Amersham Bioscience 
Expand High Fidelity PCR system 1732641 Roche 
HNPP fluorescent detection kit 1758888 Roche 
MEGAscript T7 kit 1334 Ambion 
OneStep RT-PCR kit 210210 Qiagen 
pET100D-TOPO expression kit K100-01 Invitrogen 
pTrcHis-TOPO TA expression kit K4410-01 Invitrogen 
Qiagen HiSpeed plasmid midi kit 12643 Qiagen 
Qiagen plasmid mini kit 12123 Qiagen 
QIAquick gel extraction kit 28704 Qiagen 
QIAquick PCR purification kit 28106 Qiagen 
Rapid DNA ligation kit 1635379 Roche 
RNeasy mini kit 74104 Qiagen 
 
2.5 Media 
All media were autoclaved at 121°C for 20 min. Water from the Millipore Milli Q water 
treatment system was used exclusively. Standard yeast media were used (Sherman, 1991).  
 
LBamp: 10 g Bacto-tryptone 
5 g yeast-extract 
10 g NaCl 
20 g Bacto-agar (Difco) 
ad 1 l with H2O  
1 ml 1000x Ampicillin was added 
after autoclaving 
 
YPD: 20 g Bacto-peptone 
10 g yeast extract 
20 g dextrose 
20 g Bacto-agar (Difco) 
ad 1 l H2O 
 
YPD-G418: 20 g Bacto-peptone 
10 g yeast extract 
20 g dextrose 
20 g Bacto-agar (Difco) 
ad 1 l H2O 
After cooling to approximately 50°C 
10 ml 100x G418 was added. 
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SOC-Medium: 5 g yeast extract 
20 g Bacto-peptone 
20 g dextrose 
10 mM NaCl 
2.5 mM KCl 
10 mM MgSO4 
ad 1 l with H2O 
 
HC-medium: 6.7 g Yeast nitrogen base without 
amino acids 
10x HC-selection mixture 
ad 1 l with H2O  
after autoclaving, a carbon source 
was added. 
 
HC-plates: a)  6.7 g Yeast nitrogen base without 
amino acids 
 20 g dextrose 
 10 ml 10x HC-selection mixture 
 ad 0.5 l with H2O  
b) 20 g Bacto-agar (Difco) 
 ad 0.5 l with H2O  
 
a) and b) were mixed after 
autoclaving 
 
Spo-plates 1% KAc 
1x Selection mixture complete 
20 g Bacto-agar (Difco) 
ad 1 l with H2O 
 
Super Spo-plates 1.5% KAc 
1x Selection mixture comlete 
0.25% yeast extract 
0.05% dextrose 
20 g Bacto-agar (Difco) 
ad 1 l with H2O 
 
YMP+ plates: 6.3 g Yeast nitrogen base without 
 amino acids and ammonium 
 sulfate 
4.5 g yeast extract 
9.0 g Bacto-peptone 
9.0 g succinic acid 
5.4 g NaOH 
20 g dextrose 
25 g (NH4)2SO4 
20 g Bacto-agar (Difco) 
ad 1 l with H2O 
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Calcofluor white plates: a)  6.7 g Yeast nitrogen base without 
 amino acids 
 1.0 g yeast extract 
 20 g dextrose 
 1x HC-selection mixture 
 ad 0.5 l with H2O  
b) 20 g Bacto-agar (Difco) 
 ad 0.4 l with H2O  
 
a) and b) were mixed after 
autoclaving 
100 ml 10 % MES-buffer pH 6.0 
were added, Calcofluor white stock 
solution was added dropwise to 0.1 
mg/ml final. 
 
5-FOA-plates: 0.34 g Yeast nitrogen base without 
 amino acids 
0.05 g 5-Fluoroorotic acid 
1 g dextrose 
1x HC-selection mixture 
5 ml H2O 
filter sterilized 
mix with 4% Bacto-agar (55°C) 
 
2.6 Commonly used solutions and buffers 
H2O filtered by Millipore Milli Q water treatment system was used exclusively for all 
solutions and buffers.  
 
1000x ampicillin: 100 mg/ml, filter sterilized 
 
1000x carbenicillin: 100 mg/ml, filter sterilized 
 
150x IPTG: 150 mM, filter sterilized 
 
50x lysozym: 50 mg/ml  
 
250x kanamycin: 10 mg/ml, filter sterilized 
 
Myristic acid: 125 mM Na-myristate 
Dissolved by heating in the 
microwave and filter 
sterilized while still warm. 
 
1000x pepstatin A/leupeptin: each 1 mg/ml in DMSO 
 
100x PMSF: 0.1 M in isopropanol 
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10x HC-selection mixture 0.2 mg/ml adenine hemi-
sulfate 
0.35 mg/ml uracil 
0.8 mg/ml L-tryptophan 
0.2 mg/ml L-histidine-HCl 
0.8 mg/ml L-leucine 
1.2 mg/ml L-lysine-HCl 
0.2 mg/ml L-methionine 
0.6 mg/ml L-tyrosine 
0.8 mg/ml L-isoleucine 
0.5 mg/ml L-phenylalanine 
1.0 mg/ml L-glutamic acid 
2.0 mg/ml L-threonine 
1.0 mg/ml L-aspartic acid 
1.5 mg/ml L-valine 
4.0 mg/ml L-serine 
0.2 mg/ml L-arginine-HCl 
autoclaved without the 
components to select for 
 
6x loading buffer for agarose gel-electrophoresis: 0.25% bromphenolblue 
0.25% xylencyanole 
30% glycerol 
 
B88-buffer: 20 mM HEPES/KOH pH 6.8 
250 mM sorbitol 
150 mM KAc 
5 mM Mg(Ac)2 
filter sterilized 
 
5x Laemmli-buffer: 62.5 mM Tris/HCl pH 6.8 
5% β-mercaptoethanol 
10% glycerol 
2% SDS 
0.0025% bromphenolblue 
 
STE-Puffer: 50 mM Tris/HCl pH 8.0 
25% sucrose 
40 mM EDTA 
autoclaved 
 
50x TAE-buffer: 2 M Tris/HAc pH 7.7 
5 mM EDTA 
 
20x TBS: 60 g Tris/HCl pH 7.4 
160 g NaCl 
4 g KCl 
ad 1 l with H2O 
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20x PBS 46.6 g Na2HPO4 ⋅ 12 H2O  
4.2 g KH2PO4  
175.2 g NaCl 
44.8 g KCl 
ad 1 l with H2O 
 
TBST: TBS with 0.1% Tween-20 
 
TE: 10 mM Tris/HCl pH 8.0 
1 mM EDTA 
 
100x G418: 20 mg/ml Geneticin,  
filter sterilized 
 
Calcofluor white stock: 50 mg/ml 
NaOH added dropwise to 
dissolve 
 
50x Denhardt’s reagent: 10 g Ficoll type 400 
10 g BSA fraction V 
10 g polyvinylpyrrolidone 
ad 1 l with H2O 
filter sterilized, stored at  
–20°C 
 
20x SSC 3 M NaCl 
0.3 M Na-citrate/NaOH pH 
7.0 
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2.7 Strains, plasmids, antibodies, oligonucleotide primers 
Table 1: Plasmids used 
Plasmid Description Source 
pUG6 loxP-Kanamycin cassette Johannes Hegemann 
pUG27 loxP-HIS5 cassette Johannes Hegemann 
pUG72 loxP-URA3 cassette Johannes Hegemann 
pUG73 loxP-LEU2 cassette Johannes Hegemann 
pSH63 Cre-recombinase, TRP1 Johannes Hegemann 
pSH47 Cre-recombinase, URA3 Johannes Hegemann 
pBS-3GFP-TRP1 3GFP-TRP1 John Cooper 
pYM-3GFP-TRP1 3GFP-TRP1 template This study 
pEG203 Bait two hybrid plasmid Rainer Duden 
pEG203-∆N17-Arf1-Q71L Bait two hybrid plasmid Rainer Duden 
pJG4-5 Prey two hybrid plasmid Rainer Duden 
pJG4-5-PAB1 Prey two hybrid plasmid This study 
pJG4-5-PUB1 Prey two hybrid plasmid This study 
pJG4-5-GLO3 Prey two hybrid plasmid Rainer Duden 
pUSE-SEC7-GFP-URA SEC7-GFP tagging Ben Glick 
pDH3 CFP-KAN template Yeast Resource Center 
pDH5 YFP-HIS5 template Yeast Resource Center 
pRJ-2GFP-TRP1 2GFP tagging Ralf Jansen 
pCY204 YCp50-HO-endonuclease Andreas Mayer 
pUG35 CEN URA3 METprom-GFP Johannes Hegemann 
pU6H3VSV 6His-3VSV template Dieter Gallwitz 
pUGLys2 LoxP-LYS2 cassette Steven Oliver 
pRJ-ASH1-myc9 URA3 Dieter Gallwitz 
pYM1 - pYM12 Template tagging plasmide Elmar Schiebel 
pG14-MS2-GFP GFP-MS2 Pascal Chartrand 
YEP lac195-Lz-MS2-ASH1 3‘UTR ASH1-MS2-binding sites Pascal Chartrand 
YEP lac195-Lz-MS2-ADH II ADH1-MS2-binding sites Pascal Chartrand 
pRS315 CEN LEU2 Sikorski and Hieter, 1989 
pRS425 2µ LEU2 Phil Hieter 
pCRP12-CHS3-GFP CHS3-GFP (CEN HIS3) Valdivia et al., 2002 
pRS426-CHS7 CHS7 (2µ URA3) Trilla et al., 1999 
pRS315-CHS6 CHS6 (CEN LEU2) This study 
pRS425-CHS6 CHS6 (2µ LEU2) This study 
pRS315-BUD7 BUD7 (CEN LEU2) This study 
pRS425-BUD7 BUD7 (2µ LEU2) This study 
pRS315-YMR237w YMR237w (CEN LEU2) This study 
PRS425-YMR237w YMR237w (2µ LEU2) This study 
pRS315-YKR027w YKR027w (CEN LEU2) This study 
PRS425-YKR027w YKR027w (2µ LEU2) This study 
YEpGFP*-BUD8F GFP-BUD8 (2µ LEU2) Schenkman et al., 2002 
YEpGFP*-BUD9 GFP-BUD9 (2µ URA3) Schenkman et al., 2002 
pKU76 TAT2-GFP (CEN URA3) Umebayashi and Nakano, 2003 
pUG35-FUS1-GFP FUS1-GFP (CEN URA3) This study 
p424-GPD (2 µ TRP1) Mumberg et al., 1995 
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Table 2: E. coli expression strains 
Strain Plasmid Source 
M15 pREP4; pQE30-∆N17-Arf1p-Q71L-His6 Rainer Duden 
M15 pREP4; pQE30-∆N17-Arf1p-T31N-His6 Rainer Duden 
M15 pREP4; ∆N17-wt-Arf1p-His6 Rainer Duden 
BL21 (DE3) wt-Arf1p; Nmt1p Richard Kahn 
BL21 (DE3) Star pET100D-His6-Pab1p This study 
BL21 (DE3) Star pET100D-His6-Chs5p This study 
BL21 Codon Plus pTrc-His-TOPO-Bfr1p This study 
 
Table 3: Antibodies used.  
Antibodies Dilution (WB) Source 
Rabbit anti-coatomer, polyclonal 1:1.000; IP Randy Schekman 
Rabbit anti-Gea2p, polyclonal 1:1.000 Anne Spang 
Rabbit anti-Glo3p, polyclonal 1:1.000 Pak Poon 
Rabbit anti-Arf1p, polyclonal 1:1.000; IP Anne Spang 
Rabbit anti-Emp47p, polyclonal 1:1.000 Stefan Schröder-Köhne
Rabbit anti-Bet1p, polyclonal 1:1.000 Randy Schekman 
Mouse anti-HA-epitope, monoclonal HA.11 1:1.000; IP Eurogentec 
Mouse anti-HA-epitope, monoclonal HA-7 1:1.000 IF Sigma 
Mouse anti-myc-epitope, monoclonal 9E10 1:1.000 WB; 1:1000 IF Sigma 
Mouse anti-GFP, monoclonal 1:1.000 Abcam 
Sheep anti GFP, polyclonal IP Michael Knop 
Rabbit anti-GFP, polyclonal purified 1:1.000 WB; 1:400 IF; IP Torrey Pines 
Rabbit anti-AU5 epitope, polyclonal purified 1:1.000 WB; IP Abcam 
Mouse anti-Pab1p, monoclonal 1:2.000 Alan Sachs 
Goat anti-rabbit-HRP  1:25.000 – 1:100.000 Pierce 
Goat anti-mouse-HRP, polyclonal purified 1:25.000 – 1:100.000 Pierce 
Rabbit anti-Pab1p, polyclonal, affinity purified 1:250 This study 
Rabbit anti-Chs5p, polyclonal,  IP This study 
Rabbit anti-Chs5p, polyclonal, affinity purified 1:500 Robert Gauss 
Rabbit anti-Arf1p, polyclonal, affinity purified 1:1.000; IP This study 
Rabbit IgG, purified IP-control Dianova 
Goat anti-mouse-Cy3 1:400 IF Jackson ImmunoRes. 
Donkey anti-rabbit-FITC 1:200 IF Jackson ImmunoRes. 
Sheep anti-digoxigenin-AP Fab-fragments  1:5.000 in situ hybridization Roche 
 
WB western blot, IF immunofluorescence, IP immunoprecipitation.
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2.8 Biochemical Methods 
2.8.1 Determination of yeast cell density 
1 OD600 corresponds to 2.75⋅107 yeast cells per ml on the spectrophotometer DU 640 
(Beckman). For OD600 measurements, cells were diluted to yield an OD600 of no more than 
0.5. Unless otherwise indicated, logarithmically growing cells were harvested at an OD600 
of no more than 0.5.  
 
2.8.2 Preparation of yeast total cell extract 
2 OD600 of yeast cells were harvested and resuspended in 150 µl 5x Laemmli-buffer (65°C, 
including 1 mM PMSF). Approximately 120 µl glass beads were added. After vigorous 
vortexing for 5 min, samples were incubated for 5 min at 65°C followed by 1 min of 
vortexing. Cell debris and glass beads were sedimented (2 min, 20,000 g, 4°C) and the 
supernatant was transferred to a fresh reaction tube. For subsequent analysis by SDS-
PAGE and immunoblotting, 5 µl of the lysate were used. 
For comparison of protein expression levels in different mutants grown at non-permissive 
temperature, the following procedure was used: 2 OD600 cells were resuspended in 150 µl 
lysis buffer and lysed by vortexing for 10 min at 4°C with roughly 120 µl glass beads. The 
crude lysate obtained after settling of the beads was centrifuged for 10 min at 20,000 g at 
4°C. The supernatant contained soluble proteins. The lysates were normalized to equal 
total protein concentration using the Biorad protein assay. 
 
Lysis buffer 
50 mM Tris/HCl pH 7.5 
1 mM EDTA 
50 mM DTT 
PMSF, Pepstatin A, Leupeptin 
 
2.8.3 Preparation of yeast cytosol 
Yeast cytosol was prepared as described before (Spang and Schekman, 1998). Usually, 3 l 
of mid-logarithmic liquid culture (OD600 between 1.0 and 1.5) were harvested (5 min, 
5,000 rpm, GS3-rotor, 4°C) and washed once in water. The cell pellet was resuspended in 
2 ml B88 and slowly pipetted into liquid nitrogen to allow small beads to form. Cell beads 
were either stored at –70°C or immediately processed. Lysis of cells occurred under liquid 
nitrogen in a mortar (placed on dry ice) in which the cells were ground for approximately 
30 min. Alternatively, a blender was used for 15 min. The resulting fine powder was 
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thawed in an ice/water bath and supplemented with the same volume of B88. After a pre-
clearing step (10 min, 8,000 rpm, GS3-rotor, 4°C), the lysate was spun at 100,000 g (60 
min, 39,000 rpm, Ti 50.2-rotor, 2°C). The supernatant was carefully collected avoiding the 
lipid layer on top. The protein concentration was measured by Biorad protein assay. 
Aliquots were frozen in liquid nitrogen and stored at –70°C.  
 
2.8.4 Preparation of enriched Golgi membranes from yeast 
For the preparation of enriched Golgi-membranes from yeast (Spang and Schekman, 
1998), cells were grown to an OD600 of no more than 0.5 (early to mid-logarithmic growth 
phase). Usually, 3 l of liquid culture were harvested (5 min, 5,000 rpm, GS3-rotor, 4°C) 
and washed once in water. The cell pellet was resuspended in 2 ml B88 and slowly 
pipetted into liquid nitrogen to allow small cell beads to form. Cells were either stored at –
70°C or immediately processed. Lysis of cells occurred under liquid nitrogen in a mortar 
(placed on dry ice) in which the cells were ground for approximately 30 min. The resulting 
fine powder was thawed in an ice/water bath and supplemented with the same volume of 
B88 (supplemented with 1 mM DTT and 1mM PMSF). The lysate was pre-cleared by 
centrifugation with 3,000 g (2 min, 5,000 rpm, SS34-rotor, 4°C). The supernatant was 
collected and centrifuged twice at 27,000 g (15 min, 15,000 rpm, SS34-rotor, 4°C). The 
ER-free supernatant was loaded on a 60% (w/w) sucrose cushion (in 20 mM HEPES/KOH 
pH 6.8) and spun at 100,000 g (30 min, 25,000 rpm, SW28-rotor, 4°C). The membranes 
were carefully collected at the interface and diluted again to the initial volume before ultra-
centrifugation in order to wash away cytosolic contaminants. The ultra-centrifugation step 
was repeated and the enriched Golgi-membranes were collected at the interface. The 
protein concentration was determined by the Biorad DC protein assay. Aliquots were 
frozen in liquid nitrogen and stored at –70°C.  
 
2.8.5 Protein determination 
The determination of protein concentrations of detergent-free solutions were performed 
using the Biorad protein assay, which is based on the Bradford method (Bradford, 1976). 
Bovine γ-globulin served as protein standard. For detergent-containing solutions, the 
detergent-compatible Biorad DC protein assay was used which is based on the Lowry 
method (Lowry et al., 1951). In this case, bovine serum albumin served as standard. For 
relative determination of peptide amounts in order to estimate peptide coupling 
efficiencies, the BCA-asssay from Piece was used which is based on the BCA-method 
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(Smith et al., 1985). All determinations were performed according to the manufacturer’s 
recommendations. 
 
2.8.6 Trichloro acetic acid precipitation 
TCA-precipitations of proteins were conducted essentially as described (Bensadoun and 
Weinstein, 1976). 1/10 volume of 100% (w/v) TCA (4°C) was added to the ice-cold 
protein solution. After incubation on ice for 30 min, the sample was centrifuged for 15 min 
(14.000 rpm, Eppendorf 5417 R, 4°C). The pellet was washed with 1 ml acetone (-20°C) 
and sedimented again. After aspiration of the acetone, the pellet was dried for 
approximately 5 min at 65°C and dissolved in a smaller volume of 100 mM Tris pH 8.0.  
 
2.8.7 SDS-PAGE 
For the discontinuous, denaturing SDS-polyacrylamide-gel-electrophoresis (Davis, 1964; 
Ornstein, 1964; Laemmli, 1970), both mini-gels (8 cm x 6.5 cm x 0.075 cm) as well as 
large gels (14.5 cm x 10 cm x 0.1 cm with 0.8% agarose used for sealing) were used. In 
both instances, the stacking gel was 4%. The percentage of the separation gel was chosen 
according to the analytical problem. The protein samples to be analyzed were 
complemented by 1/2 volume of 5x Laemmli-buffer, incubated at 65°C for 5 – 10 min and 
spun shortly. The separation was performed at constant current (25 mA for mini-gels, 50 
mA for large gels). Examples of standard gel compositions are given. 
 
Table 11: Composition of 12.5% SDS-mini-gels, sufficient for 13 gels. 
 12.5% separation gel 4% stacking gel 
Acrylamide 29.2%/Bisacrylamide 0.8% 25 ml 5 ml 
1.5 M Tris/HCl pH 8.0 15 ml --- 
0.5 M Tris/HCl pH 6.8 --- 7,5 ml 
10% SDS 300 µl 150 µl 
H2O  19.5 ml 17.1 ml 
TEMED 40 µl 36 µl 
10% APS 400 µl 240 µl 
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Table 12: Composition of large 10% SDS-gels, sufficient for 2 gels. 
 10% separation gel 4% stacking gel 
Acrylamide 29.2%/Bisacrylamide 0.8% 12 ml 1.25 ml 
1.5 M Tris/HCl pH 8.0 9 ml --- 
0.5 M Tris/HCl pH 6.8 --- 1.9 ml 
10% SDS 180 µl 37.5 µl 
H2O  14.7 ml 4.3 ml 
TEMED 15 µl 9 µl 
10% APS 180 µl 60 µl 
 
SDS-PAGE running buffer 
25 mM Tris 
192 mM glycine 
0.1% SDS 
 
2.8.8 Coomassie-Blue staining of polyacrylamide gels 
Polyacrylamide gels were routinely stained after electrophoresis for 15 min in Coomassie-
staining solution at room temperature (Meyer and Lamberts, 1965). Destaining of the gels 
was usually performed overnight in destaining solution at 4°C. The gels were equilibrated 
in water and dried for documentation.  
 
Coomassie-staining solution 
7.5% acetic acid 
50% methanol 
0.25% Serva Brillant Blue R250 
 
Destaining solution 
7.5% acetic acid 
50% methanol 
 
 
2.8.9 Colloidal Cooomassie-Blue staining of polyacrylamide gels 
according to Fairbanks 
For improved sensitivity, especially if protein bands were to be cut out for protein 
identification by mass spectrometry, the polyacrylamide gels were stained using the 
Fairbanks method (Fairbanks et al., 1971). The gels were agitated gently for 1 h in 
destaining solution. Staining was performed overnight in solution A. The destaining was 
accomplished by stepwise incubation for 1 h in solution B, 1 h in solution C and finally by 
incubation in solution D until the background was completely removed.  
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Solution A 
25% isopropanol 
10% acetic acid 
0.05% Serva Brillant Blue G250 
 
Solution B 
25% isopropanol 
10% acetic acid 
0.005% Serva Brillant Blue G250 
 
Solution C 
10% actetic acid 
0.002% Serva Brillant Blue G250 
 
Solution D 
10% acetic acid 
 
Destaining solution 
7.5% acetic acid 
50% methanol 
 
 
 
2.8.10 Silver staining of polyacrylamide gels 
The staining was performed essentially as described (Blum et al., 1987). The different 
steps are listed in table 13. 
 
Table 13: Silver staining procedure 
Step Solution* Time scale 
Fixation 70% MetOH, 0,037% HCHO ≥ 10 min 
Washing step H2O  2 x 5 min 
Sensitizing 0,02% Na2S2O3 1 min 
Washing step H2O  2 x 20 s 
Silver staining 0.1% AgNO3 ≥ 30 min 
Washing step H2O  2 x 20 s 
Developing 3% Na2CO3, 0.0004% Na2S2O3, 0.037% HCHO 3 – 10 min 
Stop 10% HAc 10 min 
*except for 70% MetOH, the 2% Na2S2O3-stock solution, and the 3% Na2CO3, everything was prepared 
freshly. 
 
2.8.11 Blue Native PAGE 
The Blue Native PAGE was performed as described before (Schagger and von Jagow, 
1991; Schagger, 2001). The separation of proteins occurred with the aid of 4 – 20.5% large 
gradient polyacrylamide gels. The gels were cast with the help of a gradient mixer. The 
compositions of gradient gels and buffers used are given in table 14. 
To prepare yeast lysates, 10 OD600 of yeast cells were incubated in 2 ml DTT-buffer (10 
mM Tris/HCl pH 9.4, 10 mM DTT) for 5 min at 30°C. The buffer was replaced by 2 ml 
SP-buffer (76% YPD, 0.7 M sorbitol, 10 mM Tris/HCl pH 7.5) and supplemented with 30 
µl Zymolyase T-20 (10 mg/ml). The cells were spheroplasted for 40 min at 30°C. The 
46  2 Materials and Methods 
 
spheroplasts were sedimented (3 min, 1,000 g) and lysed in 0.5 ml BNP-solubilization 
buffer. After solublization for 3 min at RT, the lysate was cleared by centrifugation (10 
min, 14,000 rpm, Eppendorf 5417 R, 4°C). 25 µl 50% glycerol were added to 100 µl of the 
supernatant . The samples were immediately loaded onto a 4 – 20.5% Blue Native gradient 
gel. 20 µl of each sample were loaded and BSA (66 kDa, 132 kDa), Apoferritin (443 kDa) 
and Thyroglobin (667 kDa) served as molecular weight markers. Electrophoresis was 
performed initially for 75 min at 100 V/15 mA, and then for further 165 min at 500 V/15 
mA (both steps at 4°C). The gel was briefly washed in electrode buffer and the proteins 
were transferred to a PVDF-membrane using the semi-dry method (at 4°C, 20 V for 150 
min or overnight). The membrane was processed as usual for immunoblots except that 
unspecific binding sites were blocked for at least 12 h in 5% non-fat milk in TBS. 
 
Table 14: Composition of a 4% - 20.5% Blue native polyacrylamide gradient gel. 
 Sample gel Gradient separation gel 
 4% T 4% T 20.5% T 
AB-Mix 0.33 ml 0.92 ml 3.75 ml 
3x gel buffer 1.33 ml 3.67 ml 3 ml 
H2O 2.33 ml 6.4 ml - 
50% glycerol   2.25 ml 
TEMED 40 µl 60 µl 40 µl 
10% APS* 4 µl 6 µl 4 µl 
 4 ml 11 ml 9 ml 
* prepared freshly 
 
AB-Mix (49.5% T, 3% C) 
48% (w/v) acrylamide 
1.5% (w/v) bisacrylamide 
filtered 
 
3x gel buffer 
75 mM imidazole/HCl pH7.0 
1.5 M 6-aminohexanoic acid 
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SB cathode buffer 
50 mM Tricine 
7.5 mM imidazole  
(resulting pH is around 7.0) 
0.002% Serva blue G250 
 
Electrode buffer (for semi-dry transfer) 
25 mM tricine 
7.5 mM imidazole  
(resulting pH is around 7.0) 
 
Anode buffer 
25 mM imidazole/HCl pH 7.0 
 
 
2.8.12 Immunoblots 
Generally, proteins were transferred onto nitrocellulose or PVDF membranes, depending 
on the analytical problem. The transfer was usually carried out using the wet-blot method 
(Towbin et al., 1979). Alternatively, for low molecular weight proteins (< 80 kDa), the 
faster semi-dry method was employed (Kyhse-Andersen, 1984). In either method, a 
sandwich is assembled consisting of the gel, the membrane and 3 gel blotting papers on 
each side. The proteins are electro-transferred in transfer buffer (wet-blot: 3 h at RT or 
overnight at 4°C, 30 V/250 mA; semi-dry: 45 min at RT, 15 V/2 A). 
After the transfer, the nitrocellulose was stained in Ponceau S solution for 1 min 
(optionally). The background was removed by washes in water. Complete destaining was 
accomplished by incubation in TBS. The PVDF membrane was stained in colloidal 
Coomassie-solution for 5 min. The background was removed by washes in destain 
solution. Complete destaining was obtained by incubation in methanol.  
Unspecific binding sites were blocked by incubation for 1 h in 5% milk (non-fat milk 
powder in TBS; 0.02% NaN3). The membrane was decorated with primary antibodies 
diluted usually in 5% milk for 1 h at RT or overnight at 4°C. The membrane was washed in 
TBST (3 x brief washes, 1 x 15 min, 3 x 5 min). The secondary antibody coupled to 
horseradish-peroxidase was diluted in TBST and incubated for 1 h at RT. After repeated 
washes in TBST, the signals were detected using either the ECL, ECL+ or ECL advance 
system (Amersham Bioscience) according to the manufacturer’s recommendations. The 
chemoluminescence was reported on ECL hyperfilms employing different exposure times. 
 
Transfer buffer: 
25 mM Tris 
192 mM glycine 
0.25% SDS 
20% methanol 
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2.8.13 Purification of recombinant Arf1p proteins with His6-tag from E. 
coli 
For the purification of ∆N17-Arf1p, ∆N17-Arf1p-Q71L or ∆N17-Arf1p-T31N, E. coli 
stocks were freshly streaked out. 50 ml of LBamp were inoculated with a single colony and 
incubated overnight at 37°C. 1.5 l LBamp were inoculated with the overnight culture and 
after 2 h of growth at 37°C, protein expression was induced by addition of 1 mM IPTG. 
After incubation for additional 3 h at 37°C, cells were harvested (10 min 6,000 rpm, GS-3 
rotor, 4°C) and washed in STE-buffer (10 min, 10,000 rpm, SS34-rotor, 4°C). The cell 
pellet was frozen in liquid nitrogen and stored at –70°C.  
The cell pellet was thawed on ice and resuspended in 20 ml STE-buffer. Lysozyme was 
added to 1 mg/ml final concentration and the suspension was gently agitated for 15 min at 
RT. After addition of 8 ml of cold Triton buffer, the cells were sonified with several 15 s 
pulses and intermittent incubations on ice. The lysis was checked under the microscope 
and the cell debris was removed by centrifugation (15 min, 20,000 rpm, SS34, 4°C). 2.5 ml 
of pre-equilibrated Ni-NTA-agarose slurry (30 min in 20 ml binding buffer at RT) were 
added to the supernatant and agitated for 1 h at 4°C. The Ni-NTA-agarose was sedimented 
(2 min, 4,000 rpm, Eppendorf 5810 R, 4°C) and washed with 3 x 10 ml binding buffer. 
The last suspension was transferred to a Polyprep column (Biorad). The proteins were 
eluted with 10 x 1 ml elution buffer. Fractions were analyzed by SDS-PAGE and 
Coomasie-blue staining, protein-containing fractions were pooled and dialyzed twice (2.5 l 
dialysis buffer, at least 6 h each). The protein concentration was determined and aliquots 
were frozen in liquid nitrogen and stored at –70°C. 
 
Triton buffer 
50 mM Tris/HCl pH 8.0 
0.2% Triton X-100 
100 mM MgCl2
Binding buffer 
20 mM HEPES/NaOH pH 7.4 
1 mM MgCl2 
1 mM DTT 
200 mM KCl 
20 mM imidazole 
 
Dialysis buffer 
20 mM HEPES/NaOH pH 7.4 
1 mM EDTA 
100 mM NaCl 
1 mM DTT 
2 mM MgCl2
Elution buffer 
20 mM HEPES/NaOH pH 7.4 
1 mM MgCl2 
1 mM DTT 
200 mM KCl 
500 mM imidazole 
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2.8.14 Purification of other recombinant His6-tagged proteins from E. 
coli 
Chs5p and Bfr1p were purified from E. coli under denaturing conditions in 8 M urea. The 
proteins were purified by Ni-NTA (Qiagen) using protocols provided by the manufacturer. 
Pab1p was purified from E. coli under native conditions as described previously (Deardorff 
and Sachs, 1997). 
 
2.8.15 Purification of recombinant wild-type Arf1p protein from E. coli 
The purification of recombinant myristoylated Arf1p from E. coli was performed as 
described before with minor modifications (Randazzo et al., 1992). An E. coli strain co-
transformed with plasmids for Arf1p and Nmt1p (N-myristoyl-transferase 1) was used. The 
glycerol stock was streaked out on LB 0.5x kan/0.5x carb and grown overnight. 40 ml 
LBkan/carb were inoculated and grown for 3 – 4 h at 37°C to an OD600 of about 0.75. 1.5 l 
LBkan/carb were inoculated with the pre-culture. After 2 – 3 h at 37°C the culture reached 
an OD600 of about 0.5. At this point, protein expression was induced by 1 mM IPTG and 
2.4 ml 125 mM myristic acid were added. After additional incubation for 3 – 5 h at 30°C, 
cells were harvested at an OD600 between 1 and 2 (10 min 6,000 rpm, GS-3 rotor, 4°C), 
washed in STE-buffer, and sedimented (10 min, 10,000 rpm, SS34-rotor, 4°C). The cell 
pellet was frozen in liquid nitrogen and stored at –70°C. Subsequently, the cell pellet was 
thawed on ice and resuspended in 30 ml STE-buffer with protease inhibitors (PMSF, 
pepstatin A, leupeptin). Lysozyme was added to 1 mg/ml final concentration and the 
suspension was gently agitated for 15 min at RT. After addition of 12 ml of cold Triton-
buffer, the cells were sonified with several 15 s pulses intermittent by incubations on ice.  
The lysate was centrifuged at 100,000 g centrifugation (1 h, 39,000 rpm, Ti 50.2-rotor, 
2°C). The supernatant was loaded on a 50 ml DEAE-Sephacel ion-exchange 
chromatography column, which was equilibrated in DEAE-buffer. The column was 
washed with 50 ml DEAE-buffer. The flow-through was fractionated (110 drops, 
approximately 3 ml). Five µl of the fractions were added to 200 µl Biorad protein assay 
reagent on a micro-titer-plate, the protein peak was visualized by the color shift of the 
Bradford reagent. Protein containing fractions were pooled. The column was regenerated 
with 50 ml 2 M NaCl, and subsequent washes in H20. The column was stored in 20% 
ethanol. Particles in the protein pool were removed by centrifugation at 100,000 g (30 min, 
39,000 rpm, Ti 50.2-rotor, 2°C). The supernatant was concentrated using a Centriprep YM-
10 (approximately 8 h, 4,000 rpm, Eppendorf 5810 R, 4°C) to less than 10 ml.  
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The protein solution was loaded on a gel filtration column (230 ml Sephacryl S-100), 
which was pre-equilibrated with dialysis buffer, and developed with dialysis buffer. Three 
ml fractions were collected overnight at a flow-rate of 0.4 ml/min. The column was 
regenerated by 2 column volumes of dialysis buffer. For storage, NaN3 was added to 
0.02%. The fractions of the gel filtration were analyzed by SDS-PAGE and Coomassie-
blue staining. Fractions that contained appropriate protein amounts of Arf1p were pooled 
and concentrated to less than 5 ml using a Centriprep YM-10. After determination of 
protein concentration, aliquots were frozen in liquid nitrogen and stored at –70°C. 
 
DEAE-Puffer: 
20 mM Tris/HCl pH 7.4 
50 mM NaCl  
1 mM EDTA 
1 mM DTT 
 
Triton buffer 
50 mM Tris/HCl pH 8.0 
0.2% Triton X-100 
100 mM MgCl2
Dialysis buffer 
20 mM HEPES/NaOH pH 7.4 
1 mM EDTA 
100 mM NaCl 
1 mM DTT 
2 mM MgCl2
 
 
2.8.16 Preparation of affinity material 
Proteins were covalently coupled to column material using NHS-Agarose (Amersham 
Bioscience). The carboxyl groups of the column material (with aminohexanoic acid as 
spacer) were activated by N-hydroxysuccinimid and reacted with amino groups of the 
proteins forming amide bonds. Coupling, blocking of non-reacted groups and washing was 
performed according to the manufacturer’s recommendations. The coupling efficiency was 
estimated by measuring the protein concentration in the flow-through.  
Peptides were covalently coupled to Ultralink Iodacetyl resin (Pierce). The terminal 
iodacetyl group of a 15 atom spacer reacted with sulfhydryl groups forming a thioether 
linkage. Coupling, blocking of non-reacted groups and washing was performed according 
to the manufacturer’s recommendations. The coupling efficiency was estimated by 
measuring the absorbances of the peptides in the BCA-assay before and after coupling.  
 
2.8.17 Differential Arf1p-affinity chromatography 
Recombinant ∆N17-Arf1p-Q71L and ∆N17-Arf1p-T31N were expressed in E. coli. Fifty 
mg of each protein were covalently coupled to 1.2 ml NHS-activated sepharose 4 fast flow 
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(Amersham Bioscience). For the affinity chromatography, the columns were pre-
equilibrated with 10 ml NE buffer. The nucleotide exchange was performed in 3 ml NE 
buffer with 200 µM of the corresponding nucleotide for 1 h at 37°C (GTP for Arf1p-Q71L, 
GDP for Arf1p-T31N). The control column without protein was treated in the same way as 
the Arf1p-Q71L-column. The columns were washed with 10 ml NS buffer. Yeast cytosol 
(125 mg) was allowed to bind for 1 h at 4°C. The columns were washed with 60 ml NS 
buffer (+ 0.1% Triton X-100) and subsequently with 10 ml pre-warmed exchange buffer 
containing 10 µM GXP. Proteins were eluted using 4 x 1 ml exchange buffer containing 
500 µM GX’P (GDP for Arf1p-Q71L, GTP for Arf1p-T31N). For the first elution, the 
columns were incubated for 30 min at 37°C, whereas for the following elution steps 10 
min were used. The samples were analyzed by SDS-PAGE and silver staining and 
immunoblotting. For protein identification by mass spectrometry, the elutions were TCA-
precipitated and separated on a large 10% SDS-poyacrylamide gel and stained by the 
Fairbanks method. Protein bands that were clearly enriched in one or the other eluate were 
cut out and subjected to mass spectrometric analysis. 
 
Nucleotide exchange buffer (NE) 
25 mM HEPES pH 7.7 
100 mM NaCl 
1 mM EDTA 
0.5 mM MgCl2 
0.1 % Na-cholate 
Nucleotide stabilization buffer (NS) 
20 mM HEPES pH 7.4 
100 mM NaCl 
1 mM DTT 
1 mM EDTA 
2 mM MgCl2
10 µM GXP 
 
2.8.18 Affinity purification of immunoglobulins 
Affinity purifications of immunoglobulins were carried out essentially as described 
previously (Harlow and Lane, 1988). Although the purification was performed at RT, all 
solutions were kept on ice. Ten ml of the antiserum were thawed on ice and diluted with 10 
ml PBS. The solution was filtered through a 0.2 µm membrane and passed three times over 
the appropriate affinity column (antigen covalently coupled to the resin). The column was 
washed with 20 ml Tris/HCl pH 7.5 and 20 ml Tris/HCl pH 7.5, 0.5 M NaCl. The first 
elution of the antibodies was carried out with 100 mM glycine pH 2.5. 10 x 1 ml fractions 
were collected in reaction tubes containing 100 mM Tris/HCl pH 8.0. The elution was 
performed rapidly and care was taken as to immediately neutralize the elutions. The 
column was washed with 10 ml 100 mM Tris/HCl pH 7.5. The second elution of high-
affinity antibodies was carried out with 10 x 1 ml 4.5 M MgCl2. The column was 
regenerated by washes with TBS and stored at 4°C with 0.02% NaN3. 
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Appropriate fractions of the glycine and MgCl2 elutions were pooled separately and 
dialyzed twice against PBS (2 x 2.5 l, at least 6 h each). The protein concentration was 
determined. Aliquots were frozen in liquid nitrogen and stored at –70°C. The quality and 
titers of the affinity purified antibodies were tested in immunoblots, in 
immunoprecipitations and in immunofluorescence. 
 
2.8.19 In-gel digestion and mass spectrometric identification of proteins 
The in-gel digestions were carried out by Jörn Dengjel. Mass spectrometric analysis of the 
trypric digests were performed by Jörn Dengjel and Markus Schirle. Both are present and 
past members of the AG Rammensee, University of Tübingen. 
In-gel tryptic digestions were performed as described previously (Shevchenko et al., 1996) 
and modified as outlined below. Briefly, protein bands were excised from gels, fully 
destained, and digested for 3 h with porcine trypsin (sequencing grade, modified; Promega, 
Madison, WI) at a concentration of 67 ng/µl in 25 mM ammonium bicarbonate, pH 8.1, at 
37°C. Before peptide mass mapping and sequencing of tryptic fragments by tandem mass 
spectrometry, peptide mixtures were extracted from gels by 1% formic acid followed by 
two changes of 50% acetonitrile. The combined extracts were vacuum-dried until only 1 – 
2 µl was left, and the peptides were purified by ZipTip according to the manufacturer's 
instructions (Millipore, Bedford, MA). MALDI-time of flight (TOF) analysis from the 
matrix α-cyano-4-hydroxycinnamic acid/nitrocellulose prepared on the target by using the 
fast evaporation method (Arnott et al., 1998) was performed on a Bruker Reflex III 
(Bruker Daltonik, Bremen, Germany) equipped with a N2 337-nm laser and gridless pulsed 
ion extraction. Sequence verifications of some fragments were performed by 
nanoelectrospray tandem mass spectrometry on either a Q-Tof I mass spectrometer 
(Micromass, Manchester, England) or a QStar Pulsar i Qqoa Tof mass spectrometer 
(Applied Biosystems-MDS Sciex, Weiterstadt, Germany) equipped with a nanoflow 
electrospray ionization source. Gold-coated glass capillary nanoflow needles were obtained 
from Protana (Odense, Denmark) (type medium NanoES spray capillaries). Database 
searches (NCBInr, nonredundant protein database) were done using the MASCOT 
software (Perkins et al., 1999). 
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2.8.20 In vitro Golgi-budding assay 
2.8.20.1 With purified coat components 
The Golgi budding assay was performed as described by Spang and Schekman (1998) with 
minor modifications. For the Golgi budding reactions, membranes were incubated with 0.1 
mM GTP or GTPγS, coatomer (125 µg/ml which was available in the laboratory), and 
wild-type, myristoylated Arf1p (25 µg/ml) at 30°C for 30 min in a total volume of 400 µl. 
After chilling on ice for 5 min, the samples were loaded on a Ficoll-sucrose gradient 
consisting of 0.3 ml 60% (w/w) sucrose, 0.8 ml 7.5 %, 1 ml 5, 4, and 3 % and 0.8 ml 2% 
(w/w) Ficoll in 15 % (w/w) sucrose in 20 mM HEPES/KOH pH 6.8, 5 mM Mg(Ac)2. The 
vesicles were separated from the Golgi apparatus by centrifugation for 2 h at 35,000 rpm 
(SW50.1 rotor, 2°C). Fractions (400 µl) were collected from the top. Fractions 4-6 of the 
gradient were pooled, mixed with an equal volume of 80% (w/v) Nycodenz in B88*, and 
overlaid with 600 µl of 35, 25, 20, and 15% and 400 µl 10% (w/v) Nycodenz in B88*. 
Gradients were centrifuged for 16 h at 40,000 rpm (SW50.1 rotor, 2°C). Fractions (300 µl) 
were collected from the top, TCA precipitated, and analyzed by immunoblot.  
 
B88 
20 mM HEPES/KOH pH 6.8 
5 mM Mg(Ac)2
150 mM KAc 
250 mM sorbitol 
 
B88* 
20 mM HEPES/KOH pH 6.8 
5 mM Mg(Ac)2
150 mM KAc 
ATP-regeneration system 
55 mg ATP 
1.31 g creatine phosphate 
add cold B88 to near 10 ml 
adjust pH to 6.8 with 1 M KOH (~75 µl) 
add 20 mg creatine phosphokinase 
adjust to 10 ml with B88 
aliquot and freeze in liquid N2, store at –80°C 
 
2.8.20.2 With cytosol 
For the Golgi budding reactions using cytosol, 150 µl Golgi membranes were incubated 
with 0.2 mM GTPγS, 75 µl cytosol and 10 µl ATP-regeneration system at 30°C for 30 min 
in a total volume of 240 µl. After chilling on ice and dilution with 160 µl B88, the samples 
were loaded on a Ficoll-sucrose gradient consisting of 0.3 ml 60% (w/w) sucrose, 0.8 ml 
7.5 %, 1 ml 5, 4, and 3 % and 0.8 ml 2% (w/w) Ficoll in 15 % (w/w) sucrose in 20 mM 
HEPES/KOH pH 6.8, 5 mM Mg(Ac)2. Vesicles were separated from the Golgi apparatus 
by centrifugation for 2 h at 35,000 rpm (SW50.1 rotor, 2°C). Fractions (400 µl) were 
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collected from the top. Fractions 4-6 of the gradients were pooled, mixed with an equal 
volume of 80% (w/v) Nycodenz in B88*, and overlaid with 1.6 ml 30%, 0.6 ml 20% and 
0.6 ml 10% (w/v) Nycodenz in B88*. The gradients were centrifuged for 16 h at 40,000 
rpm (SW50.1 rotor, 2°C). Fractions (300 µl for fractions 1-10 and 1.2 ml for fractions 11 
and 12) were collected from the top, precipitated by TCA, resolved on SDS-PAGE and 
analyzed by immunoblot. 
 
2.8.21 Co-immunoprecipitation 
Co-immunoprecipitation experiments were performed essentially as described previously 
(Harlow and Lane, 1988). To prepare yeast lysates for co-immuno-precipitations, 10 OD600 
of logarithmically growing yeast cells were incubated in 2 ml DTT-buffer (10 mM 
Tris/HCl pH 9.4, 10 mM DTT) for 5 min at 30°C. The buffer was replaced by 2 ml SP-
buffer (0.76% YPD, 0.7 M sorbitol, 10 mM Tris/HCl pH 7.5), supplemented with 30 µl 
Zymolyase T-20 (10 mg/ml). Cells were spheroplasted for 40 min at 30°C. The 
spheroplasts were sedimented (2 min, 1,000 x g) and lysed in B150-TW20. The lysates 
were cleared by centrifugation (10 min, 16,000 x g, RT).  
Immunoprecitpitations were performed using either 10 µg affinity-purified α-Arf1p 
antibodies or affinity-purified rabbit IgGs, 10 µl α-Chs5p serum or pre-immune serum, 5 
µl α-HA.11 (Eurogentec, mouse monoclonal), 5 µl α-Myc (9E10, Sigma, mouse 
monoclonal), 5 µl α-AU5 (Abcam, rabbit polyclonal) or 5 µl α-GFP (Torrey Pines, rabbit 
polyclonal) per 1 ml cleared lysate for 1 hr at 4°C. The beads were washed with B150-
TW20 (the last wash was in B150 buffer), and resuspended in 50 µl Laemmli-buffer. 
Aliquots were analyzed by SDS-PAGE and subsequent immunoblotting. 
The co-immunoprecipitations probing the Arf1p-Pab1p interactions were performed with 
10 µl α-Arf1p serum, 10µl α-Coatomer serum or control serum per 1 ml lysate for 1 hr at 
4°C. In other cases, 7 µl α-HA.11 (Eurogentec, mouse monoclonal) or 5 µl α-myc 9E10 
(9E10, Sigma, mouse monoclonal) were added to the lysate. The beads were washed, and 
resuspended in 50 µl Laemmli-buffer. Aliquots were analyzed by SDS-PAGE and 
subsequent immunoblotting. 
For Bfr1p co-immunoprecipitation, the lysate was incubated with 10 µg of affinity purified 
anti-Arf1p antibody cross-linked to 25 µl ProteinA magnetic beads (NEB) using DMP 
(Pierce) according to the manufacturer’s recommendations. The antibody-protein 
interaction was severed by elution with 0.2 M glycin pH 2.5. 
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For RNA digestion experiments, the lysates were treated for 35 min at 4°C with 200 µg 
RNase A (Roche) or 500 U RNase-free DNase I and centrifuged (10 min, 14,000 rpm, 
Eppendorf 5417 R, 4°C) before precipitation.  
 
B150-TW20 
20 mM HEPES/KOH pH 6.8 
150 mM KAc 
5 mM Mg(Ac)2
1% Tween-20 
B150 
20 mM HEPES/KOH pH 6.8 
150 mM KAc 
5 mM Mg(Ac)2
 
 
 
2.9 Molecular biological methods 
 
Standard techniques for nucleic acid manipulations were used throughout in this study 
(Sambrook et al., 1989). 
 
2.9.1 Transformation of E. coli 
Routinely, E. coli cells were transformed chemically. Usually, 20 µl chemically competent 
cells (which were available in the laboratory) were thawed on ice and mixed with 0.3 µl 
plasmid DNA (or 50 µl cells with 5 µl of a ligation reaction). The cells were heat-shocked 
for 30 s at 42°C and immediately placed on ice. SOC-medium (240 µl) was added to the 
cells. The mixture was incubated on a shaker for 30 min at 37°C before the cells were 
plated out on selection plates. In case a plasmid with ampicillin-resistance was 
transformed, this last incubation step was not necessary.  
Alternatively, E. coli cells were transformed by electroporation (Dower et al., 1988). Fifty 
µl of electrocompetent cells (which were available in the laboratory) were thawed on ice 
and mixed with DNA. The mixture was pipetted in an electroporation cuvette which had 
been placed on ice before. The electroporation was performed with 2,500 V, 960 µF and 
200 Ω. After the electroporation pulse, 1 ml of SOC-medium was added immediately to 
the cuvette. The cell suspension was incubated on a shaker at 37°C for 30 – 60 min before 
the cells were plated out on selection plates. 
 
2.9.2 Plasmid preparation from E. coli 
Plasmid preparations were performed according to the alkaline lysis method described by 
Birnboim and Doly (1979) with minor modifications. Routinely, 1.5 ml of an overnight 
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culture were harvested (5 min, 14,000 rpm, Eppendorf 5417 R, 4°C). Cells were 
resuspended in 300 µl P1-buffer and 300 µl P2-buffer was added. After incubation for 5 
min at RT, 300 µl of buffer P3 were added. The solution was cleared by centrifugation (10 
min, 14,000 rpm, Eppendorf 5417 R, 4°C). The plasmid DNA in the supernatant was 
precipitated by adding 600 µl isopropanol and subsequent centrifugation (10 min, 14,000 
rpm, Eppendorf 5417 R, 4°C). The resulting pellet was washed with 1 ml 70% ethanol and 
spun again (5 min, 14,000 rpm, Eppendorf 5417 R, 4°C). The pellet was dried at 65°C for 
about 5 min and the DNA was dissolved in 20 µl H20 and stored at –20°C. 
In case the DNA was to be used for sequencing reactions or larger amounts were needed, 
the Qiagen plasmid mini kit or the Qiagen HiSpeed plasmid midi kit were used according 
to the supplier’s recommendations. 
 
P1-buffer 
20 mM Tris/HCl pH 8.0 
10 mM EDTA 
100 µg/ml RNase 
 
P2-buffer 
0.2 M NaOH 
1% SDS 
P3-buffer 
3 M KAc pH 5.5 
 
 
2.9.3 Determination of nucleic acid concentration 
The concentration of nucleic acids was determined using a spectrophotometer (Beckman 
DU 640). The nucleic acids were diluted in H2O and the absorption at 260 nm was 
determined. It was assumed that an absorption of 1.0 at 260 nm corresponds to 50 µg/ml 
double-stranded DNA or 40 µg/ml single-stranded RNA.  
 
2.9.4 Restriction digest of DNA 
Plasmid preperations were analyzed by restriction digest and agarose gel-electrophoresis 
with subsequent ethidium bromide staining. The guidelines provided the supplier’s of 
restriction endonucleases (NEB or Roche) for enzymatic digests were followed. For 
purification of restriction digest for cloning purposes or gel-elution of DNA fragments, the 
purifications kits from Qiagen (PCR purification kit/Gel extraction kit) were used 
according to the manufacturer’s recommendations.  
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2.9.5 Cloning of DNA 
The DNA fragment for (sub-)cloning was obtained by restriction digest of plasmid DNA or 
by PCR amplification from genomic yeast DNA. In case of PCR amplification, suitable 
restriction site sequences were included into the primers. If the gene was to be placed 
under the control of endogenous regulatory sequences, at least 500 bp upstream the start 
codon were co-amplified. Purified vector DNA and purified DNA insert were ligated using 
the rapid ligation kit from Roche following the manufacturer’s recommendations. 
Occasionally, 5’-dephosphorylation of the vector was necessary to prevent excessive re-
ligation. Alternatively, TOPO cloning kits (Invitrogen) were used according to the 
manufacturer’s recommendation. Positive clones were identified by restriction digest and 
verified by DNA-sequencing. 
 
2.9.6 Polymerase-chain-reaction (PCR) 
To produce DNA fragments for DNA cloning or homologous recombination, polymerase-
chain-reaction was used (Mullis et al., 1986). The proof-reading Expand High Fidelity 
System (Roche) was used for preparative production of DNA. A typical reaction contained 
37 µl H20, 5 µl 10x reaction buffer, 5 µl 2 mM dNTPs, 2 x 1 µl 10 mM oligonucleotide 
primer and 1 µl template DNA. Usually, 35 cycles were performed for amplification. The 
annealing temperature was typically between 52°C and 56°C and 1 min/1,000 bp was 
allowed for elongation.  
 
2.9.7 Reverse-Transcription-PCR (RT-PCR) 
For RT-PCR, the beads and the lysates of co-immunoprecipitation experiments were 
extracted as described by Gonsalvez et al. (2003). Briefly, the beads were extracted with 
RNA-elution buffer (50 mM Tris/HCl, 100 mM NaCl, 10 mM EDTA, 1%SDS) and 
heating to 65°C for 5 min. Subsequently, RNA was purified by Phenol/Chloroform 
extraction and precipitated with Pellet Paint (Merck). DNA was digested by RNase free 
RQ1-DNase (Promega) for 15 min at 37°C in the presence of RNasin (Promega). The 
RNA was re-extracted, re-precipitated and re-dissolved in 50 µl RNase-free H2O. RT-PCR 
was performed on 2 µl aliquots using the One-Step RT-PCR-Kit (Qiagen) for 25 or 30 
cycles using primers specific for certain mRNAs and the conditions recommended by the 
manufacturer. 20 µl of the reactions were analyzed on 3% Metaphor agarose gels.  
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2.9.8 DNA-sequencing 
DNA was sequenced by the dideoxynucleotide method (Sanger et al., 1977) using four 
fluorescently labeled dideoxynucleotides. The sequencing reaction contained 0.5 µl big 
dye terminator mix V3.1, 2 µl 5x BDT-reaction buffer, 0.5 µl 10 mM oligonucleotide-
primer and 150 – 300 ng plasmid DNA or 5 – 20 ng PCR-product in a final volume of 10 
µl. After denaturation for 20 s at 95°C, 28 cycles were carried out: 20 s 96°C, 10 s 50°C, 4 
min 60°C. The reaction was stored at –20°C until it was analyzed by capillary 
electrophoresis by the in house sequencing service (AG Stefan Schuster). The DNA-
sequence was analyzed using the Seqman II software (DNASTAR). 
 
2.9.9 Gylcerol stocks 
For the preparation of E. coli glycerol stocks, 750 µl of an overnight culture were mixed 
with 500 µl 50% glycerol and stored at –70°C. For the preparation of yeast glycerol stocks, 
yeast cells streaked out as rectangle were grown on appropriate plates. The plates were 
incubated until a dense lawn of cells was obtained. The cells were transferred with a sterile 
glass pipette into 800 µl 15% glycerol and stored at –70°C. 
 
2.9.10 Chromosomal manipulations of yeast cells 
To delete or manipulate genes in yeast cells, the methods described by Guldener et al. 
(1996), Knop et al. (1999), De Antoni and Gallwitz (2000), and Gueldener et al. (2002) 
were followed. Briefly, preparative PCR was performed on template plasmids with primers 
having 45 bp 5’-overhangs homologous to the desired target site in the yeast genome. The 
PCR-product was transformed directly into yeast cells without further purification. Cells 
were selected for with the corresponding auxotrophy/resistance markers, correct 
integrations were confirmed by analytical colony-PCR. Wherever possible, the expression 
was checked by immunoblotting of total yeast lysates. Occasionally, the chromosomal 
manipulation had to be sequenced. In this case, the PCR product using the proof-reading 
Expand PCR system (Roche) on genomic yeast DNA was sequenced to confirm the 
desired manipulation.  
 
2.9.11 Preparation of genomic yeast DNA 
Crude yeast DNA was obtained by following the procedure of Hoffman and Winston 
(1987): Five ml of yeast culture were grown to saturation. The cells were harvested and 
resuspended in 200 µl buffer A. Approximately 200 µl glass beads and 200 µl 
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phenol:chloroform:isoamylalcohol 25:24:1 were added. After vigorous vortexing for 5 
min, 200 µl H2O were added. Phase separation was accomplished by centrifugation (5 min, 
20,000 g, 4°C). The aqueous phase was transferred to a fresh reaction tube and 1 ml 100% 
EtOH (RT) was added. The DNA was pelleted by centrifugation for 2 min (20,000 g). The 
resulting DNA pellet was dried at 65°C for about 5 min and resuspended in 40 µl H2O. 
 
Buffer A: 
10 mM Tris/HCl pH 8.0 
100 mM NaCl 
1 mM EDTA 
2% Triton X-100 
1% SDS 
 
2.9.12 Yeast transformation 
Yeast cells were transformed by a high-efficiency lithium acetate transformation method 
(Gietz et al., 1995). Cells were grown overnight in liquid culture to logarithmic phase. Best 
results were obtained with an OD600 of about 0.1. 5 OD600 of cells were harvested and 
washed once in sterile water. The cells were incubated for 5 min at 30°C in 100 mM LiAc. 
Subsequently, they were resuspended in 360 µl transformation mix and mixed thoroughly 
for 1 min. A heat-shock was employed for 40 min at 42°C, after which the cells were 
pelleted (10 s, 13,000 rpm, Eppendorf 5417 R, 4°C). The cell pellet was resuspended in 1 
ml sterile water and 200 µl aliquots were plated on appropriate selection plates. Colonies 
obtained were subjected to a second round of selection.  
In case a kanamycin resistance cassette was transformed, cells were first incubated in YPD 
for 3 h at 30°C before plating on YPD-G418 plates. Fast growing colonies were chosen for 
the second round of selection. Sometimes, replica plating was necessary to allow for the 
selection of stable transformants.  
 
Transformation mix 
240 µl 50% (w/v) PEG (AMW 3.350) 
36 µl 1 M LiAc 
50 µl 2 mg/ml single-stranded salmon sperm DNA  
(obtained by heating for 5 min at 95°C and fast cooling in an ice/water bath) 
5 µl of PCR product or 0.25 µl plasmid DNA 
ad 360 µl with H20  
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2.9.13 Analytical PCR of yeast colonies 
Analytical PCR of yeast colonies was performed to confirm chromosomal manipulations 
of yeast cells or to determine the mating type after mating or sporulation. The primers were 
chosen in a way that in either case a PCR product was obtained and that after agarose gel 
electrophoresis the altered size of the product (as compared to a wild-type colony) 
confirmed the chromosomal manipulation. A typical reaction contained 18.5 µl H2O, 2.5 µl 
10x reaction buffer, 2.5 µl 2 mM dNTPs, 2x 0.5 µl 10 µM oligonucleotide-primer, 0.3 µl 
Taq DNA-polymerase (Roche) and a small portion of a yeast colony. Usually, the 
annealing temperature was between 52°C and 56°C, the elongation time was between 3 
min and 6 min and 35 – 40 cylces were used for amplification. Routinely, 20 µl of the 
reaction were analyzed by agarose gel-electrophoresis. For mating type PCRs (Huxley et 
al., 1990), 10 µl of the reaction were resolved on a 1.2% agarose gel.  
 
2.9.14 Two-hybrid assay 
The two-hybrid assay was performed with the LexA two-hybrid system (Estojak et al., 
1995; Golemis and Khazak, 1997). The yeast reporter strain EGY48 as well as the bait 
plasmid pEG202, the prey plasmid pJG4-5 and the reporter plasmid pSH18-34 (Golemis et 
al., 1996) were used. Bait vector with ∆N17-ARF1-Q71L and prey vector with GLO3 as a 
positive control were obtained from Rainer Duden (Eugster et al., 2000). 
PAB1 and PUB1 were amplified from genomic yeast DNA by PCR carrying restriction 
sites for EcoRI and XhoI and cloned into pJG4-5. Constructs were verified by DNA 
sequencing.  
The constructs were co-transformed into the EGY48 reporter strain. Transformants were 
selected on HC-HIS/-TRP/-URA plates. Four independent transformants were assessed for 
growth on HC-HIS/-TRP/-URA/-LEU plates containing 2% galactose and 1% raffinose. 
The strains were incubated for 4 days at 30 °C.  
 
2.9.15 Digoxigenin-labelling of an ASH1-antisense-RNA-probe 
A PCR was perfomed on genomic DNA with primers MT-A31 and MT-A32. The PCR-
product was purified and an in vitro-transcription using Ambion MEGAscript T7 kit was 
performed. A ratio of 1:5.6 of Dig-11-UTP:UTP was used. The concentration was 
determined by absorption at 260 nm. The integrity of the probe was checked by 
conventional agarose gel-electrophoresis. The probe was divided in 0.5 µg aliquots (in 
DEPC-treated TE), immediately frozen in liquid nitrogen, and stored at –70°C. 
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2.9.16 Northern Blot analysis 
Cells were grown overnight to logarithmic phase. Where necessary, cells were shifted for 1 
hour to the non-permissive temperature. Cells were harvested, frozen in liquid nitrogen and 
stored at –20°C until further analysis. Total RNA was extracted using the RNeasy kit from 
Qiagen using the glass-bead lysis protocol provided by the manufacturer. RNA was 
precipitated using pellet paint co-precipitant (Merck) and resuspended in a smaller volume 
of RNA-buffer. The RNA was resolved on low-formaldehyde 1.2% agarose gels. To cast 
the gels, 0.6 g agarose were boiled in 43.5 ml H2O. After cooling to about 60°C, 5 ml 10x 
MOPS and 1.5 ml 37% formaldehyde (pH >4) were added in the fume-hood. Equal 
amounts of RNA (25 µg per lane) in up to 5 µl were mixed with 15 µl RNA-sample buffer 
and heated to 65°C for 15 min. The samples were placed on ice and immediately 20 µl 
were loaded per lane. The electrophoresis was performed in 1x MOPS at 50 V. After 
electrophoresis, the gel was washed in H2O (3 x 5 min) and finally for 15 min in 10x SSC. 
The RNA was transfered overnight in 10x SSC onto Hybond N+ membrane by capillary 
blotting as described previously (Sambrook et al., 1989). The RNA was crosslinked to the 
damp membrane using the Stratalinker 1800 UV Crosslinker in the autocrosslink mode. 
The membrane was stained with methylene blue stain, washed in water and photographed 
for documentation. To prepare Northern blot probes, the AlkPhos direct labeling kit 
(Amersham Bioscience) was used according to the manufacturer’s recommendations. 
Briefly, a heat-stable alkaline phosphatase was directly crosslinked to a heat-denatured 
PCR-product. After hybridization at 60°C, the alkaline phosphatase activity was detected 
using CDP-Star substrate (Amersham Bioscience) and the chemoluminescence was 
reported on ECL Hyperfilm.  
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RNA-buffer 
10 mM Tris/HCl pH 7.4 
1 mM EDTA 
0.2% SDS 
 
10x MOPS 
230 mM MOPS/NaOH pH 7.0 
50 mM NaAC 
10 mM EDTA 
RNA-loading buffer 
1 mM EDTA/NaOH pH 8.0 
0.25% bromphenol blue 
0.25% xylene cyanol 
50% glycerol 
 
RNA-sample buffer 
5/3 µl 10x MOPS 
3 µl 37% formaldehyde 
7 µl formamide 
10/3 µl RNA-loading buffer 
 
10 x SSC 
150 mM Na-citrate/NaOH pH 7.0 
1.5 M NaCl 
 
Methylene blue stain 
0.5 M NaAc/HAc pH 5.5 
0.04% methylene blue 
For all solutions, DEPC-treated H2O was used and recommendations for working with 
RNA were followed (Sambrook et al., 1989).  
 
 
2.10 Cell biological methods 
2.10.1 Actin cytoskeleton staining 
Actin cytoskeleton staining was performed essentially as described previously (Adams and 
Pringle, 1991). Cells were grown overnight to logarithmic phase and fixed directly in 
liquid medium by addition of 37% formaldehyde to a final concentration of 4.4% and 
incubation for 30 min at RT under gentle agitation. The cells were washed twice with PBS 
containing 1 mg/ml BSA (2 min, 3,000 rpm, Eppendorf 5810 R; 30 s, 13,000 rpm, 
Eppendorf 5417 R). The cell pellet was resuspended in 25 µl PBS containing 1 mg/ml 
BSA and 5 µl of rhodamine-phalloidin were added. After incubation for 1 h at RT in the 
dark, cells were washed three times and resuspended in 500 µl PBS containing 1 mg/ml 
BSA. An aliquot was allowed to settle for 15 – 30 min on polyethylenimine-treated multi-
well slides. The slides were washed briefly in PBS, Citifluor was added and the coverslips 
were sealed with nail-polish. Slides were stored at –20°C. The rhodamine fluorescence was 
observed by epi-fluorescence microscopy using the Cy3 channel on an Axioplan 2 
fluorescence microscope from Zeiss. Pictures were taken by Axiocam MRm using 
Axiovision software. Image processing was performed using Adobe Photoshop 7.0.  
 
2.10.2 Indirect immunofluorescence microscopy 
Indirect immunofluorescence microscopy was performed essentially as described 
previously (Pringle et al., 1991). Cells were grown overnight to logarithmic phase and 
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fixed directly in the growth medium by adding 2 ml 37% formaldehyde to 18 ml culture 
and incubation for 1 h at RT under gentle agitation. The cells were washed twice with PBS 
(2 min, 3,000 rpm, Eppendorf 5810 R; 30 s, 13,000 rpm, Eppendorf 5417 R).The cell pellet 
was resuspended with 1 ml 100 mM KPi pH 7.0, 1.2 M sorbitol and  2 µl β-
mercaptoethanol were added. After incubation for 5 min at RT, the cells were 
spheroplasted by addition of 10 µl zymolyase T-100 suspension (10 mg/ml) and incubation 
for 15 min at 37°C. The cells were washed twice with 100 mM KPi pH 7.0, 1.2 M sorbitol 
and resuspended in 500 µl of the same buffer. An aliquot was allowed to settle for 15 – 30 
min on polyethylenimine-treated multi-well slides. The slides were briefly washed in PBS 
(5 min). Blocking was carried out by incubation for 30 min in 1% BSA in PBS or in 5% 
horse serum in 100 mM Tris/HCl pH 7.5, 150 mM NaCl. The primary antibody was 
diluted in the same solution. After incubation with the primary antibody in a wet chamber 
for 1 h at RT or overnight at 4°C, the slides were washed with PBS (1 x 15 min, 3 x 5 
min). The secondary antibody was incubated for 1 h at RT in the dark in a wet chamber, 
after which the slides were washed again with PBS. Sometimes, DAPI staining was 
performed at this stage (5 min in 1 µg/ml DAPI). The slides were briefly washed in water, 
Citifluor was added and slides were sealed with nail-polish. Slides were stored at –20°C. 
Epi-fluorecence microscopy was performed on an Axioplan 2 fluorescence microscope 
from Zeiss. Pictures were taken by Axiocam MRm using Axiovision software. Image 
processing was performed using Adobe Photoshop 7.0.  
 
2.10.3 Fluorescence microscopy of GFP fusion proteins in living cells 
Cells were grown overnight to logarithmic phase in the appropriate selection medium. 
YPD-medium contained 50 mg/l adenine to suppress cellular autofluorescence. An aliquot 
was taken from liquid culture (when necessary briefly washed in H2O) and visualized 
directly under an Axioplan 2 fluorescence microscope from Zeiss using the FITC-filter. 
Pictures were taken by Axiocam MRm using Axiovision software. Image processing was 
performed using Adobe Photoshop 7.0.  
 
2.10.4 In vivo RNA-localization assay 
For the visualization of ASH1-RNA localization by GFP particles, the reporter system by 
Bertrand et al. (1998), was used. Cells were transformed with the plasmids pG14-MS2-
GFP and YEP195-Lz-MS2-ASH1-3’UTR and grown overnight in HC-Leu/-Ura with 2% 
glucose. They were washed and diluted in HC-Leu/-Ura with 2% raffinose and 3% 
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galactose and grown for 4 h at 30°C upon which the cultures were divided and one half 
was shifted for 3 h to 16°C. Cells were immobilized on slides and inspected under the 
fluorescence microscope (Axioplan 2 fluorescence microscope from Zeiss using the FITC-
filter). Pictures were taken by Axiocam MRm using Axiovision software. Image 
processing was performed using Adobe Photoshop 7.0. For the evaluation, only those cells 
were taken into account which had a clearly visible green spot corresponding to the ASH1-
GFP reporter particle. At least 100 cells per experiment were counted. 
 
2.10.5 Mating of yeast cells  
Liquid YPD medium was inoculated with a small amount of cells of both mating types. 
After incubation for 12 – 24 h, cells were plated out on appropriate selection plates. In 
cases in which selection was not possible, cells were singled out and the mating type was 
determined by analytical colony PCR (Huxley et al., 1990). Quantitative mating assays to 
measure mating efficiency were carried out as described previously (Santos et al., 1997).  
 
2.10.6 Mating type switching 
Mating type switching of yeast cells was performed as described previously (Davis, 1997). 
Cells were transformed with the plasmid pCY204 bearing the HO-endonuclease under its 
endogenous promoter. The plasmid was subsequently counter-selected for by growth on 5-
FOA plates. The mating type of colonies obtained was determined by analytical colony-
PCR (Huxley et al., 1990). 
 
2.10.7 Sporulation of yeast cells 
Cells from a stationary liquid culture were harvested and plated on Spo- and Super Spo-
plates. The plates were incubated at 23°C or 30°C for 5 – 10 days. The sporulation was 
monitored by examination of a small amount of cells under the light microscope.  
 
2.10.8 Tetrade dissection 
A small amount of cells was scraped from a plate with a high sporulation efficiency and 
resuspended in 100 µl sterile H2O. The spore wall was digested by addition of 5 µl 
zymolyase T-20 suspension (2 mg/ml) for 2 – 5 min at RT. Samples were taken during that 
time and streaked on a YPD plate. The tetrads were dissected using a dissecting scope as 
described by Sherman and Hicks (1991). The YPD plate was incubated at 30°C until all 
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colonies reached a size sufficient for replica plating. The genotype was assessed by replica 
plating on different selection plates and analytical mating type PCR (Huxley et al., 1990). 
 
2.10.9 In situ hybridization of ASH1-mRNA 
In situ ASH1-RNA hybridization with digoxigenin-labeled ASH1 antisense probe was 
performed essentially as described previously (Takizawa et al., 1997). Cells were grown 
overnight to logarithmic phase. When necessary, cells were shifted for 1 hour to the non-
permissive temperature. Cells were directly fixed in liquid medium by adding 2 ml 37% 
formaldehyde to 18 ml culture and incubation for 1 h at RT under gentle agitation. The 
cells were washed twice in PBS (2 min, 3,000 rpm, Eppendorf 5810 R; 30 s, 13,000 rpm, 
Eppendorf 5417 R) and resuspended in 1 ml 100 mM KPi pH 7.0, 1.2 M sorbitol. β-
mercaptoethanol (2 µl) was added. After incubation for 5 min at RT, the cells were 
spheroplasted by addition of 4 µl of zymolyase T-100 suspension (10 mg/ml) for 20 min at 
37°C. Cells were washed twice with 100 mM KPi pH 7.0, 1.2 M sorbitol and resuspended 
in 500 µl of the same buffer. An aliquot was allowed to settle for 15 – 30 min on 
polyethylenimine-treated multi-well slides. The slides were washed twice with 50% 
formamide, 5x SSC for 5 min. Slides were put in a chamber wetted with 50% formamide, 
5x SSC. The cells were incubated with hybridization mix without probe for 1 h at RT in 
the chamber for pre-hybridization. The hybridization mix was replaced by digoxigenin-
labelled ASH1-mRNA antisense probe (0.5 µg/ml in hybridization mix) and the slides 
were incubated at 37°C overnight. Slides were rinsed with 0.2x SSC and incubated with 
0.2x SSC for 1 h at RT in a humid chamber. Blocking solution was applied for 30 min at 
RT. Fab-fragments of antibodies directed against digoxigenin and covalently coupled to 
alkaline phosphatase were diluted 1:5.000 in blocking solution and applied to the cells for 
1 h at 37°C. Slides were rinsed with washing buffer, washed 3 x 5 min in washing buffer, 
and washed 2 x 5 min in detection buffer. The HNPP/Fast Red TR mix (Roche) was 
applied for 30 min at RT after which slides were washed with water (1 x 10 min, 3 x 5 
min). Citifluor was pipetted onto the slides and they were sealed by nail polish. The slides 
were stored at –70°C. The Cy3-filter of the Axioplan 2 fluorescence microscope from 
Zeiss was used. Pictures were taken by Axiocam MRm using Axiovision software. Image 
processing was performed using Adobe Photoshop 7.0. At least 100 cells were counted for 
each condition. 
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Hybridization mix 
50% formamide 
5x SSC 
1 mg/ml yeast tRNA 
100 µg/ml heparin 
1x Denhardt’s reagent 
0.1% Tween-20 
0.1% Triton X-100 
5 mM EDTA 
 
Blocking solution 
5% horse serum 
100 mM Tris/HCl pH 7.5 
150 mM NaCl 
 
Washing buffer 
100 mM Tris/HCl pH 7.5 
150 mM NaCl 
0.05% Tween-20 
 
Detection buffer 
100 mM Tris/HCl pH 8.0 
100 mM NaCl 
10 mM MgCl2
 
Fast Red TR solution 
25 mg/ml in H2O 
prepared freshly 
 
HNPP/Fast Red TR mix 
10 µl HNPP (10 mg/ml in DMF) 
10 µl Fast Red TR solution 
1 ml detection buffer 
prepared freshly  
filtered through 0.2 µm nylon membrane 
 
 
2.10.10 Analysis of budding pattern and staining of cell wall chitin 
Analysis of the budding pattern and staining of cell wall chitin was carried out as described 
previously (Lord et al., 2002). A stationary yeast liquid culture was diluted and grown for 
at least 16 h to logarithmic phase. Cells were fixed directly in growth medium by adding 2 
ml 37% formaldehyde to 18 ml culture and incubation for 1 h at RT under gentle agitation. 
Cells were washed twice in H2O, resuspended in 250 µl 1 mg/ml calcofluor white solution 
and incubated for 5 min at RT. The cells were washed twice with H2O and resuspended in 
1 ml H2O and stored at 4°C (up to several months). For analysis of budding pattern, a small 
aliquot was squashed between slide and coverslip as to bring the bud scars of one cell into 
one focal plane and to facilitate microscopy. Cells were observed using DAPI filter under 
the epi-fluorescence microscope (Axioplan 2 fluorescence microscope from Zeiss. Pictures 
were taken by Axiocam MRm using Axiovision software. Image processing was 
performed using Adobe Photoshop 7.0). Only cells were scored with no more than 4 bud 
scars.  
 
2.10.11 Drop assays 
Strains were grown overnight to logarithmic phase. After adjusting to equal cell 
concentrations, four serial dilutions (1:10) were dropped onto different plates using a 
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“frogger” stamp (custom-built by the Max Planck workshop). The plates were incubated 
for two days at 30°C unless indicated otherwise and photographed for documentation. 
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3 Results and Discussion 
3.1 Differential affinity chromatography to idententify new 
interactors of Arf1p  
To identify new interacting proteins for Arf1p, we performed affinity chromatography with 
dominant active (∆N17-Arf1Q71Lp) and dominant inactive (∆N17-Arf1T31Np) forms of 
Arf1p (Kahn et al., 1995; Christoforidis et al., 1999). We chose an N-terminal truncated 
form of Arf1p for our experiments because the N-terminus contains a myristoylation site 
and forms an amphipathic helix. The replacement of this region of the proteins by a His6-
tag should minimize non-specific interactions on the affinity column, and it greatly 
facilitated the purification (Rein et al., 2002). Equal amounts of ∆N17-Arf1Q71Lp and 
∆N17-Arf1T31Np were covalently coupled to NHS-agarose (Fig. 8A). Guanine nucleotide 
exchange reactions were performed on the immobilized proteins in order to ensure that 
Arf1Q71Lp and Arf1T31Np were bound to GTP and GDP, respectively. Cytosolic extracts 
from a wild-type yeast strain were passed over the columns. For the elution, the 
Arf1Q71Lp column was incubated with an excess of GDP and the Arf1T31Np column 
with an excess of GTP. Although the restricted mutants are predominantly in either the 
GTP- or the GDP-bound form, an excess of the other nucleotide was able to elicit a 
conformational change under conditions that favor spontaneous guanine nucleotide 
exchange. In this way, proteins were released that bound specifically to the active or 
inactive form of Arf1p . An NHS-agarose column, which had been mock treated, served as 
a negative control. 
We validated our approach with immunoblots of eluates from the different columns and 
antibodies directed against known interactors of Arf1p e.g. coatomer, Arf1p-GEFs and the 
Arf1p-GAP Glo3p. These proteins behaved as predicted by their biological function (Fig. 
8B). Coatomer is the heptameric protein complex that forms together with Arf1p the COPI 
coat. This coat is involved in vesicular transport within the Golgi and from the Golgi to the 
ER. 
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Figure 8: Differential affinity chromatography. Yeast cytosol was incubated with either the Arf1-Q71Lp 
(Arf1p-GTP) or Arf1-T31Np (Arf1p-GDP) column. After washing, spontaneous nucleotide exchange was 
elicited resulting in a conformational change on Arf1p and the release of conformation-specific bound 
proteins. (A) Schematic drawing of the procedure. (B) The eluates (E1-E3) from a differential Arf1p affinity 
chromatography experiment were analyzed by immunoblot. FT is the flow-through of unbound protein after 
incubation of the cytosol with the Arf1p matrix. Beads without Arf1p were mock-treated and served as 
negative control. The Arf1p-GEF Gea2p is enriched in the Arf1p-GDP column, whereas both the coatomer 
complex (three subunits are shown) and the Arf1p-GAP Glo3p bind predominately to Arf1p-GTP.  
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Eluted proteins were precipitated with trichloracetic acid, then separated by SDS-PAGE 
and stained with Coomassie blue (Fig. 9A). Multiple proteins were eluted from both Arf1p 
columns. While some proteins appeared in eluates from both Arf1p-columns, a few 
proteins were at least predominantly present in fractions from only one of the columns. 
Bands present in the eluates from only one column were excised and analyzed by mass 
 
Figure 9: Identification of new interactors of Arf1p (A) The eluates from a differential affinity 
chromatography experiment were TCA precipitated and separated on an SDS gel. Bands that were enriched 
in eluates from either the Arf1p-GDP or Arf1p-GTP column were excised and subjected to mass 
spectrometric analysis. (B) Proteins identified by mass spectrometry. 
 
spectrometry. The in-gel digestions were carried out by Jörn Dengjel. Mass spectrometric 
analysis of the tryptic digests were performed by Jörn Dengjel and Markus Schirle. Both 
are present and past members of the AG Rammensee, Interfakultäres Institut für 
Zellbiologie, Abteilung Immunologie, University of Tübingen. 
The results of the analysis are summarized in Figure 9B. Six of the analyzed bands 
corresponded to known Arf1p binding proteins: subunits of the coatomer complex, the 
ARF-GEFs Gea2p and Sec7p as well as the ARF-GAP Gcs1p. Similar results were 
obtained using columns with immobilized ∆N17-Arf1p bound to GTP or GDP. 
Surprisingly, Gcs1p was found in the eluate from the GDP column. However, ARF-GAPs 
have been shown to fulfill an additional function on recruitment of SNAREs and cargo to 
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sites of vesicle emergence (Rein et al., 2002). This recruitment does not necessarily require 
the activated state of Arf1p.  
Four interactors have not been decribed in conjunction with Arf1p before, namely Pab1p, 
Chs5p and the protein products of the unknown ORFs YMR237w and YHR112c. Although 
it was possible to confirm the interaction of Yhr112p with Arf1p by co-
immunoprecipitation (Robert Gauss, unpublished data), the significance of this interaction 
remained obscure. Yhr112p is homologous to Cys3p, a cystathion-γ-lyase. Apart from the 
role of Cys3p in metabolism, a certain role in vesicular transport has been indicated 
(Matiach and Schroder-Kohne, 2001). The role of Yhr112p has not been analyzed further 
in this study. 
As it turned out during subsequent analyis, Pab1p provided an unexpected link between 
vesicular traffic and mRNA transport. This is described in Chapter 3.2. Ymr237p belongs 
to a family of highly homologous proteins in yeast. This family acts in close conjunction 
with Chs5p in Arf1p-dependent post-Golgi vesicular traffic. The genetic characterization 
of this family is described in Chapter 3.3, whereas the biochemical analysis follows in 
Chapter 3.4.  
 
3.2 Arf1p provides an unexpected link between vesicular traffic 
and mRNA transport in Saccharomyces cerevisiae 
3.2.1 Results 
3.2.1.1 Pab1p binds to a ∆N17-Arf1Q71Lp affinity matrix 
One of the new bands that we identified by mass spectrometry corresponded to Pab1p (Fig. 
9A, band 6). Pab1p is one of two major polyA-tail binding proteins in yeast. It is localized 
in the cytoplasm as well as in the nucleus and it is part of the 3’-end RNA processing 
complex (cleavage factor I). Four RNA recognition domains (RRM) mediate the 
interaction with the polyA-tail of the mRNA. To confirm the presence of Pab1p, we tested 
eluates from the affinity columns by immunoblot. Pab1p did not bind to the column 
material, but was detected in fractions from the ∆N17-Arf1Q71Lp column (Fig. 10A). A 
small amount of Pab1p was also present in eluates from the ∆N17-Arf1T31Np column. 
However, Pab1p showed a higher affinity towards the activated form of Arf1p, since the 
signal from the Arf1T31Np fractions trailed off quickly, while it persisted throughout the 
eluates from the Arf1Q71Lp matrix. This was consistent with the signal that we observed  
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Figure 10: Pab1p binds preferentially to ∆N17Arf1-Q71Lp. (A) Fractions from the columns were blotted 
and incubated with antibodies against Pab1p. Pab1p is highly enriched in eluates from the Arf1p-Q71L 
column. (B) The flow-throughs from the Arf1-Q71Lp column is depleted of Pab1p.The starting cytosol as 
well as the flow-through from the 3 columns was analyzed for the presence of Pab1p by immunoblot. Pab1p 
was less abundant in the flow-through of the Arf1p-GTP column compared to the mock-treated and the 
Arf1p-GDP column. 
 
for coatomer. If the Pab1p-Arf1Q71Lp interaction represents a high affinity contact, one 
would expect that the cytosol loaded on the column would be at least partially depleted of 
Pab1p. Therefore, the flow-throughs from different columns were analyzed by 
immunoblot. While the signal from the control and the ∆N17-Arf1T31Np columns did not 
alter significantly, the cytosol that had passed through the ∆N17-Arf1Q71Lp matrix 
contained substantially less Pab1p than the starting material (Fig. 10B).  
 
3.2.1.2 ∆N17-Arf1Q71Lp interacts with Pab1p but not Pub1p 
Pab1p is known to bind nonspecifically to many yeast proteins (Gavin et al., 2002). 
Therefore, to validate the interaction between Arf1p and Pab1p, we performed a two-
hybrid assay.  
 
Table 15: The activated form of ∆N17-ARF1 interacts with PAB1 but not with PUB1. The growth cells on 
plates lacking leucine is indicated. GLO3 served as positive, the empty vectors as negative controls.  
n. d. = not determined 
 
Two Hybrid Assay 
prey  
bait PAB1 PUB1 GLO3 pJG4-5
∆N17-ARF1-Q71L + - + - 
pEG202 - n.d. - n.d. 
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We used ∆N17-ARF1Q71L as the bait and PAB1, PUB1, and GLO3 as preys. Pub1p is the 
other major polyA-binding protein in the cell and, like Pab1p, localizes to the cytoplasm 
and the nucleus. We used growth on –LEU plates as the indicator for interactions. While 
PAB1 and ∆N17-ARF1Q71L showed an interaction in the two-hybrid assay, no growth on 
–LEU plates could be detected in strains carrying PUB1 in conjunction with ∆N17-
ARF1Q71L. GLO3 served as a positive and the empty vector as a negative control, 
respectively (Table 15). Eugster et al. (2000) have shown that GLO3 specifically interacts 
with the active form of ∆N17-ARF1 but neither with the wild type nor the inactive mutant.  
 
 
Figure 11: ARF1 but not ARF2 interacts genetically with PAB1. (A) ∆arf1 or ∆arf2 haploid strains were 
crossed with ∆pab1∆spb8 strains. The resulting diploid strains were sporulated and tetrads dissected. The 
spores were grown for 2 days at 30°C. (B) ARF1 and PAB1 were chromosomally appended with either YFP 
or CFP. The resulting strains were grown to early log phase, and serial dilutions were spotted on YPD plates. 
The plates were incubated at the indicated temperatures. 
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Pab1p is essential for cell viability. However, a suppressor mutant has been identified, 
∆spb8, which allows for survival in the absence of functional Pab1p (Boeck et al., 1998). 
ARF1 is not essential, because its homolog ARF2, which is 96% identical, can at least 
partially substitute for ARF1. Yet, Arf1p and Arf2p are not fully redundant (Spang et al., 
2001). If Arf1p and Pab1p cooperate in an essential pathway, one would predict that a 
double mutant should show at least an enhanced phenotype compared to the single 
mutants. Thus, we crossed a ∆arf1 strain with a ∆pab1 ∆spb8 strain (Fig. 11A). While the 
∆pab1 ∆spb8 mutant had a somewhat reduced growth rate compared to wild type, the 
∆arf1 ∆pab1 ∆spb8 spores were very sick and hardly grew at any temperature. In contrast, 
∆arf2 did not show the same phenotype with ∆pab1∆spb8, most likely because Arf2p is 
much less abundant in the cell than Arf1p and Arf1p is still present in ∆arf2 strains. In 
addition, we constructed a strain containing chromosomally tagged Arf1p-YFP and Pab1p-
CFP, which was cold-sensitive (Fig. 11B). The singly tagged strains do not show this 
phenotype. Therefore, the cold-sensitivity provides additional evidence for the specific 
interaction between Arf1p and Pab1p in vivo. Taken together, these results are consistent 
with an interaction of Arf1p and Pab1p in vivo. 
 
3.2.1.3 Pab1p and Arf1p form a complex in vivo 
As a further test of binding specificity, we performed co-immunoprecipitation experiments. 
First, we appended chromosomally Arf1p and Pab1p with an HA-tag and a myc-tag, 
respectively. The resulting strain, YAS238, did not show an altered phenotype when 
compared to the isogenic wild type (data not shown). Lysates of strain YAS238 were 
incubated with anti-HA or anti-myc antibodies and Protein G-sepharose. The 
immunoprecipitates were resolved by SDS-PAGE followed by immunoblot with 
antibodies against coatomer, the HA- and the myc-tag (Fig. 12A and B). As expected, 
Pab1p-myc was co-precipitated with Arf1p-HA. This precipitation was dependent on the 
presence of Arf1p-HA. A similar result was obtained when the Pab1p-myc was 
precipitated: Arf1p-HA co-sedimented only in the presence of Pab1p-myc (Fig. 12B) 
Unexpectedly, coatomer was also precipitated with Pab1p-myc. Since coatomer seemed 
also to be part of an Arf1p-Pab1p complex, we repeated the immunoprecipitation with wild 
type lysate and anti-coatomer antibodies. Indeed, Pab1p was found in the 
immunoprecipitate but not in the control (data not shown). Moreover, Pab1p 
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Figure 12: Arf1p and Pab1p are present in a ribonucleotide particle. (A) and  (B) Pab1p and Arf1p co-
immunoprecipitate. Pab1p and Arf1p were chromosomally appended with either a myc- or HA-tag. Yeast 
lysates were prepared from single or double tagged strains and subjected to immunoprecipitation with anti-
myc or anti-HA antibodies. The precipitates were analyzed by immunoblot. Lanes 1 and 2 correspond to 1.7 
% of the lysate. (C) Pab1p-Arf1p interaction depends on mRNA. Yeast lysate from a wild-type strain was 
incubated with RNAse A, DNAse I or mock treated. After the treatment an immunoprecipitation was 
performed with anti-Arf1p serum or a control serum and ProteinA-sepharose. The precipitated proteins were 
detected by immunoblot. In lane 1, 1.7 % of the lysate was loaded. (D) ASH1 mRNA is part of the Pab1p-
Arf1p ribonucleotide particle even in the absence of the SHE machinery. A co-immunoprecipitation 
experiment was performed with affinity-purified anti-Arf1p antibodies. RNA was prepared from the 
precipitate and subjected to RT-PCR with primer specific for the indicated mRNAs. -RT indicates reactions 
in the absence of reverse transcriptase. In lanes 1 and 2, 1.7 % of the lysate was loaded. 
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failed to co-immunoprecipitate when antibodies against Sar1p or Sec23p were used (data 
not shown). Sec23p is the GTPase activating protein of Sar1p, and both are essential for 
the formation of COPII coated vesicles from the ER. Thus, Pab1p does not associate 
unspecifically with vesicle coat proteins. Taken together, these results provide further 
evidence for the existence of an in vivo Pab1p-Arf1p interaction and that coatomer is part 
of this complex.  
 
3.2.1.4 Pab1p is associated with Golgi derived COPI-vesicles  
The results presented thus far support an in vivo interaction of coatomer, Arf1p and Pab1p. 
Such an interaction could take place on the Golgi or on COPI vesicles. Pab1p is evenly 
distributed throughout the cytoplasm (Anderson et al., 1993), making it difficult to assess 
the place of interaction in vivo. Therefore, we employed an in vitro Golgi budding assay, in 
which COPI-coated vesicles are formed from Golgi membranes (Spang and Schekman, 
1998). Enriched Golgi membranes that were devoid of ER were incubated in the presence 
of coatomer, Arf1p and guanine nucleotide. The generated COPI vesicles were separated 
from the Golgi membranes by velocity centrifugation. The vesicle peak was collected and 
re-fractionated based on coated membrane buoyant density. Using this purification scheme, 
vesicles are highly enriched, because contaminating particles would have to show the same 
behavior on a sedimentation gradient as well as sharing the same buoyant density, which is 
very unlikely. When GTPγS was used to generate the COPI coated vesicles, the vesicles 
peaked in fractions 5 and 6 as judged by the presence of the integral membrane cargo 
Emp47p and the v-SNARE Bos1p (Fig. 13, GTPγS). Pab1p peaked in the same fractions. 
A strong signal of Pab1p was also observed in the load. This was not surprising since we 
expected Pab1p to travel piggyback on the COPI vesicles. Thus, some protein if not most 
was lost during the flotation process. We did not detect any Sec61p, the translocon at the 
ER, or Pgk1p, a very abundant cytosolic protein in the vesicle fraction (data not shown). 
The peak changed in appearance when GTP was used instead of GTPγS. In this case, the 
coat partially disassembled due to GTP hydrolysis, which also resulted in a partial loss of 
the Pab1p signal in the vesicle fraction. Pab1p was not recovered in the vesicle peak in the 
absence of coatomer and Arf1p (data not shown). Thus, Pab1p is associated with COPI 
vesicles generated from Golgi membranes, and this association is lost after the disassembly 
of the COPI coat. 
3 Results and Discussion  77 
 
 
Figure 13: Pab1p association with COPI coated vesicles is dependent on mRNA. COPI vesicles were 
generated from Golgi membranes in the presence of GTPγS and COPI components. In one experiment RNase 
(200 µg) was added to the budding reaction. The vesicles were purified over a velocity gradient, and 
subsequently floated on a Nycodenz gradient. Fractions were collected from the top, separated by SDS-
PAGE, and analyzed by immunoblot. The arrows indicate the direction of movement of lipid particles within 
the gradient. Non-membrane associated proteins remain in the load at the bottom of the gradient. The vesicles 
peak in fractions 5 and 6. 
 
3.2.1.5 The Pab1p-Arf1p complex is dependent on the presence of mRNA 
Pab1p is the major mRNA-binding protein of the cell. Therefore, we wanted to test, if 
RNA is present in the Pab1p-Arf1p complex and if RNA is required for the stability of the 
complex. To address these questions, we performed an immunoprecipitation with anti-
Arf1p antibodies and digested the lysate with either RNase A or DNase I (Fig. 12C). Pab1p 
was co-immunoprecipitated with anti-Arf1p antibodies, and did not bind to non-related 
IgGs (Fig. 12C). Interestingly, the interaction of Arf1p and Pab1p was severed upon 
addition of RNase A. DNA digestion did not have any influence on the stability of the 
Pab1p-Arf1p complex. Furthermore, the addition of an excess of purified RNA or DNA 
did not have any impact on the Pab1p-Arf1p interaction, indicating that binding is not 
mediated by a nonspecific association of protein and RNA. Thus, Arf1p seems to be part of 
a ribonucleotide particle. Next, we wondered if Arf1p might be part of special 3’-end RNA 
processing complexes. Therefore, we performed RT-PCRs on anti-Arf1p 
immunoprecipitates (Fig. 12D). We tested eight mRNAs that differ in their abundance and 
that are either symmetrically or asymmetrically localized. In S. cerevisiae, at least two 
asymmetrically localized mRNAs have been identified: ASH1 and IST2. They are 
transported into the bud along actin cables via the SHE machinery and anchored at the bud 
tip of a growing cell (Long et al., 1997; Munchow et al., 1999; Takizawa et al., 2000) (Fig. 
14). The motor protein Myo4p forms a complex with the RNA binding protein She2p via 
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She3p (Bohl et al., 2000; Long et al., 2000; Takizawa and Vale, 2000). This complex 
delivers the mRNA to the bud tip where it is anchored.  
 
 
Figure 14: Model for restriction of mating type switching to mother cells in S. cerevisiae. ASH1 mRNA is 
transported by the SHE machinery (including the myosin Myo4p/She1p) along acting cables to the distal bud 
tip of the daughter cell. Little is known about the anchoring of ASH1 mRNA at this site. Local translation of 
ASH1 mRNA occurs resulting in an asymmtric Ash1p distribution. Ash1p is a transcriptional repressor of the 
HO-endonuclease, which is responsible for mating type switching. Thus, even in S. cerevisiae, mother and 
daughter cells have different cell fates. The mother is able to switch its mating type whereas the daughter 
cannot (adapted from Lodish et al., 2003). 
 
As shown before, Pab1p specifically precipitated with affinity purified anti-Arf1p 
antibodies and not with control IgGs (Fig. 12D). Using this precipitate as template for the 
RT-PCR for different mRNAs resulted in a positive signal for all tested mRNAs. These 
signals were specific since no product was detected in the lanes where a precipitate with 
control IgGs had been used at 25 cycles. Increasing the cycle number to 30 resulted in a 
signal also in the control for most of the mRNAs except for ASH1. This result indicates 
that the Arf1p-Pab1p particles contain a variety of different mRNAs. 
Since we also detected the asymmetrically localized ASH1 and IST2 mRNAs in Arf1p-
Pab1p ribonucleotide particles, we asked, whether interfering with the SHE machinery 
would also affect the association of the asymmetrically localized ASH1 mRNA with the 
COPI vesicles. Therefore, we repeated the Arf1p immunoprecipitation in strains where 
either SHE1/MYO4 or SHE3 had been deleted. As observed in the wild type, Pab1p co-
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sedimented with Arf1p (Fig. 12D, compare lane 4 with lanes 6 and 7). Furthermore, the 
precipitated mRNA contained ASH1 mRNA. Therefore, the association of the 
asymmetrically localized mRNA ASH1 with the Arf1p-Pab1p complex is independent of 
its transport by the SHE machinery.  
We have established that Pab1p is present on COPI vesicles. Furthermore, ASH1 mRNA 
was detected on the COPI vesicle fraction of a Golgi budding experiment (data not shown). 
Yet, does this interaction of Pab1p and Arf1p depend on the presence of mRNA? To 
address this question, we again performed a Golgi budding experiment (Fig. 13). This 
time, however, we added RNase during COPI vesicle generation. Treatment of the Golgi 
membranes with RNase did not affect vesicle generation but the association of Pab1p with 
the COPI vesicles was completely lost. Therefore, the attachment of Pab1p with Golgi-
derived COPI vesicles requires the presence of mRNA. 
 
3.2.1.6 Asymmetric mRNA localization is disturbed in arf1 mutants 
The Arf1p-Pab1p ribonucleotide particles contain asymmetrically and symmetrically 
localized mRNA. Thus, COPI vesicles are likely to contain a wide repertoire of mRNAs. 
These COPI vesicles are required for intra-Golgi as well as Golgi to ER retrograde 
transport. Because COPI vesicles are transport carrier, it seemed reasonable to look for a 
link to mRNA transport. One possible role for the mRNA association with the vesicles 
could be to bring the mRNA to the ER. The ER is a reticulate structure distributed 
throughout the cell and we found it hard to study the transport of symmetrically localized 
mRNAs. Therefore, we investigated an asymmetrically distributed mRNA, ASH1, that was 
also found on COPI vesicles. First, we tested whether deletion of ARF1 interferes with the 
localization of ASH1 mRNA using a GFP-based mRNA-localization assay (Bertrand et al., 
1998). GFP is fused to sequences encoding the viral MS2 coat protein, while an ASH1 
mRNA reporter construct contains MS2 binding sites. A nuclear localization signal on the 
GFP containing plasmid restricts GFP to the nucleus. Only after interaction of the MS2 
coat protein with MS2 binding sites can GFP exit the nucleus with ASH1 mRNA. We 
compared the ASH1 mRNA localization of wild type yeast cells to that in a ∆arf1 strain 
(Fig. 15). We scored 3 different phenotypes: bud tip (correct localization), bud neck and 
mother cell. In the wild-type strain over 60% of cells showed the correct localization of 
ASH1 mRNA in the bud tip at 30°C and 16°C. In contrast, ASH1 mRNA seemed to be 
mislocalized in ∆arf1 cells at the permissive temperature and even more severely at the 
restrictive temperature. Only in about 20% of the ∆arf1 cells incubated at the restrictive 
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temperature was the GFP signal confined to the bud tip. The ASH1 mRNA never seemed 
to reach the bud tip in the remaining 80% of the cells. The GFP particle was either stuck in 
the bud neck or was randomly localized in the mother cell. This result indicates that Arf1p 
is required for the correct localization of ASH1 mRNA.  
 
 
 
Figure 15: ASH1 mRNA is mislocalized in ∆arf1 mutant cells. An ASH1 mRNA-GFP reporter system was 
transformed in either wild type or the isogenic ∆arf1 strain. Cells were grown to early log phase at 30°C. One 
half of the cultures were shifted to 16°C for 3 hours. At least 100 cells per strain and temperature were 
analyzed for the localization of the GFP particle. The scored phenotypes are indicated. The arrowheads point 
towards the green fluorescent particle. 
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We extended our results by using temperature-sensitive arf1 alleles in a ∆arf2 background 
generated by Yahara et al. (2001). In these strains, ARF function is only provided by the 
arf1 ts-allele. In addition, we switched our detection method to fluorescence in situ 
hybridization (FISH). The strains were grown over-night under permissive conditions, 
shifted for 1 hour to the restrictive temperature and then prepared for FISH analysis. To 
score the phenotypes as objectively as possible, double-blind experiments were performed. 
Strain NYY 0-1 corresponds to the ‘wild type’ in this experiment, since it contains the 
wild-type allele of ARF1 in a ∆arf2 background, while NYY11-1, NYY17-1 and NYY18-1 
represent different point mutants (Fig. 16B). NYY11-1 carries three point mutations one of 
which is in proximity to the switch 1 domain. The other two mutations are towards the C-
terminus, which is probably involved in protein-protein interaction. NYY11-1 has a strong 
defect in Golgi to ER transport. NYY17-1 (mutated in the switch 1 region) seems to be a 
weaker allele and is a member of a different intragenic complementation group. NYY18-1 
 
Figure 16: Arf1p and Pab1p are required for ASH1 mRNA localization to the bud tip. (A) Overview of 
scored phenotypes. (B) List of mutants used in the analysis in (C). (C) The defect in mRNA localization is 
allele specific. Different mutants in ARF1 were grown to early log-phase at 23°C and then shifted for 1 hour 
to 37°C. ASH1 mRNA in the cells was visualized by FISH. At least 100 cells/strain were scored. (D) ASH1 
mRNA levels are not sensitive to shift to the restrictive temperature. Different mutants in ARF1 were grown 
to early log-phase at 23°C and then shifted for 1 hour to 37°C; the deletion mutants in ARF1 and PAB1 SPB8 
as well as a wild-type strain were grown at 30°C. Total RNA was extracted from the different strains and 
analyzed by Northern blot. The blot was incubated with probes for ASH1 mRNA and ADH1 mRNA. Upon 
temperature-shift, no significant changes in mRNA levels were observed. (E) Ash1p levels are not altered in 
different mutants. The strains were transformed with a CEN plasmid encoding C-terminally myc9-tagged 
Ash1p and grown as described in (D). Soluble extracts were prepared and analyzed by immunoblot for the 
presence of Ash1p-myc and Arf1p.  The translation of ASH1 mRNA appeared to be unaffected by shift to 
restrictive temperature. The Arf-signal in the ∆arf1 mutant corresponds to Arf2p, which is upregulated in 
∆arf1 strains. Arf2p is 10 times less abundant than Arf1p in wild-type strains. 
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is supposed to disturb transport at the Golgi and carries a mutation in the switch 2 region 
(Fig. 16B). At the restrictive temperature, only about 50% of the ARF1 wild-type showed 
correct localization of the ASH1 mRNA (Fig. 16C). However, the mutant NYY17-1 was 
not defective in mRNA localization and showed about 70% correctly anchored ASH1 
mRNA. In contrast, the mRNA localization in NYY11-1 and NYY18-1 was severely 
affected. The predominant defect was delocalized mRNA throughout the cell, indicating 
that these mutants were either deficient in transport or anchoring of the mRNA in the bud 
tip. These results indicate that the mRNA mislocalization phenotype displayed by the 
different mutants is due to a specific involvement of Arf1p in this process.  
 
3.2.1.7 arf1 mutants show no defects in transcription or translation of ASH1 
Anchoring of ASH1 mRNA depends at least in part on Ash1 protein translation (Gonzalez 
et al., 1999). Therefore, the results presented above, although specific for Arf1p, could also 
be interpreted as a defect in transcription, mRNA instability or down regulation of 
translation of ASH1. In addition, some mutants of components along the secretory pathway 
led to a defect in ribosome biosynthesis (Mizuta and Warner, 1994). Moreover, Deloche et 
al. (2004) reported that translation initiation was attenuated very rapidly and protein 
synthesis was reduced in secretion mutants upon shift to restrictive conditions. To test 
effects on ASH1 mRNA stability and Ash1p protein synthesis in arf1 and pab1 mutant 
strains before and after shift to the restrictive temperature, we performed Northern and 
Western blots (Fig. 16D and E). Yet, no significant variations in ASH1 mRNA levels were 
detected in arf1 ts-mutant strains upon shift to non-permissive conditions or in strains 
where ARF1 or PAB1 had been deleted (Fig. 16D). Detection of ADH1 mRNA served as 
internal control. A myc-tagged version of Ash1p is functional and has been used to assess 
the Ash1p content in cells (Cosma et al., 1999; McBride et al., 2001). Therefore, we used 
Ash1p-myc expressed from a CEN plasmid (single copy) to determine Ash1p levels in arf1 
and pab1 mutants. Soluble yeast lysates were analyzed for the presence of Ash1p-myc and 
Arf1p (Fig. 16E). As observed for the mRNA levels, no significant differences in the 
Ash1p levels were eminent. Thus, it is unlikely, that transcription or translation of ASH1 is 
disturbed in the arf1 mutants and that this would be the cause of the ASH1 mRNA 
localization defect.  
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3.2.1.8 ∆pab1∆sbp8, ∆scp160, and ∆bfr1 are defective in ASH1 mRNA localization 
Next, we wanted to check, if Pab1p is also required for asymmetric mRNA localization. 
Cells of a ∆pab1∆sbp8 strain were grown at 30°C and prepared for FISH as described 
above. Indeed, a similar phenotype was observed as for a ∆arf1 mutant (Fig. 17A).  
 
Figure 17: Pab1p binding proteins display abnormal ASH1 mRNA localization. Cells were grown to early 
log phase at 30°C and FISH for ASH1 mRNA was performed. BY4741 is the corresponding wild type for the 
strains in (A). At least 100 cells/strain were scored. (B) ARF1 and BFR1 interact genetically. Single and 
double mutants in ARF1 and BFR1 were grown at 30°C. Serial dilutions were dropped on plates and 
incubated at the indicated temperatures for 2 days. (C) Bfr1p interacts with Arf1p. An immunoprecipitation 
from yeast lysate was performed with affinity-purified antibodies against Arf1p or control IgGs. Bfr1p was 
co-precipitated with Arf1p. 
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In both cases about 60% of the ASH1 mRNA was mislocalized while in the wild-type 60% 
of the cells the signal was observed anchored in the bud-tip. Pab1p is known to interact 
with two other proteins, Scp160p and Bfr1p (Lang and Fridovich-Keil, 2000). Moreover, 
Scp160p has been identified as a multicopy suppressor of a gea1-4 ∆gea2 mutant and 
physically interacts with Gea1p (Peyroche and Jackson, 2001). Gea1p and Gea2p are 
Arf1p-GEFs that have overlapping functions in retrograde transport from the Golgi to the 
ER (Peyroche et al., 1996; Spang et al., 2001). Scp160p is a polysome-associated protein 
that was shown to be defective in anchoring asymmetrically localized mRNA (Irie et al., 
2002). Bfr1p is a protein of unknown function that was found in a screen for resistance 
against brefeldin A (Jackson and Kepes, 1994). Brefeldin A is an un-competitive inhibitor 
of Arf-GEFs (Peyroche et al., 1999). Bfr1p is required for the association of Scp160p with 
polysomes but not with Pab1p (Lang et al., 2001). In addition, we found that ∆bfr1 and 
∆arf1 are synthetically lethal at 37°C (Fig. 17B). Furthermore, Bfr1p co-
immunoprecipitates with Arf1p (Fig. 17C). Therefore, at least a part of Arf1p function 
might be connected to Scp160p and Bfr1p, and it seemed likely that ∆bfr1 might also be 
deficient in correct mRNA localization. Indeed, ∆bfr1 showed the same phenotype as 
∆scp160, which was stronger than the one observed for ∆arf1 and ∆pab1 ∆sbp8 (Fig. 
17A). This is consistent with the probable involvement of Scp160p and Bfr1p in the 
general translation machinery. In the absence of Arf1p, some mRNA could still get to the 
ER and interact there with Scp160p or Bfr1p. However, upon deletion of BFR1 or SCP160 
the translation and thus restriction of mRNA at the ER could be more severely affected. 
 
3.2.1.9 Characterization of the cytoskeleton in the arf1 mutants 
So far, we presented evidence that Arf1p is involved in mRNA transport and that the 
existence of an Arf1p-Pab1p-ASH1 ribonucleotide particle seemed to be independent of 
the SHE machinery. ASH1 mRNA was mislocalized in ARF mutants as determined by two 
different methods (Fig. 15 and 16C). However, it is known that mutations in ARF can also 
affect the actin cytoskeleton and might also have some effect on microtubules. In order to 
rule out any general defects in cytoskeletal organization or polarity, we examined the 
microtubules and actin cytoskeleton in the NYY strains at the permissive and restrictive 
temperature. All strains showed wild-type microtubules at both temperatures as judged by 
indirect immunofluorescence (Anne Spang, data not shown). In addition, none of the 
strains was sensitive towards benomyl, a microtubule depolymerizing drug (Anne Spang, 
data not shown). Next, we examined the actin localization by staining with rhodamine-
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Figure 18: Localization of She1p/Myo4p and actin in arf1 point mutants. (A) The actin cytoskeleton is only 
disturbed in NYY18-1 at the restrictive temperature. Different mutants in ARF1 were grown to early log-
phase at 23°C and then shifted for 1 hour to 37°C. Cells were fixed and the actin cytoskeleton was stained 
with rhodamine-phalloidin. (B) She1p/Myo4p localizes to the bud tip in arf1mutants. MYO4 was 
chromosomally appended with 2xGFP. Different mutants in ARF1 were grown to early log-phase at 23°C 
and then shifted for 1 hour to 37°C. Cells were examined directly. For the restrictive temperature, a heated 
stage was mounted onto the microscope to keep the cells at 37°C during the observation. (Fluorescence 
microscopy was perfomed by Anne Spang.) 
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phalloidin. NYY0-1, NYY11-1 and NYY17-1 did show correctly polarized actin cables 
and patches at the permissive and the restrictive temperature (Fig. 18A). In contrast, while 
NYY18-1 behaved like wild type at 23°C, after the shift to the non-permissive temperature 
the actin cables were missing and the actin patches were distributed randomly throughout 
the cell. Thus, the mRNA localization defect in NYY18-1 might be explained by the 
aberrant actin cytoskeleton. However, the polarity of the cell was not entirely lost, since 
bud site selection and budding still seemed to be normal as in the other strains tested (Anne 
Spang, data not shown). The second arf1 mutant with an ASH1 mRNA localization defect, 
NYY11-1, behaved like wild type. Thus, the mRNA distribution phenotype in at least 
NYY11-1 is not caused by general defects in polarity and cytoskeletal organization. 
 
3.2.1.10 She1p/Myo4p localizes correctly to the bud tip in arf1 mutants 
The actin cytoskeleton was visibly disturbed only in NYY18-1 at the restrictive 
temperature. Nonetheless, more subtle defects might conceivably prevent the SHE 
machinery from reaching the bud tip in the arf mutants. To test this possibility, we 
determined the localization of the motor protein She1p/Myo4p in the arf1 point mutants. 
The localization of She1p/Myo4p in the bud tip depends on the presence of She2p and 
She3p (Kruse et al., 2002). Thus, by checking She1p/Myo4p, we can examine the 
functionality of the entire SHE machinery. MYO4 was chromosomally appended by 2xGFP 
in the different NYY strains as described by Kruse et al. (2002).  At the permissive 
temperature as well as after a shift to the restrictive temperature for at least 1 hour, Myo4p-
GFP localized correctly to the bud tip in the arf1 point mutants irrespective to their defect 
in ASH1 mRNA localization (Fig. 18B). Most importantly, Myo4p-GFP was localized 
correctly at the bud tip in NYY11-1 and NYY18-1 (Fig. 18B). Our data indicate that the 
SHE machinery is functional in the arf1 mutants and that Arf1p is most likely involved in 
retaining ASH1 mRNA in the bud tip after the SHE proteins fulfilled their duty. These 
results demonstrate, that the involvement of Arf1p in mRNA localization is independent of 
the SHE machinery. This is in agreement with our findings that the coatomer-Arf1p-Pab1p 
complex contains also symmetrically localized mRNAs that are not a substrate for the SHE 
machinery and that the deletion of members of the SHE machinery did not sever the ASH1 
mRNA interaction with Pab1p and Arf1p.  
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3.2.1.11 Components of the early secretory pathway are required for ASH1 mRNA 
localization 
We found that mRNA is associated with COPI coated vesicles that are destined to the ER. 
Therefore, we wondered if vesicular traffic, especially through COPI transport carriers, 
might play a role in mRNA localization. To this end, we performed FISH with 
temperature-sensitive mutants in components of the early secretory pathway. Surprisingly, 
not only sec21-1, a mutant in the γ-subunit of coatomer was defective but also sec23-1 and 
sar1-D32G (Fig. 19).  
 
Figure 19: A functional early secretory pathway is necessary for ASH1 mRNA localization. Strains were 
grown to early log phase at 30°C or 23°C for ts-strains. In case of the ts-strains, one half of the cultures were 
shifted to 37°C for 1 hour. RSY248 corresponds to the wild-type strain for the ts-mutants and is isogenic to 
sec18-1. BY4741 is the corresponding wild type for the deletion strains. At least 100 cells were scored per 
strain and condition. 
 
Sar1p is the counterpart of Arf1p in the generation of COPII vesicles, and Sec23p is the 
GTPase activating protein for Sar1p (Barlowe, 2000). Furthermore, the NEM-sensitive 
factor Sec18p, which is involved in homotypic and heterotypic membrane fusion (Novick 
et al., 1981; Graham and Emr, 1991), also seemed to be required for the anchoring of 
ASH1 mRNA because in about 80% of the cells the FISH signal was mostly distributed all 
over the cell, and could not be found concentrated in the bud tip. In contrast, two other 
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mutants in the ß-subunit (sec27) and ε-subunit (sec28) of coatomer behaved like wild type, 
indicating that the mRNA localization is a specific event involving coatomer. The 
phenotype that we detected was not due to a general secretion defect, because mutants in 
two Arf1p interacting proteins, Gga2p (a GGA protein) and Gcs1p (an Arf1p-GAP), were 
not defective in ASH1 mRNA localization. Our results indicate, that restricting ASH1 
mRNA to the bud tip requires functional ER-Golgi transport. 
 
3.2.1.12 The actin cytoskeleton is not generally disturbed in ER-Golgi transport mutants. 
We repeated the actin-phalloidin staining with the temperature-sensitive secretion mutants 
that were defective in ASH1 mRNA localization (Fig. 20). The mutant strains sec18-1, 
sec21-1, and sar1-D32G displayed a correctly polarized actin cytoskeleton at the 
permissive and at the restrictive temperature. In contrast, sec23-1 cells had a disorganized 
actin cytoskeleton after one hour shift to the restrictive temperature. Thus, the defect in 
mRNA localization in these mutants (except for sec23-1) is not due to a lack of actin 
organization in the cell.  
 
Taken together, our results indicate a novel and unexpected role for components of the 
early secretory pathway in short-range mRNA localization most likely through interaction 
with Pab1p. This process is independent of the SHE machinery. We have only investigated 
the localization of the asymmetrically localized mRNA ASH1. However, these results 
might also reflect a mechanism by which symmetrically localized mRNA is concentrated 
at the ER. 
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Figure 20: The actin cytoskeleton is not disturbed as a result of a defect in secretion. Secretion mutants that 
displayed an ASH1 mRNA localization defect were examined for a functional actin cytoskeleton. The strains 
were grown to early log-phase at 23°C and then shifted for one hour to 37°C. Cells were fixed and actin was 
stained with rhodamine-phalloidin. 
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3.2.2 Discussion 
We have used a differential affinity chromatography approach to identify new interactors 
of the small GTPase Arf1p. This approach is valid because known regulators were re-
identified. We have identified Pab1p as a new interactor of the small GTPase Arf1p. Pab1p 
interacts predominantly with the GTP bound form of Arf1p. In a high-throughput protein 
complex analysis in yeast, Pab1p was found to be one of the major contaminants (Gavin et 
al., 2002) indicating that Pab1p might interact nonspecifically with many other proteins. 
Therefore, we confirmed the specificity of interaction by two-hybrid analysis and genetic 
interaction as well as by mutual co-immunoprecipitation. Furthermore, the interaction 
between Pab1p and Arf1p is dependent on the presence of mRNA in the complex. 
Moreover, we found that Pab1p is associated peripherally with COPI vesicles generated 
from enriched Golgi membranes. Taken together, these results argue strongly that the 
Arf1p-Pab1p complex is specific. If and how Pab1p is incorporated into the vesicle coat 
remains elusive at present. Pab1p might not become an intrinsic part of the coat but might 
be peripherally associated with the vesicles through interactions with Arf1p and coatomer. 
COPI vesicles still form upon RNase treatment, which prohibits the Pab1p interaction with 
the coat. 
We tested Arf1p immunoprecipitates for the presence of a number of different 
mRNAs,which varied in their abundance and in their subcellular localization, by RT-PCR. 
After the immunoprecipitation, essentially all mRNAs were amplified. Thus, no 
specialized 3’end processing complexes were associated with COPI vesicles. To further 
investigate the role of Arf1p, Pab1p and the COPI coat in mRNA transport, we 
concentrated our efforts in studying the asymmetrically distributed ASH1 mRNA. In wild 
type cells, ASH1 mRNA is asymmetrically localized to the bud tip of a growing yeast cell. 
However, when we investigated the role of mutants in ARF1 and PAB1 in asymmetric 
mRNA distribution, we found that they mislocalize ASH1 mRNA. Furthermore, using 
enriched COPI vesicles from the Golgi budding assay, we could detect ASH1 mRNA by 
RT-PCR.  
The fact that the ASH1 mRNA mislocalization phenotype in arf1 mutants was allele 
specific indicates that not the whole repertoire of ARF dependent traffic is needed for 
mRNA localization. Moreover, this finding provides strong evidence that the ASH1 
mRNA localization defect is not brought about by a secondary effect. This idea is 
corroborated by the data showing that some coatomer mutants did show a defect while 
others did not. Furthermore, the extent of ASH1 mRNA mislocalization was quite variable 
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in the different mutants of the early secretory pathway. However, other mutants of the 
early secretory pathway localized ASH1 mRNA correctly to the bud tip. Thus, the 
asymmetric mRNA distribution phenotype cannot be attributed to a general secretion 
defect. In addition to mutants in the early secretory pathway, we tested also mutants in late 
acting components. They either had no effects (∆gga2) or the ASH1 mRNA 
mislocalization phenotype could be related to a defect in the actin cytoskeleton (sec1-1 and 
sec6-4; Mark Trautwein and Anne Spang, unpublished data). Moreover, the ASH1 mRNA 
localization defect was not due to defects in the actin cytoskeleton, the microtubules 
organization or cell polarity. Finally, we ruled out the possibility that ASH1 mRNA 
stability or translation efficiency were compromised in arf1 mutants. Ribosome 
biosynthesis and translation efficiency are affected in secretion mutants (Mizuta and 
Warner, 1994; Deloche et al., 2004). However, we did not observe this effect in arf1 and 
∆pab1∆spb8 mutants, which is most likely due to the use of different mutants and different 
strain backgrounds: the pool of mutants tested in the various studies is non-overlapping. 
Thus, we are confident that the mRNA localization defect is not due to a secondary effect. 
Transport of asymmetrically distributed mRNA into the bud tip was shown to be 
dependent upon the SHE proteins: She1p/Myo4p is an unconventional myosin that 
transports She2p, an RNA binding protein. The interaction between these two proteins is 
mediated by She3p. The role of She4p and She5p/Bni1p in mRNA localization is less well 
understood, but they seem to be involved in stabilization and polarization of the actin 
cytoskeleton. They are thought to play a role in anchoring mRNA by a thus far unknown 
mechanism (Beach and Bloom, 2001). However, Bloom and Beach (1999) speculated that 
once mRNA reaches the vicinity of its final destination, cytoplasmic flow or passive 
diffusion may enable mRNA accumulation at that site (the bud tip in yeast). Thus, a 
mechanism for restricting ASH1 mRNA in the bud is required, which might be 
independent of the SHE machinery. It further indicates the transport by the SHE machinery 
is a prerequisite but not sufficient for anchoring ASH1 mRNA at the bud tip. This is in 
perfect agreement with our finding that the aberrant ASH1 mRNA localization observed 
could not be correlated with defects in the SHE machinery, because Myo4p-GFP was 
restricted to the bud tip in arf1 mutants. Furthermore, deletion of SHE1/MYO4 or SHE3 did 
not disrupt the Arf1p-Pab1p ribonucleotide particle. Therefore, the defects in ASH1 
mRNA localization in the early secretion mutants are independent, and most likely 
downstream, of the SHE machinery. Our data are suggestive of COPI vesicles acting as 
short-range mRNA transport and localization vehicles: The asymmetric distribution of the 
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ASH1 mRNA is brought about by the SHE machinery and does not depend on Arf1p and 
COPI vesicles; they may act only to restrict the mRNA in the bud tip when it is not 
efficiently anchored. The long-range mRNA transport is dependent on the SHE machinery 
while the short-range localization might be reliant on COPI vesicles.  
We concentrated our efforts on the study of the asymmetrically distributed ASH1 mRNA, 
because the pathway of ASH1 mRNA localization is well known and more amenable for 
experiments than symmetrically distributed mRNA. However, since the defects in mRNA 
localization are independent of the SHE machinery, our observations could also apply to 
the symmetrically distributed mRNAs. What might be the role then of the early secretory 
pathway in mRNA localization? We would like to suggest a model in which the mRNA is 
transported to the ER via the COPI machinery. This mRNA COPI interaction could take 
place at the Golgi.  Pab1p was detected on purified Golgi membranes that we used to 
generate COPI vesicles in vitro. These vesicles contained proteins (e.g. the ER-Golgi v-
SNARE Bos1p) that cycle between the Golgi and the ER. Thus, we believe that these 
COPI vesicles are destined to the ER. Alternatively, the COPI vesicles might be directly 
loaded on route. This would lead to a fast and efficient way to bring mRNA to the ER. If 
the mRNA cannot be anchored at the ER and diffuses away, the COPI vesicles destined to 
the ER might be an efficient transport system for relocation of the mRNA. Thus, COPI 
vesicles could act as molecular sieve to bring Pab1p containing ribonucleotide particles to 
the ER. Yet, one other possible explanation for the transport of mRNA on COPI vesicles 
might be the clearance of the ribosome-free Golgi region from mRNA. Although this 
might be a likely scenario for mammalian cells, the Golgi in S. cerevisiae is scattered 
throughout the cell and the single different cisternae are surrounded by ribosomes in the 
cytoplasm. There is no ribosome-free Golgi region in S. cerevisiae. Still, we cannot 
exclude the possibility that there might be an ancient mechanism for mRNA clearance. 
Alternatively, symmetrically and asymmetrically mRNA transport to the ER might result 
in an enhancement of membrane-bound ribosome turnover at the ER. At least in 
mammalian cells, it has been shown, that membrane-bound ribosomes do not distinguish 
between mRNA substrates and therefore can initiate the translation of any protein, 
regardless of whether it is cytosolic or destined for translocation/secretion (Potter and 
Nicchitta, 2000). However, when membrane-bound ribosomes were provided with mRNAs 
encoding model cytosolic proteins, subsequent translation yielded the release of the 
ribosome-nascent chain complex from the ER to the cytosol (Potter and Nicchitta, 2000; 
Potter et al., 2001). Furthermore, mRNAs encoding cytosolic proteins are well represented 
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in the ER membrane-bound polysome fraction (Diehn et al., 2000; Lerner et al., 2003). 
Nicchitta (2002) proposed a model suggesting that the exchange of ribosomes on the ER 
membrane is dependent on and driven by the translation of cytosolic proteins by 
membrane-bound ribosomes. Our data are in agreement with this hypothesis because COPI 
vesicles could act as carriers for mRNAs to the ER to allow for the ribosome exchange. 
The mutant in the COPII component Sar1p could display such a strong defect for two 
reasons, which might lead to an additive effect: Since COPII vesicles are no longer formed 
in these mutants, the lipid and protein composition of the ER membrane is changed. As a 
result, the mRNA complex might ‘adhere’ less efficiently at the ER membrane. The 
mRNA complex diffuses away and cannot be brought back since blocking anterograde 
COPII transport from the ER to the Golgi immediately abrogates retrograde COPI 
transport from the Golgi to the ER. Hence, one would observe a stronger phenotype than in 
the retrograde transport mutants. Although we cannot exclude a direct involvement of 
COPII components in mRNA localization, Pab1p did not interact with Sar1p or Sec23p. 
Therefore, we favor an indirect role of the COPII components in mRNA transport. 
 
Taken together, our results provide the first evidence for a role of Pab1p and COPI vesicles 
in concentrating mRNA at the ER. Because, we tested only 8 different mRNAs, we cannot 
exclude that not all mRNAs travel on COPI vesicles. Performing a DNA microarray 
analysis similar to that was used to identify 22 bud-localized transcripts (Shepard et al., 
2003) might prove useful in solving this problem. 
 
94  3 Results and Discussion 
 
3.3 Genetic evidence for interaction with a new family of 
putative cargo receptors at the trans-Golgi in S. cerevisiae 
3.3.1 Results 
3.3.1.1 Chs5p and Ymr237p are new interactors of activated Arf1p 
In Chapter 3.1, we described the identification of new interactors of Arf1p by means of a 
differential Arf1p-affinity chromatography approach with mutant proteins restricted to the 
either GTP or GDP-bound form of Arf1p. Out of ten protein bands analyzed, six 
corresponded to already known interactors of Arf1p. Two protein bands corresponded to 
Chs5p and the protein product of the uncharacterized ORF YMR237w. Both proteins were 
enriched in the Arf1p-GTP affinity eluate. We generated an antiserum against Chs5p and 
binding to Arf1p-GTP was confirmed by immunoblotting of the Arf1p affinity eluates 
(Fig. 21). Attempts to raise antisera against full-length Ymr237p or against peptides 
derived from Ymr237p were unsuccessful. However, the fact that Ymr237p was clearly 
enriched in the Arf1p-GTP eluate (and therefore chosen for MS analysis) strongly suggests 
that Ymr237p also interacts predominantly with Arf1p-GTP. Thus, Chs5p and Ymr237p 
were identified as new interactors of activated Arf1p. 
 
 
Figure 21: Chs5p binds to Arf1p-GTP. Yeast cytosol was incubated with either Arf1p-Q71L (Arf1p-GTP) or 
Arf1p-T31N (Arf1p-GDP) column material. After washing, spontaneous nucleotide exchange was elicited 
resulting in a conformational change on Arf1p and the release of conformation-specific bound proteins. 
Eluates (E1-E4) from the Arf1p affinity chromatography were analyzed for the presence of Chs5p by 
immunoblot. Chs5p is highly enriched in eluates from the Arf1p-GTP column. Beads without Arf1p were 
mock-treated and served as negative control.  
 
3.3.1.2 Chs5p and the Bud7-Chs6 family 
Chs5p is a protein that has been implicated in chitin synthesis, cell fusion and mating 
(Santos et al., 1997). More specifically, it is required for chitin synthase III activity in vivo 
and probably mediates exit of the chitin synthase Chs3p from the trans-Golgi-network 
(TGN) (Santos and Snyder, 1997). Chs3p is the enzymatic subunit of chitin synthase III 
complex, which is responsible for formation of a chitin ring at the mother-bud neck at the 
time of cytokinesis. After cell division, remnants of the chitin rings are still visible as bud 
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scars. In addition, Chs5p has been shown to be essential for the polarized localization of 
the cell fusion factor Fus1p to the shmoo tip during mating (Santos and Snyder, 2003). It 
harbors a Fibronectin type III (FN3) domain, which is found in approximately 2% of all 
animal proteins. FN3-like domains are also present in bacterial proteins. Another feature of 
Chs5p is the breast cancer carboxy-terminal domain (BRCT), which is found within many 
DNA damage repair and cell cycle checkpoint proteins. This domain presumably serves to 
mediate homo- and hetero-multimer formation. Besides, Chs5p contains small blocks of 
homology with Sec16p, a COPII vesicle coat protein at the ER (Espenshade et al., 1995). 
Therefore, Chs5p has been proposed to reside on the outside of Chs3p-containing vesicles 
(Santos and Snyder, 1997).  
Protein sequence alignments suggest that the proteins Ymr237p, Bud7p, Ykr027p and 
Chs6p are a family of paralogous proteins in Saccharomyces cerevisiae (Fig 22). Ymr237p 
and Bud7p share 54% sequence identity while Ykr027p and Chs6p are slightly less similar 
(43% sequence identity). Both sub-branches of the family have around 25% sequence 
identity. Ymr237p is probably the ancestral protein of which Chs6p is derived by gene 
duplication. Another gene duplication event resulted in Ykr027p and Bud7p. No obvious 
putative domains within the Bud7-Chs6 family were identified. Orthologous proteins are 
 
Figure 22: Scheme depicting the relationship of the members of the Bud7-Chs6 family. The percentage of 
protein sequence identity is given. 
 
only found in fungi, indicating a fungi-specific role for this protein family. Bud7p was 
identified in a screen for mutants defective in bipolar budding pattern of diploid yeast cells 
(Zahner et al., 1996). BUD7 diploid deletion mutants exhibit an axial-like budding pattern 
(Ni and Snyder, 2001). Depending on the strain background, the pattern appears also often 
to be random (Ni and Snyder, 2001). In contrast to Bud7p, virtually nothing is known 
about Ymr237p. Ykr027p was found in the proteome of highly enriched mitochondria 
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(Sickmann et al., 2003). However, in a genome-wide GFP-localization approach Ykr027p 
was localized to the Golgi-apparatus (Huh et al., 2003). Chs6p is required for the 
anterograde transport of Chs3p from internal endosome-like structures (“chitosomes”) to 
the plasma membrane (Ziman et al., 1998; Valdivia et al., 2002). Hence, both Chs5p and 
Chs6p are required for the transport of the chitin synthase Chs3p to the plasma membrane. 
This raises the possibility that Chs5p acts not only together with Chs6p on the same 
pathway but might fulfill an additional role in conjunction with the other three Bud7-Chs6 
family members Alternatively, the other three family members might also be implicated in 
the transport of Chs3p. 
We are going to refer to Ymr237p and Ykr027p as Bch1p and Bch2p (for Bud7-Chs6 
homologous proteins 1 and 2), respectively. 
 
3.3.1.3 Members of the Bud7-Chs6 family fulfill different functions 
In order to study the Bud7-Chs6 family in a systematic manner, we created single deletion 
strains of the Bud7-Chs6 family members. The single deletion strains were assayed for 
growth at various temperatures, on different nutrient sources and for growth on plates 
containing the chitin binding dye calcofluor white (Fig. 23). This dye is toxic to cells with 
normal chitin levels whereas mutants defective in chitin synthesis or chitin synthase 
trafficking are unaffected. A deletion of CHS6 was resistant to the chitin binding dye 
calcofluor white while ∆bud7, ∆bch1 or ∆bch2 were sensitive similar to the wild-type (Fig. 
23A). From all the deletion strains, only the ∆chs6 strain was temperature-sensitive at 
37°C (Fig. 23B). In contrast, a ∆bch1 strain grew slowly at 23°C and was highly sensitive 
to growth on YMP+ plates (Fig. 23B and C). YMP+ is a rich medium containing elevated 
levels of ammonium. Deletion of any of the other three members of the Bud7-Chs6 family 
was no more sensitive than the wild-type towards YMP+. For a ∆bch2 strain we did not 
observe any obvious defect. As reported before, a homozygous diploid  ∆bud7 strain 
displayed a random budding pattern (Fig. 23D). The ∆bch1 and ∆bch2 homozygous 
diploid deletions budded in a normal bipolar budding pattern. We were unable to assess the 
budding pattern of a ∆chs6 homozygous diploid strain due to extremely low staining with 
calcofluor white, which is used to visualize the bud scars. Instead, sometimes chitin 
staining was obtained at protrusion of the cell wall. However, it was possible to score the 
budding pattern in another strain background (BY4743, Robert Gauss, unpublished 
observation). There, the CHS6 deletion did not affect the diploid-specific budding pattern. 
3 Results and Discussion  97 
 
Another phenotype observed for a ∆bud7 deletion was the fast growth on plates buffered at 
pH 7.5 (Fig. 2E). The fact that phenotypes observed for specific mutants  
are only associated with one member of the Bud7-Chs6 family demonstrates that the 
proteins of the Bud7-Chs6 family serve different functions in the cell and are not 
redundant. 
 
 
Figure 23: Analysis of single deletion mutants of the Bud7-Chs6 family together with mutants in CHS5 and 
ARF1. For the drop assays, haploid strains were grown overnight to logarithmic phase in rich medium. After 
adjusting the cell concentration, serial dilutions (1:10) were dropped onto plates and incubated for two days 
at 30°C unless indicated otherwise. (A) Growth on plates containing the toxic chitin-binding dye calcofluor 
white. (B) Growth at different temperatures. (C) Growth on YMP+ plates. These rich medium plates contain 
an elevated level of ammonium sulfate. (D) Analysis of the budding pattern. Diploid yeast strains were 
grown for at least 16 h to logarithmic phase. After fixation with formaldehyde, the cells were stained with 
calcofluor white to visualize the bud scars under the fluorescent microscope. (E) Growth on minimal medium 
plates buffered at pH 5.8 and pH 7.5.  
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Most strikingly, the ∆chs5 deletion strain exhibited all phenotypes observed for the 
deletion of different members of the Bud7-Chs6 family (Fig. 23), namely resistance to 
calcofluor white, temperature- and cold-sensitivity, YMP+ sensitive growth, fast growth on 
plates at pH 7.5, and a random budding pattern in diploid strains (again not scorable in 
YPH501 but in BY4743, Robert Gauss, unpublished results; also reported by Santos et al., 
1997). While the single deletions of the Bud7-Chs6 family resulted in distinct phenotypes 
typical for a single gene, the CHS5 deletion combined all the different phenotypes. This 
indicates that Chs5p is either an upstream regulator or a downstream converging point of 
Bud7-Chs6 protein family-related pathways. 
 
3.3.1.4 Members of the Bud7-Chs6 family genetically interact with each other and with 
ARF1 
Because we identified Chs5p and Bch1p as interactors of Arf1p-GTP, we wanted to 
explore the genetic relationship between ARF1 and the Bud7-Chs6 family or CHS5. We 
therefore created double deletion strains. An ARF1 deletion restored the calcofluor white 
sensitivity of both ∆chs5 and ∆chs6 (Fig. 23 B). The sensitivity to growth on YMP+ plates 
was abolished for both ∆chs5 and ∆bch1 (Fig. 23 C). Interestingly, a single ARF1 deletion 
itself was growing better than the wild-type strain on YMP+ plates. However, the random 
budding pattern of a diploid ∆bud7 strain was not rescued by an additional ARF1 deletion 
(data not shown). Thus, we could demonstrate a genetic interaction between ARF1 and at 
least part of the Bud7-Chs6 family and CHS5. 
All single deletions of the Bud7-Chs6 family resulted in viable strains. We wanted to 
determine whether there was a genetic relationship between the four paralogs of the Bud7-
Chs6 family themselves. Therefore, we created strains of all possible combinations of 
double, triple and quadruple deletions. As for the single deletions strains, these 
combinations were assayed for their growth on different plates (Table 16). The calcofluor 
white resistance of a CHS6 deletion was not rescued in any deletion combination. 
However, the temperature-sensitivity was rescued by an additional BCH1 deletion 
demonstrating that the calcofluor white resistance and temperature-sensitivity are 
separable. The sensitivity of a BCH1 deletion towards YMP+ was not changed in any 
combination. Surprisingly, a quadruple deletion did not show a deleterious phenotype as 
could have been anticipated for a family null mutant. Unexpectedly, the ∆bud7 ∆bch1 
double deletion resulted in a calcofluor white resistant phenotype which was not altered in 
a ∆chs6 ∆bud7 ∆bch1 triple deletion (Table 16 and Fig. 23). Furthermore, a double 
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deletion of ∆chs6 and ∆bch2 was partially sensitive to YMP+. Taken together, members of 
the Bud7-Chs6 family interact genetically. 
 
Table 16: Phenotypes of strains with combined deletions of Bud7-Chs6 family members. 
 Temperature 
sensitive at 37°C 
Calcofluor white 
resistant 
Slow 
growth at 
23°C 
YMP+ 
sensitive 
WT - - - - 
∆chs5 + + + + 
∆chs6 + + - - 
∆bud7 - - - - 
∆bch1 - - + + 
∆bch2 - - - - 
∆chs6 ∆bud7 + + - - 
∆chs6 ∆bch1 - + + + 
∆chs6 ∆bch2 + + + +/- 
∆bud7 ∆bch1 - + - + 
∆bud7 ∆bch2 - - - - 
∆bch1 ∆bch2 - - + + 
∆bud7 ∆bch1 ∆bch2 + + + + 
∆chs6 ∆bch1 ∆bch2 - + + + 
∆chs6 ∆bud7 ∆bch2 + + - - 
∆chs6 ∆bud7 ∆bch1 - + - + 
∆chs6 ∆bud7 ∆bch1 ∆bch2 - + + + 
 
 
3.3.1.5 The protein expression levels of the Bud7-Chs6 family are tightly regulated  
In the single deletion experiments, only ∆chs6 was resistant to calcofluor white. This 
suggested that from the Bud7-Chs6 family only Chs6p is needed for trafficking of the 
chitin synthase Chs3p to the cell surface. As reported above, a double deletion of ∆bud7 
∆bch1 surprisingly also resulted in calcofluor white resistance. One explanation for that 
could be that Chs6p is subtracted from Chs3p trafficking events to compensate the loss of 
Bud7p and Bch1p by fulfilling part of Bud7p/Bch1p functions under these conditions. 
Hence, Chs6p overexpression (or possibly also overexpression of the closest homolog 
Bch2p) should restore calcofluor sensitivity in a ∆bud7 ∆bch1 strain. Alternatively, Bud7p 
and Bch1p might both be directly involved in Chs3p transport and therefore 
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overexpression of Chs6p should not be able to restore calcofluor white sensitivity of a 
∆bud7 ∆bch1 strain. 
 
 
Figure 24: The protein expression levels of the Bud7-Chs6 family are tightly regulated. Haploid yeast cells 
transformed with different plasmids were grown overnight in selective minimal medium to logarithmic 
phase. After adjusting the cell concentration, serial dilutions (1:10) were dropped onto plates and incubated 
for two days at 30°C unless otherwise indicated. (A) Rescue of a CHS6 deletion. Wild-type and ∆chs6 cells 
transformed with empty vector or low-copy plasmids expressing members of the Bud7-Chs6 family were 
analyzed for growth at 37°C and on calcofluor white plates (B) Rescue of a BCH1 deletion. Wild-type and 
∆bch1 cells transformed with empty vector or high-copy plasmids expressing members of the Bud7-Chs6 
family were analyzed for growth at 23°C and on YMP+ plates. 
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Surprisingly, however, already the rescue of ∆chs6 was problematic. Specifically, the 
calcofluor white resistance of a ∆chs6 strain could neither be rescued by expression of 
Chs6p from a low- nor a high-copy plasmid (Fig. 24A and data not shown). Yet, in both 
cases the temperature-sensitivity of the ∆chs6 strain was rescued which indicated protein 
expression and provided further evidence for two separable functions of Chs6p. No other 
member of the Bud7-Chs6 family was competent to restore wild-type growth of ∆chs6 at 
37°C. Similarly, the sensitivity of ∆bch1 towards YMP+ was not rescued by expression of 
Bch1p from a low copy plasmid. When expressed from a high copy plasmid, both Bud7p 
and Bch1p were able to remedy the phenotype (Fig. 24B and data not shown). In case of 
the ∆bud7 ∆bch1 double deletion, only the sensitivity towards YMP+ (but not the 
calcofluor white resistance) was rescued by expression of Bud7p or Bch1p from a high 
copy plasmid (data not shown). These results indicate that simple overexpression is not 
sufficient to rescue all associated phenotypes. Moreover, the expression of Bud7-Chs6 
family members appears to be tightly regulated and needs possibly to be adjusted for each 
member to a certain level. Alternatively, the expression level of one individual member 
might depend on other members. Furthermore, Bud7p and Bch1p are more tightly linked 
than the others since only Bud7p (but not Chs6p or Bch2p) was able to rescue the BCH1 
deletion. The inability of Chs6p to replace Bch1p (and vice versa) under overexpression 
conditions argues for a direct involvement of Bud7p and Bch1p in the trafficking of Chs3p. 
Therefore, it is unlikely that Chs6p becomes distracted from Chs3p-trafficking events to 
compensate loss of Bud7p or Bch1p.  
 
3.3.1.6 Transport of the chitin synthase Chs3p 
Since Arf1p is a protein involved in vesicular transport and at least Chs5p and Chs6p have 
been implicated in trafficking of vesicular cargo, we investigated the transport of known 
and putative cargo molecules. Given that not only Chs5p and Chs6p but also Bud7p/Bch1p 
are required for trafficking and sorting of the chitin synthase Chs3p to the bud neck, we 
analyzed the localization of Chs3p in vivo with a system developed by Valdivia et al. 
(2002). In this system, Chs7p (the ER export factor for Chs3p) and Chs3p-GFP are 
ectopically co-expressed and the localization of Chs3p-GFP is determined by fluorescence 
microscopy. In wild-type cells, we observed a GFP signal for structures resembling the 
TGN as well as a more dispersed signal which probably corresponds to chitosomes, similar 
to the results obtained by Valdivia et al. (2002). Occasionally, Chs3p-GFP was present 
also at the mother-bud neck (Fig. 25). In ∆chs5 and in ∆chs6 cells, the GFP signal was 
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exclusively in structures corresponding to the TGN. This is consistent with the assumption 
that Chs5p and Chs6p are required for transport of Chs3p from the TGN to the plasma 
 
Figure 25: Transport of the chitin synthase Chs3p. Haploid yeast cells co-transformed with Chs3p-GFP and 
Chs7p were grown overnight in selective medium to logarithmic phase. GFP was visualized by fluorescence 
microscopy. Pictures were taken from freshly mounted cells. The GFP signal is localized in structures 
resembling the trans-Golgi-network. A dispersed signal corresponding to the chitosomes is evident only in 
wild-type cells. 
 
membrane, or more specifically to the bud neck. Chs3p would be a cargo of special 
vesicles directed to the mother bud neck. Surprisingly, in a ∆bud7 ∆bch1 double deletion 
strain, we observed a mixed population of cells. Few cells looked like wild-type whereas 
the majority of cells had Chs3p-GFP only in TGN structures. We also stained the deletion 
strains with calcofluor white in order to assess the chitin levels in the cell wall and to 
correlate chitin synthesis at the cell wall with Chs3p transport. As expected, in both ∆chs5 
and ∆chs6 cells, the cell wall was stained very poorly. This poor staining was remedied by 
an additional ARF1 deletion (data not shown). In case of the ∆bud7 ∆bch1 double deletion, 
there was only weak staining of the cell wall. Taken together, this indicates that in the 
∆bud7 ∆bch1 double deletion strain either Chs3p trafficking was disturbed or Chs3p was 
not fully active or a combination of both. This was already denoted by the calcofluor white 
resistance phenotype of this strain. This result implies that Chs6p acts in concert with 
Bud7p/Bch1p to localize Chs3p to the cell surface and at least the presence of either Bud7p 
or Bch1p is required. 
 
3.3.1.7 The Bud7-Chs6 family is not required for transport of cell fusion factor Fus1p or 
of the amino acid permeases Gap1p and Tat2p 
It has been reported that Chs5p but not Chs6p is required for mating and more specifically 
for polarized localization of the cell fusion factor Fus1p to the shmoo tip during mating 
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(Santos and Snyder, 2003). It seemed obvious to examine whether any other member of the 
Bud7-Chs6 family apart from Chs6p would be required for mating and Fus1p trafficking. 
Although we observed a very dramatic mating efficiency defect for ∆chs5 x ∆chs5, this 
was not the case for any of the single deletions of the Bud7-Chs6 family. Also, mating of 
the quadruple deletions resulted only in a minor (if at all) defect in mating efficiency (data 
not shown). In addition, Fus1p-GFP expressed from a plasmid was correctly localized to 
the tip of the shmoo and the cell fusion plane in mating cultures of the single deletion 
strains whereas this was not the case in ∆chs5 mating mixtures (data not shown). 
Therefore, it is likely that Chs5p is also involved in other pathways apart from the Bud7-
Chs6 family-related pathways.  
A ∆bch1 strain is sensitive to growth on YMP+ plates. An apparent feature of these plates 
is the elevated ammonium level. We therefore considered the possibility that Bch1p is 
involved in nitrogen regulation and might be required for transport of amino acid 
permeases to the cell surface. The general amino acid permease Gap1p is routed to the cell 
surface under nitrogen starvation conditions and degraded in the vacuole under non-
starvation conditions (Roberg et al., 1997). The tryptophane permease Tat2p is inversely 
regulated and degraded in the vacuole in nitrogen-starved cells and localized to the cell 
surface under nutrient-rich conditions (Beck et al., 1999). We examined the localization of 
Gap1p-GFP and Tat2p-GFP in both wild-type and ∆bch1 strains. However, both Gap1p-
GFP and Tat2p-GFP were localized to the cell surface in both wild-type and ∆bch1 strains 
under appropriate conditions (data not shown). Hence, Bch1p is not required for trafficking 
of Gap1p or Tat2p.  
 
3.3.1.8 Intracellular localization of the budding pattern landmark proteins Bud8p and 
Bud9p 
A ∆bud7 homozygous diploid strain exhibits a random budding pattern unlike the wild-
type bipolar budding pattern. Therefore, we wanted to analyze the localization of the 
putative landmark proteins for bipolar budding pattern, Bud8p and Bud9p. These proteins 
are thought to interact with the general bud-site selection machinery, which then in turn 
establishes cell polarity (Casamayor and Snyder, 2002). Bud8p has been reported to mark 
the distal cell pole and therefore showing a localization at the distal bud tip (Harkins et al., 
2001). The localization of Bud9p is either at the bud side of the bud neck, marking the 
proximal pole as a true landmark protein (Harkins et al., 2001), or it is also at the distal 
bud tip and possibly acts there as an inhibitor of Bud8p (Taheri et al., 2000). We 
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Figure 26: Localization of the bipolar landmark proteins Bud8p and Bud9p is independent of the Bud7-Chs6 
family. Diploid wild-type and ∆bud7/∆bud7 yeast strains were grown for at least 16 h to logarithmic phase in 
either minimal selective medium (ectopic expression) or YPD (chromosomal integrations). YPD medium 
contained 50 mg/l adenine to suppress cellular autofluorescence associated with the ade2 mutation. Cells 
were washed briefly with water and pictures were taken immediately afterwards. (A) Ectopic expression of 
GFP-Bud8p and GFP-Bud9p. Cells were directly visualized under the fluorescent microscope. (B) 
Immunofluorescence of chromosomally tagged Bud8p-6HA and Bud9p-6HA. Cells were fixed in 
formaldehyde and stained with HA antibodies. The fluorescent dye Cy3 was used for visualization of the 
proteins. (C) Expression of chromosomally tagged Bud8p-3GFP and Bud9p-3GFP.  
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investigated the localization of Bud8p and Bud9p in wild-type diploid as well as in a  
homozygous BUD7 deletion strains. We initially visualized the proteins by ectopic 
expression of Bud8p-GFP and Bud9p-GFP fusion proteins (Schenkman et al., 2002). For 
Bud8p, we observed in both wild-type and BUD7 deletion strains a localization at the 
distal bud tip (Fig. 26A). Furthermore, we detected Bud9p at the bud side of the mother-
bud neck in both wild-type and ∆bud7/∆bud7 strains. However, it has been reported that 
overexpression of Bud8p was able to partially suppress the budding pattern defect of a 
∆bud7/∆bud7 strain (Ni and Snyder, 2001). We were therefore concerned that the 
overexpression of GFP-Bud8p would veil a mislocalization of this protein under 
physiological conditions in a ∆bud7/∆bud7 strain. Consequently, we constructed 
homozygous diploid strains in which Bud8p and Bud9p were C-terminally chromosomally 
tagged with 6HA in both wild-type and ∆bud7/∆bud7 strains resulting in endogenous 
expression levels. The wild-type strains exhibited a bipolar budding pattern indicating that 
the chromosomal fusions were functional. We performed immunofluorescence on these 
strains and Bud8p-6HA localized in both wild-type and ∆bud7/∆bud7 strains again to the 
distal bud tip (Fig. 26B). To our surprise, Bud9p-6HA localized also to the distal bud tip 
and to one pole in unbudded cells in both wild-type and ∆bud7/∆bud7 strains. To resolve 
this discrepancy, we chromosomally appended Bud8p and Bud9p with 3GFP in order to be 
able to visualize the proteins directly in living cells at endogenous expression levels. Both 
Bud8p-3GFP and Bud9p-3GFP homozygous diploid strains showed a bipolar budding 
pattern indicating functional fusion proteins. Again, Bud8p-3GFP localized to the distal 
bud tip (Fig. 26C). Additionally, however, a localization at the mother-bud neck junction 
was observed later in the cell cycle. Bud9p-3GFP localized to the distal bud tip in cells 
with small and medium size buds and to the mother-bud neck in cells with large buds, 
similar to the ectopic expression. It seemed that Bud9p-3GFP reached the mother-bud neck 
earlier than Bud8p-3GFP during the cell cycle. The localization of Bud8p-3GFP and 
Bud9p-3GFP was indistinguishable from wild-type in ∆bud7/∆bud7 cells. Bud8p-6HA and 
Bud9p-6HA at the mother-bud junction might be less amenable to antibody staining in 
immunofluorescence. This might be the reason why only the bud tip was stained in these 
experiments. Most importantly, however, both Bud8p and Bud9p localizations were 
unaffected by the deletion of BUD7 indicating that Bud7p is not involved in the transport 
of these bipolar landmark proteins. 
 
106  3 Results and Discussion 
 
3.3.1.9 Transport of the inherited protein Rax2p which is required for bipolar budding 
pattern 
Since the bipolar landmark proteins Bud8p and Bud9p were not transported in a Bud7p-
dependent fashion, we were searching for genes that resulted in a similar phenotype as a 
BUD7 deletion and might therefore be acting on the same pathway. BUD7 is member of a 
small class of genes in which mutations exhibit the peculiar axial-like budding pattern 
phenotype (Ni and Snyder, 2001). It is characteristic for this class of mutants that they 
neither bud in a bipolar nor in a true axial fashion, which is the normal budding pattern for 
haploid strains (Fig. 27). However, the budding pattern is distinct from a random budding 
pattern, which is the predominant phentotype in many mutants. Apparently, it depends on 
the strain background to which extent the axial-specific markers, which are present in 
diploids, can take over when bipolar landmarks are missing (Ni and Snyder, 2001). The 
axial-like phenotype is shifted to a random budding pattern in strain backgrounds in which 
the influence of the axial-specific markers in diploids is weak. In our strain background, 
we observed a random budding pattern for homozygous BUD7 deletions. ISY1, YOR300w, 
RAX1, RAX2, and BUD7 are so far the only members of the axial-like budding pattern 
class (Ni and Snyder, 2001). Isy1p is supposedly a protein involved in transcription and 
localizes to the nucleus. YOR300w overlaps both with the 3’-end of BUD7 and the 
promoter of RAX1. Therefore, it is likely that this ORF is not expressed as the effects of a 
deletion can be readily explained by concomitant deletion of the C-terminus of Bud7p 
(compare Chapter 3.4) and interference with Rax1p expression. Thus, we wanted to 
investigate the localization of the remaining candidates, Rax1p and Rax2p, in wild-type 
and ∆bud7/∆bud7 strains. We constructed strains in which the proteins were 
chromosomally tagged under their endogenous promoters. Although a RAX2-GFP/RAX2-
GFP strain exhibited a bipolar budding pattern, the C-terminal fusions of Rax1p with 6HA, 
9Myc or GFP resulted in nonfunctional proteins because the resulting strains budded 
randomly. Hence, we were unable to include Rax1p in our analysis. Rax2p-GFP was 
visible in wild-type cells at the bud neck, older bud scars and occasionally in the distal bud 
tip (Fig. 28A). In a ∆bud7/∆bud7 strain, Rax2p-GFP still localized to the bud neck, the 
distal bud tip and to older bud scars (Fig. 28B). However, the older bud scars were 
randomly distributed in the ∆bud7/∆bud7 strain. This means the localization of this protein 
to a cellular structure, namely the bud scars, was correct but the structures themselves were 
mislocalized.  
3 Results and Discussion  107 
 
 
Figure 27: (A) Axial and bipolar budding patterns in yeast cells. Staining with the calcofluor dye permits 
visualization of two types of scars on the surface of yeast cells. The scar marking the place where the cell 
was initially attached to its mother  cell (M) is called the birth scar. Smaller scars that originated by 
cytokinesis of the daughter cells (D) are named bud scars. Examination of the pattern of bud and/or birth 
scars reveals the budding pattern. The axial budding pattern is typically found in haploid cells, and is 
characterized by adjacent budding to the birth scar in both mother and daughter cells. Diploid cells follow a 
bipolar budding pattern in which daughter cells usually bud distally (that is, at the opposite pole to the birth 
scar), and the mother cell buds at either pole. The birth scar is represented by a curved black line, and 
subsequent bud scars are represented by curved white lines. (B) Localization of birth and bud scars denotes 
wild-type and mutant budding patterns (axial, bipolar, etc.) in yeast cells. The bipolar budding pattern 
naturally occurs in diploid cells. However, it can also be found in haploid cells mutated in any of the genes 
included in gene set I. Conversely, a diploid cell containing mutations affecting any gene in gene set II 
exhibits a preference for the axial budding pattern. Random, distal and proximal budding patterns can be 
consequences of mutation in any of the genes in gene sets III, IV, V or VI, depending on whether the cell is 
diploid or haploid (adapted from Casamayor and Snyder, 2002) 
 
Since localization of Rax2p is dependent on Rax1p (Chen et al., 2000; Fujita et al., 2004), 
it is likely that also Rax1p is correctly localized to the bud scars in ∆bud7/∆bud7 strains. 
Both ∆rax1/∆rax1 and ∆rax2/∆rax2 also display random budding patterns and Rax1p has 
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been shown to be required for Bud8p localization (Ni and Snyder, 2001; Fujita et al., 
2004). This places them upstream of the bud site selection process. Rax2p is correctly 
localized to bud scars (which are themselves mislocalized) in ∆bud7/∆bud7 strains. Bud8p 
and Bud9p are correctly localized in a ∆bud7/∆bud7 strain, yet the strain shows a random 
budding pattern. Our results provide evidence that BUD7 acts in a pathway downstream of 
RAX2 but upstream of BUD8 and BUD9. 
 
Figure 28: Localization of the inherited protein Rax2p required for maintenance of bipolar budding pattern is 
independent of the Bud7-Chs6 family. (A) Diploid wild-type and (B) ∆bud7/∆bud7 yeast cells expressing 
two chromosomal versions of Rax2p tagged with GFP at the C-terminus were grown in YPD containing 50 
mg/l adenine for at least 16 h to logarithmic phase. Cells were briefly washed in water and pictures were 
taken immediately afterwards using the fluorescence microscope. To correlate the Rax2p-GFP signal (green) 
with bud scars, living cells were stained with calcofluor white (blue) and the fluorescence of GFP and 
calcofluor white was compared (merge). In both wild-type and ∆bud7 cells, Rax2p-GFP co-localized with 
bud scars. 
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3.3.2 Discussion 
Using differential Arf1p affinity chromatography, we were able to identify Chs5p and 
Ymr237p as new interactors of Arf1p-GTP. Ymr237p (Bch1p) is member of a family of 
four paralogous proteins in yeast. This family also includes Chs6p, Bud7p and Ykr027p 
(Bch2p). Both Chs5p and Chs6p have been implicated in the trafficking of the chitin 
synthase Chs3p to the bud neck (Santos and Snyder, 1997; Ziman et al., 1998). Bud7p is 
required for bipolar bud-site selection in diploid strains (Zahner et al., 1996; Ni and 
Snyder, 2001). Little was known about the so far uncharacterized ORFs YMR237w and 
YKR027w. Orthologs of Bud7-Chs6 family proteins are only found in fungi indicating a 
fungi-specific role for this protein family. Chs5p has already been proposed to reside on 
the outside of vesicles containing Chs3p (Santos and Snyder, 1997). Activated Arf1p is 
able to recruit different components from the cytosol to the Golgi membrane to initiate 
vesicle formation. As Chs5p and Bch1p interacted with activated Arf1p, it was tempting to 
speculate that Arf1p would initiate budding of a special kind of post-Golgi vesicles. It is 
conceivable that Chs5p could be recruited from the cytosol to the Golgi membrane by 
Arf1p. Depending on the cell’s needs, different cargoes could be selected for incorporation 
into a vesicle and one or more members of the Bud7-Chs6 family would mediate this cargo 
selection process. Chs5p and the Bud7-Chs6 family would then serve at the same time as 
coat proteins and cargo receptors for a specialized kind of vesicles initiated by Arf1p (see 
also Chapter 3.4). 
We examined the phenotypes of different single deletion as well as of multiple deletion 
strains of the Bud7-Chs6 family in a systematic manner. Except for BCH2, we have 
established testable phenotypes for the different members of the Bud7-Chs6 family as well 
as for CHS5. Phenotypes we observed for a deletion of one member of the family were not 
observed for a single of any other member indicating that the proteins serve different 
functions and are not overlapping at a first glance. In contrast, all phenotypes observed for 
mutants in the Bud7-Chs6 family were also present in a ∆chs5 strain. This indicates that 
Chs5p is acting upstream the Bud7-Chs6 family or downstream at a converging point.  
Chs5p has been shown to be required for polarized secretion of Fus1p to the distal shmoo 
tip during mating (Santos and Snyder, 2003). Although we observed a very dramatic 
mating efficiency defect in ∆chs5 strains, this was not the case in a quadruple deletion of 
the Bud7-Chs6 family. Furthermore, all single deletions were able to localize Fus1p to the 
distal shmoo tip during mating whereas this was not the case for ∆chs5 cells. This 
demonstrates an additional role for Chs5p in secretion other than mediating the actions of 
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the Bud7-Chs6 protein family. These results are consistent with specific functions for each 
member of the Bud7-Chs6 protein family and a more general function for Chs5p. 
It is noteworthy at this point that in case of Fus1p trafficking, the cargo is directed to the 
distal tip and not to the mother-bud junction. Thus, Chs5p might be responsible for 
trafficking of cargo to either site; the Bud7-Chs6 family might be required for trafficking 
only to the mother-bud neck region. Site-specific delivery might be more critical for some 
cargo proteins than for others.  
The calcofluor resistance phenotype of a ∆chs5 and a ∆chs6 strain was rescued by an 
additional ARF1 deletion. Valdivia et al. (2002) have proposed, that the chitin synthase 
Chs3p does no longer reach the plasma membrane in these strains and is instead trapped in 
an endosomal pool and constantly recycled back to the TGN. An additional ARF1 deletion 
would then block this recycling step and Chs3p would escape the endosomal pool and 
reach the plasma membrane, although not in a site-specific manner. This explains the 
restored calcofluor white sensitivity of the double deletion strains and the restored staining 
of cell wall chitin. Interestingly, in a ∆bud7 ∆arf1 strain, the putative Bud7p cargo would 
also reach the plasma membrane but at no specific site and thereby the bipolar budding 
pattern would not be rescued because in this case it is critical that the Bud7p cargo reaches 
a specific site. 
Although Chs6p is present in ∆bud7 ∆bch1 cells, Chs3p was mislocalized and the cell wall 
was only poorly stainable for chitin. This implies that both Chs6p and at least one of the 
proteins Bud7p or Bch1p are directly required for transport of Chs3p. One explanation for 
this is that only Chs6p is directly responsible for incorporation of Chs3p. In this case, at 
least one protein of each sub-branch of the Bud7-Chs6 family could be essential to 
generate vesicles as such and the specific members could be responsible for the selection 
of certain cargo. In a ∆chs6 strain, the protein responsible for incorporation of Chs3p 
would be missing, however, vesicles could be formed. In single deletion strains of either 
BUD7 or BCH1, one protein could compensate for the loss of the other. This is suggested 
by the ability of Bud7p to rescue a BCH1 deletion under overexpression conditions. In the 
∆bud7 ∆bch1 strain, Chs6p is be present, however, because both members of one Bud7-
Chs6 family sub-branch are missing, no vesicles are formed. This model would predict that 
CHS6 BCH2 double deletion should exhibit phenotypes associated with a BUD7 or a 
BCH1 deletions. A ∆chs6 ∆bch2 strain is indeed at least partially sensitive to YMP+.  
Rax1p has been shown to be required for the delivery of Rax2p through the secretory 
pathway (Chen et al., 2000; Fujita et al., 2004). Both proteins appear to localize to the 
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distal bud tip as well as the bud neck and to form rings at these sites. Both Rax1p and 
Rax2p are not required for the establishment but for the maintenance of bipolar budding 
pattern. They are highly stable and inherited throughout the generations to mark the sites of 
previous divisions. It has already been proposed that the proteins act upstream of Bud8p 
and Bud9p and a yet to be identified factor X may accentuate the establishment of Bud8 
and Bud9 landmarks (Fujita et al., 2004). The bipolar landmark proteins Bud8p and Bud9p 
are correctly localized in a ∆bud7/∆bud7 strain. Nevertheless, it exhibits a random budding 
pattern. Moreover, Rax2p, which is not required for the establishment but for the 
maintenance of the bipolar budding pattern, is localized correctly. This indicates that 
Rax2p alone is not sufficient to maintain the bipolar budding pattern and that therefore 
another factor must be involved. Furthermore, it strongly argues for BUD7 acting 
downstream of RAX2. 
We would like to propose a refined model for the establishment of bipolar budding pattern 
and postulate that the yet to be identified fidelity factor X is a cargo of Bud7p-dependent 
vesicles destined to the bud neck (akin to Chs3p). Both Bud8p and Bud9p are landmark 
proteins which define the budding site and mediate downstream interaction with the 
general bud-site selection complex resulting in polarity establishment. At the time of 
cytokinesis, memory rings of Rax1p and Rax2p would form at the distal bud tip and the 
mother-bud neck thereby marking these cell poles for the next budding events. The fidelity 
factor X could be brought to the mother-bud neck in Bud7p-dependent vesicles, much in 
the same way as the chitin synthase Chs3p is brought to the mother-bud neck by vesicles in 
a Chs6p-dependent manner. There, the factor X might possibly interact with or modulate 
Bud8p and/or Bud9p function. The Rax1/2 memory rings could help to confine this 
guidance factor at this site. The factor X would then guide the new landmarks to define 
new budding sites in close proximity of the memory rings. In ∆bud7/∆bud7, ∆rax1/∆rax1 
and ∆rax2/∆rax2 cells, the fidelity factor X would have no or no clear localization and the 
guidance for the new landmarks would be missing. This would result in a random budding 
pattern (or an axial-like if the axial cues are partially used) as is observed for the strains 
mentioned. This model also predicts a random budding pattern (or an axial-like) for BUD7 
BUD8 or BUD7 BUD9 double mutant strains, which is indeed the case (Zahner et al., 
1996). 
 
In conclusion, we propose that Chs5p in conjunction with the Bud7-Chs6 protein family 
mediates trafficking of fungi-specific post-Golgi vesicles directed to the mother bud neck. 
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The chitin synthase Chs3p is one cargo whose incorporation is ensured by Chs6p. A yet to 
be identified fidelity factor required for the maintenance of bipolar budding pattern might 
be incorporated by Bud7p and transported to the mother-bud junction. Bch1p would 
transport a factor required for growth on YMP+ and also Bch2p is likely to transport an 
unknown factor to this site. 
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3.4 Biochemical analysis of the Bud7-Chs6 cargo receptor 
protein family in Saccharomyces cerevisiae 
3.4.1 Results 
3.4.1.1 Chromosomal epitope tagging of the Bud7-Chs6 family members 
In Chapter 3.3, we described the characterization of the Bud7-Chs6 family on a genetic 
level. The involvement of Chs6p and at least either Bud7p or Bch1p in the trafficking of 
the chitin synthase Chs3p to the mother-bud neck suggested a possible role of the Bud7-
Chs6 family as cargo receptors in Arf1p-dependent post-Golgi traffic. In order to be able to 
analyze the functions of Bud7-Chs6 family proteins on a biochemical level, we decided to 
epitope tag each family member. Antisera raised against the proteins were problematic due 
to cross-reactivity between the family members. We were unable to raise specific antisera 
for a single member. To obtain functional fusion proteins at endogenous expression levels, 
we chromosomally tagged the proteins at the C-terminus with different epitope tags and 
tested the resulting fusion proteins for their functionality (Table 17). Strains provided by 
Robert Gauss are indicated in Chapter 2.7. 
 
Table 17:  Analysis of the functionality of C-terminal chromosomal epitope tags of the Bud7-Chs6 family 
proteins.  
 
Chs6p Bud7p Bch1p 
Tag Phenotype Tag Phenotype Tag Phenotype 
none - none bipolar budding none - 
9myc - 9myc bipolar budding 3myc - 
Prot A - 6HA bipolar budding 9myc not applicable 
GST -   3HA - 
yEGFP -   2AU5 - 
6HA ts, resistant to 
calcofluor 
white 
  GST sensitive to 
YMP+, slow 
growth at 23°C 
3VSV-6His ts, resistant to 
calcofluor 
white 
  yEGFP sensitive to 
YMP+, slow 
growth at 23°C 
    3VSV-6His sensitive to 
YMP+, slow 
growth at 23°C 
 
A CHS6 deletion renders the yeast cells temperature-sensitive and resistant to calcofluor 
white (a chitin binding dye). This was also observed for 6HA and 3VSV-6His tags 
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indicating that these tags lead to non-functional proteins. However, we obtained functional 
Chs6p fusions for 9myc, Protein A, GST and GFP. The protein expression level was, 
however, too low for visualization of the GFP fusion by fluorescence microscopy. 
Homozygous diploid ∆bud7 strains bud in a random fashion unlike wild-type diploid yeast 
cells which bud in a bipolar manner. Both homozygous diploid strains with Bud7p-6HA 
and Bud7p-9myc exhibited a bipolar budding pattern suggesting that both of these Bud7p 
fusions were functional. C-terminal fusions of GST, GFP or 3VSV-6His to Bch1p resulted 
in strains sensitive to YMP+ and in slow growth at 23°C, which was the same phenotype 
observed in BCH1 deletion strains. In contrast, Bch1p fused to 3myc, 3HA or 2AU5 gave 
no detectable phenotype. The Bch1p-9myc fusion was impossible to score since this 
construct uses the K. lactis TRP1 marker. We noticed that the TRP1-gene alone was able to 
rescue both the slow growth and the sensitivity to YMP+, thereby compromising the 
assessment of the functionality of the fusion protein. The reason for this behavior is 
unknown, although not without precedence. It has been reported before that TRP1 and 
related genes are able to suppress cold-sensitive phenotypes (Hampsey, 1997). However, 
biochemical data discussed below strongly suggest that also the Bch1p-9myc fusion is 
functional. A deletion of BCH2 resulted in no detectable phenotype. Therefore, the 
functionality of Bch2p fusion was not scorable. In our experiments, we used 9myc (which 
worked for the other three family members) and also 3HA (which is a rather small tag, 
minimizing unfavorable effects). In cases in which we employed chromosomally tagged 
Chs5p, we used Chs5p-6HA. The corresponding strain exhibited no phenotype unlike the 
CHS5 deletion, indicating that Chs5p-6HA is functional. In conclusion, we successfully 
constructed a set of strains with functional epitope tagged proteins expressed at 
endogenous levels. 
 
3.4.1.2 A short deletion of the C-terminus renders Bud7-Chs6 family proteins non-
functional 
During the construction of the epitope tagged strains, we obtained two clones of Chs6p-
9myc, which were both positive as judged by analytical colony-PCR. To our surprise, one 
clone behaved like wild-type whereas the other was both temperature-sensitive and 
calcofluor white resistant, which is identical to the phenotype of a ∆chs6 strain. Hence, we 
sequenced the C-terminus of CHS6 in these strains and found that the non-functional 
fusion clone had a frame-shift resulting in a stop codon just after that frame-shift. The 
resulting protein had lost the last 13 amino acids at the C-terminus. To exploit the 
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importance of the C-terminus, we constructed strains in which a short peptide at the C-
terminus of the Bud7-Chs6 family proteins is replaced by a 9myc epitope (or the 3HA 
epitope in case of Bch1p to circumvent the TRP1 marker problem mentioned above) (Fig. 
29A). As expected, the CHS6∆c-9myc strain showed the features of a ∆chs6 strain, 
temperature-sensitivity and calcofluor white resistance (Fig. 29B). The BCH1∆c-3HA 
strain was sensitive to YMP+ and grew slowly at 23°C, both features are hallmarks of a 
∆bch1 strain (Fig. 29B). A diploid BUD7∆c-9myc/BUD7∆c-9myc strain budded in a 
random fashion (like a ∆bud7/∆bud7 strain) (Fig. 29C). The C-terminal deleted proteins 
 
Figure 29: The C-terminus of the Bud7-Chs6 family proteins is essential for their function. (A) Protein 
sequence alignment of the C-terminus of the Bud7-Chs6 family proteins. The last 13 amino acids of Chs6p 
were deleted and replaced by 9myc. The C-termini of the other three family members were deleted and 
replaced by epitope tags according to this alignment. A dashed line indicates the site of deletion. (B) Growth 
of the C-terminal deleted strains as compared to wild-type and full-deletions on different plates and different 
conditions. Haploid strains were grown overnight in rich medium to logarithmic phase. After adjusting the 
cell concentrations, serial dilutions (1:10) were dropped on various plates and incubated at 30°C for two days 
unless otherwise indicated. Note that the CHS6∆c-9myc strain grew even faster than the wild-type on YMP+ 
plates because of the concomitantly introduced TRP1 marker. (C) Budding pattern of a homozygous diploid 
BUD7∆c-9myc strain. Diploid yeast strains were grown for at least 16 h to logarithmic phase. After fixation 
with formaldehyde, the cells were stained with calcofluor white to visualize the bud scars and were observed 
under the fluorescence microscope. 
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were expressed and stable since the proteins were still detected with the same efficiency as 
the epitope-tagged wild-type versions in lysates (Fig. 30 A-D, compare lane 1 and 3). Only 
in the case of Bch2p∆c-9myc was the protein level lower, most likely because this strain 
contained the longest deletion (Fig. 29A). This means that short deletions at the C-termini 
resulted in the same phenotypes as the corresponding complete deletions. The fact that C-
terminal truncated versions of Chs6p with and without epitope tag resulted in the 
corresponding deletion phenotype indicates that the effects are not just due to altered 
protein structure imposed by the epitope tag. These experiments imply that short sequences 
at the C-terminus of these proteins are essential for protein function (and in the case of 
Bch2p also for protein stability). Because the non-functional proteins were still expressed, 
the C-terminal deleted strains served as valuable tools in the course of further experiments. 
 
3.4.1.3 All Bud7-Chs6 family members interact with Arf1p and Chs5p 
We reported that Bch1p interacts physically with the activated form of Arf1p and that both 
BCH1 and CHS6 genetically interact with ARF1 (Chapter 3.3). Furthermore, the functions 
of the Bud7-Chs6 family seemed to be strongly linked to CHS5. Hence, we wanted to 
study the interactions between Arf1p, Chs5p and all members of the Bud7-Chs6 family 
biochemically. To this end, we performed co-immunoprecipitation experiments with 
affinity-purified αArf1p-IgGs in different strains. As shown in Fig. 30 (A-D, lane 5), 
Chs6p-9myc, Bud7p-9myc, Bch1p-9myc and Bch2p-9myc were co-immmunoprecipitated 
with αArf1p-IgGs. Neither the deletion of CHS5 (Fig. 30, A-D, lane 7) nor the deletion of 
the three remaining members of the Bud7-Chs6 family (Fig. 30, A-D, lane 9) had an 
impact on the precipitation efficiency. However, the short deletion of the C-terminus 
increased the amount of protein which was precipitated in the case of Chs6p, Bud7p, and 
Bch1p (Fig. 30, A-C, lane 8). As already mentioned, Bch2p∆c-9myc resulted in lower 
protein concentration, therefore it was prudent not to draw conclusions from this data. 
Since Bch1p interacted with Arf1p-GTP, it is reasonable to assume that also the other 
members might preferably interact with the activated Arf1p-form. Most of the cellular 
Arf1p is present in the inactive GDP-form: this explains why the recovery of Arf1p-GTP 
associated proteins is so small. In conclusion, all members of the Bud7-Chs6 family 
interact independently with Arf1p and neither their complete C-terminus nor Chs5p are 
required for this interaction.  
We found previously by genetic means that Chs5p is either an upstream regulator or a 
downstream converging point of the Bud7-Chs6 family (Chapter 3.3). To study the 
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physical relationship of Chs5p and the Bud7-Chs6 family, we performed co-
immunoprecipitations with Chs5p antiserum (Fig. 30). Again, the four proteins of the 
Bud7-Chs6 family were co-precipitated (Fig. 30, A-D, lane 10). The deletion of the three 
remaining members of the Bud7-Chs6 family did not change significantly the precipitation 
efficiency (Fig. 30, A-D, lane 13). However, Chs6p∆c-9myc and Bch1p∆c-9myc were not 
co-precipitated (Fig. 30, A-B, lane12). The amount of precipitated Bud7p∆c-9myc was 
only slightly reduced. As observed before, no clear judgment for Bch2p∆c-9myc could be 
made because of the low protein level. Most importantly, however, these experiments 
provide evidence that the members of the Bud7-Chs6 family bind independently from each  
 
Figure 30: The Bud7-Chs6 family proteins interact with Arf1p and Chs5p. Co-immunoprecipitation 
experiments were performed using strains in which the Bud7-Chs6 family proteins were chromosomally 
tagged with 9myc. In addition to wild-type and ∆chs5, we analyzed strains in which the C-terminus of the 
proteins was replaced by 9myc (∆c-9myc) and strains in which the remaining members of the Bud7-Chs6 
family were deleted (∆∆∆). The lysates were treated with either affinity purified αArf1p-IgGs or αChs5p 
antiserum and Protein A-Sepharose. The precipitate was analyzed by SDS-PAGE and immunoblotted with 
antibodies directed against the myc epitope. Analysis of myc tagged strains of CHS6, BUD7, BCH1, and 
BCH2 in (A), (B), (C), and (D), respectively. 1.7% of the lysates used for immunoprecipitations was loaded 
in lane 1.  
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other to Chs5p and that their C-terminus is required for this interaction. Furthermore, the 
fact that a short deletion of the C-terminus leads to non-functional proteins can now be 
related to the inability to interact with Chs5p.  
 
3.4.1.4 The Bud7-Chs6 family members interact with each other 
The co-immunoprecipitation experiments could be interpreted in a way that both Arf1p and 
Chs5p form individual complexes with each member of the Bud7-Chs6 family. However, 
we had also found genetic interactions within the Bud7-Chs6 family. Furthermore, the 
protein expression levels within the family seemed tightly regulated (Chapter 3.3). For 
instance, simple overexpression of Chs6p was not able to restore calcofluor white 
sensitivity of a ∆chs6 strain. In addition, both Chs6p as well as either Bud7p or Bch1p 
were essential for trafficking of the chitin synthase Chs3p to the plasma membrane in the 
mother-bud neck. We therefore also considered the possibility that members of the Bud7-
Chs6 family interact with each other.  
 
Figure 31: The Bud7-Chs6 family proteins interact with each other. A quadruply tagged strain along with 
control strains were subjected to immunoprecipitation. The precipitates were analyzed by SDS-PAGE and 
immunoblotted with antibodies directed against all four different epitope tags. Precipitation with αAU5 and 
with αmyc-IgGs are shown. 1.7% of the lysates used for immunoprecipiations were loaded in lanes 1, 2, and 
5 – 7.  
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To test this possibility, we constructed a quadruply tagged strain. Chs6p was fused to GFP, 
Bud7p appended with 9myc, Bch1p carried a double AU5 epitope and Bch2p was tagged 
with 3HA. The resulting strain behaved like the corresponding wild-type strain again 
indicating that all chromosomal fusions were functional. Again, co-immunoprecipitation 
experiments were performed. When polyclonal AU5 antibodies were used for 
precipitation, all the three other members of the Bud7-Chs6 family could be detected (Fig. 
31, lane 3). This was not the case in control strains lacking the AU5 tag (Fig. 31, lane 4). A 
similar result was obtained when Bud7p-9myc was precipitated with monoclonal myc 
antibodies (Fig. 31). Again, Bch2p, Chs6p and Bch1p were detected in the precipitate by 
the use of their epitope tags (Fig. 31, lane 7). The signals were absent when control lysates 
lacking the myc-epitope were used (Fig. 31, lane 8 and 9). Similar results were obtained 
for co-immunoprecipitations with monoclonal HA antibodies and polyclonal GFP 
antibodies (data not shown). The intensities of the signals of the precipitations suggest that 
the Bud7-Chs6 family proteins form complexes with variable stoichiometries. In 
conlcusion, these experiments demonstrate that the four members of the Bud7-Chs6 family 
are not only able to interact with Arf1p and Chs5p but also with each other. 
 
3.4.1.5 Analysis of native complexes by Blue Native PAGE 
We have established previously that apart from Chs6p, the presence of either Bud7p or 
Bch1p is required for transport of Chs3p to the plasma membrane. We had therefore 
proposed that the Bud7-Chs6 family might act as cargo receptors. For the p24 cargo 
receptor family, it has been shown that their members are able to form homo- and 
heteromers and that the oligomerization state might contribute to cargo sorting function 
(Gommel et al., 1999). Because the members of the Bud7-Chs6 family were able to 
interact not only with Arf1p and Chs5p but also with each other, we wondered if a similar 
mode of action might also apply to the Bud7-Chs6 family.  
One suitable way to look at native protein complexes is Blue Native PAGE (Schagger, 
2001). This technique is used to separate native protein complexes according to their 
apparent molecular weight. In order to study the native complexes of the Bud7-Chs6 
family, we prepared lysates from different strains in which the individual members of the 
Bud7-Chs6 family were tagged with 9myc. These lysates were subjected to Blue Native 
PAGE and analyzed by immunoblot (Fig. 32). The strongest signal for Chs6p was detected 
in a form migrating with an apparent molecular weight of approximately 150 kDa which 
could represent either the monomeric or dimeric form of Chs6p (Fig. 32A). In addition, 
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Chs6p was present in a complex of high apparent molecular weight of around 400-500 
kDa, visible as a smear. Upon deletion of CHS5, all Chs6p was converted to the low 
molecular weight species. A similar result was obtained when the C-terminus was deleted. 
Yet, a high molecular weight smear persisted that migrated faster than in wild-type. 
However, deletion of the three other Bud7-Chs6 family members resulted in a behavior 
comparable to that from wild-type lysate. A similar pattern was observed for Bch2p (Fig. 
32B). Bch2p was present in both a high- and low molecular weight forms. The deletion of 
 
Figure 32: The members of the Bud7-Chs6 family form lower and higher molecular weight complexes. 
Lysates were prepared from different strains in which the Bud7-Chs6 family proteins were chromosomally 
tagged with 9myc. In addition to wild-type and ∆chs5, we analyzed strains in which the C-terminus of the 
proteins was replaced by 9myc (∆c-9myc) and strains in which the remaining members of the Bud7-Chs6 
family were deleted (∆∆∆). The lysates were separated by Blue-Native-PAGE and the protein complexes 
were blotted onto a PVDF-membrane which was decorated with antibodies directed against the myc epitope. 
Analysis of myc tagged strains of CHS6, BCH2, BUD7, and BCH1 are shown in (A), (B), (C) and (D), 
respectively. 
 
CHS5 converted all Bch2p to the low molecular weight species. Because of the low protein 
level in the BCH2∆c-9myc strain, no protein signal was detected. Triple deletion of the 
remaining Bud7-Chs6 family members did not change mobilities as compared to wild-type 
lysates. Bud7p was present in low-, medium and high molecular weight species (Fig. 32C). 
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Only the deletion of CHS5 had a major impact on electrophoretic mobility. In this case, 
Bud7p was converted to a fast migrating species. Bch1p, in contrast, displayed different 
characteristics (Fig. 32D). Here, in wild-type cells and in cells in which the other members 
of the Bud7-Chs6 family were deleted, only a fast migrating species was evident. 
Surprisingly, this was altered upon deletion of CHS5 which decreased electrophoretic 
mobility. This was even reinforced in a BCH1∆c-9myc strain in which Bch1p migrated 
also in a high-molecular weight complex.  
In conclusion, Chs6p, Bud7p, and Bch2p are present in low-molecular weight forms and 
high-molecular weight complexes at steady-state in cells grown under standard conditions. 
The electrophoretic mobility of these high molecular weight forms is consistent with a 
complex of at least three additional members of the Bud7-Chs6 family. The unaltered 
mobilities in triple deletion strains are an indication that the complexes do not represent 
obligate hetero-multimers. This is dramatically changed in ∆chs5 strains, in which Chs6p, 
Bud7p, and Bch2p are only present in low-molecular weight species indicating that Chs5p 
is required for complex formation or stability. The inability of a single member of Chs6p, 
Bud7p, and Bch2p to bind to Chs5p does not prevent complex formation and interation 
with other proteins as is evident from analysis of the C-terminal deleted strains. 
In contrast to that, most of Bch1p is present in a low-molecular weight form. This indicates 
that most of Bch1p is not part of a multimeric complex in wild-type cells under standard 
conditions. However, deletion of CHS5 or the C-terminus of Bch1p drive complex 
formation. This was particularly noticeable in the C-terminal deletion. These complexes 
looked very reminiscent to those of Bud7p. Strikingly, the complexes of the Bud7-Chs6 
family had different molecular weights reflecting the possibility that the members might 
interact with different cargo molecules.  
 
3.4.1.6 Intracellular distribution of the Bud7-Chs6 family is dependent on Chs5p 
We wanted to determine if the interactions we detected  biochemically would be also 
reflected in the intracellular distribution of the Bud7-Chs6 family. It has been reported that 
activated Arf1p resides on Golgi membranes (Stearns et al., 1990b). Furthermore, it has 
been shown that Chs5p is associated with the TGN (Santos and Snyder, 1997). As the 
whole Bud7-Chs6 family is able to interact with Chs5p and (activated) Arf1p, we expected 
the Bud7-Chs6 family also to localize to the Golgi. To investigate the localization of the 
members of the Bud7-Chs6 family, we performed immunofluorescence on strains in which 
the members of the Bud7-Chs6 family were tagged with 9myc. For comparison, these 
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strains also contained a chromosomal SEC7-GFP, which was used as a marker of the TGN. 
As expected, both Chs6p and Bud7p localized to the TGN (co-localization with Sec7p-
GFP) as well as to punctate structures in wild-type cells (Fig. 33). In contrast, Bch1p 
exhibited a very diffuse staining throughout the cytoplasm and only Bch2p was exclusively 
localized to the TGN. Whereas Chs6p, Bud7p and Bch2p appeared to be expressed to 
about the same level, Bch1p was expressed noticeably higher. This was evident from 
immunofluorescence (the exposure time was much shorter for Bch1p) as well as from 
earlier results of immoblots of the lysates (data not shown). However, all members of the 
Bud7-Chs6 family were at least partially localized to the TGN (Fig. 33, merge).  
 
Figure 33: All Bud7-Chs6 family members are at least partially localized to the TGN. The Bud7-Chs6 
family members were chromosomally tagged with 9myc and Sec7p with GFP. Strains were grown overnight 
in rich medium in logarithmic phase. Cells were fixed in formaldehyde and stained with anti-myc and anti-
GFP antibodies. The fluorescent dye Cy3 was used for visualization of myc-tagged proteins (first column), 
whereas Sec7p was visualized by fluorescein (second column). The merge of the two fluorecence channels is 
shown in the third column.  
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Since the interaction of the members of the Bud7-Chs6 family with Chs5p is essential for 
protein function, we analyzed the distribution in suitable deletion strains. The deletion of 
CHS5 had a dramatic impact on both expression levels as well as localization of the Bud7-
Chs6 family members. In ∆chs5 strains, Bud7p is up- and Bch1p downregulated, both 
evident in immunofluorescence (Fig. 34A, first column) and immunoblots (Fig. 30B and C, 
lanes 1 and 2). Chs6p, Bud7p and Bch2p lost their partial or complete TGN-localization 
and showed a diffuse staining. As expected, the deletion of the C-terminus of the Bud7-
Chs6 family proteins had a similar effect like the CHS5 deletion for Chs6p, Bud7p and 
Bch2p (Fig. 34A, second column). The impact on the localization of Bch1p was generally 
hard to score because of the already very diffuse staining of this protein in wild-type cells. 
These experiments provide further evidence that Chs5p as well as the C-terminus of the 
Bud7-Chs6 family proteins is required for either recruitment to or stabilization of the 
Bud7-Chs6 family at the TGN. Localization to the TGN might therefore be a prerequisite 
for protein function.  
We next investigated the influence of the Bud7-Chs6 family on the localization of each 
other by performing immunofluorescence in triple deletion strains (Fig. 34A, third 
column). The most dramatic effect was observed for Chs6p, which showed a punctate 
staining. The TGN-localization was not completely lost for Bud7p and Bch2p retained 
TGN-staining. Generally, the localization of the Bud7-Chs6 family members was less 
dependent on each other than on Chs5p and the C-terminus of the proteins. 
In contrast, the Bud7-Chs6 family has no effect on the localization of Chs5p. In Fig. 34B, 
we show an immunofluorescence of Chs5p-6HA cells. Chs5p displayed a localization 
corresponding to the TGN. The deletion of the whole Bud7-Chs6 family did not affect the 
localization of Chs5p to any greater extent (Fig. 34B). This demonstrates that Chs5p 
localizes to the TGN independently of the Bud7-Chs6 family. 
 
124  3 Results and Discussion 
 
 
Figure 34: Changes in intracellular distribution of the Bud7-Chs6 family proteins and Chs5p as determined 
by immunofluorescence. The strains were grown overnight in rich medium into logarithmic phase. Cells were 
fixed in formaldehyde and incubated with HA or myc antibodies. The fluorescent dye Cy3 coupled to a 
secondary antibody  was used for visualization of the proteins. The same exposure time as in Figure 33 was 
used for each protein within one row. (A) Immunofluorescence of CHS5-deleted strains in which the Bud7-
Chs6 family proteins were chromosomally tagged with 9myc (first column). The second column shows 
strains in which the C-terminus of the proteins were replaced by 9myc (∆c-9myc). The third column shows 
strains in which the remaining members of the Bud7-Chs6 family were deleted (∆∆∆). (B) Chs5p-6HA 
staining in wild-type cells and in cells in which the whole Bud7-Chs6 family was deleted (∆∆∆∆).  
3 Results and Discussion  125 
 
3.4.1.7 Vesicle association 
The Bud7-Chs6 family members and the p24 family members have been proposed to act as 
cargo receptors (Chapter 3.3; Belden and Barlowe, 1996). The latter ones are cycling 
between ER and Golgi and are an integral part of COPI- and COPII- coated vesicles. A 
direct interaction with cargo proteins was demonstrated in later studies (Muniz et al., 
2000). All members of the Bud7-Chs6 family are soluble proteins but for each of them a 
membrane-associated pool exists and they are all at least partially localized at the TGN. 
Therefore, a “cycling” could be achieved by membrane association and dissociation 
events. Similar to the p24-family, the Bud7-Chs6 family proteins are able to associate into 
higher molecular weight complexes. An important consideration is whether the Bud7-Chs6 
family proteins become associated with vesicles. To address this issue, we employed a 
Golgi-budding assay. This in vitro assay has been used successfully in the studies of COPI-
coated vesicle generation (Spang and Schekman, 1998). Enriched Golgi membranes were 
incubated with cytosol, GTPγS and an energy regeneration system. By this procedure, 
COPI-coated and other vesicles were formed. These vesicles can be separated from the 
Golgi membranes by a sedimentation centrifugation. The vesicle peak was collected and 
further enriched by a flotation based on coated membrane buoyant density. Using this 
purification scheme, vesicles were highly enriched, because contaminating particles would 
have to show the same behavior on a sedimentation gradient as well as sharing the same 
buoyant density. The result of such an experiment is shown in Fig. 35. Golgi membranes 
and cytosol from a strain containing only tagged members of the Bud7-Chs6 family were 
used. The fractions of the flotation step were analyzed by immunoblot. As observed before, 
this procedure resulted in COPI-coated vesicles which are marked by the vesicular 
transmembrane cargo Emp47 peaking in fractions 4 – 7. Bud7p-9myc and Bch2p-3HA 
were detected in fractions 3 – 5. This is a strong indication for vesicle association since 
only proteins associated with lipids are able to float in this gradient during the 
centrifugation. Most of the signal remained in the load of the gradient, which is expected 
for peripherally associated proteins. For Chs6p-GFP and Bch1p-2AU5, we obtained a 
signal only in the fractions corresponding to the load of the gradient (data not shown). 
However, this might be due to detection problems and does not formally exclude the 
possibility that these proteins were associated with vesicles. This experiment demonstrates 
that at least Bud7p and Bch2p, both members of different sub-branches of the Bud7-Chs6 
family, are associated with vesicles derived from Golgi membranes. Moreover, these 
vesicles are distinct from COPI-coated vesicles, which peak in denser fractions. 
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Figure 35: Bud7p and Bch2p are present on Golgi derived vesicles. Golgi membranes and cytosol were 
prepared from a strain in which all members of the Bud7-Chs6 were chromosomally tagged with different 
epitopes. Vesicles were generated from these Golgi membranes in the presence of GTPγS and cytosol. The 
vesicles were separated from the Golgi membranes and subsequently further purified by flotation on a 
Nycodenz gradient. Fractions were collected from the top, separated by SDS-PAGE, and analyzed by 
immunoblot. The arrows indicate the direction of movement of lipid particles within the gradient. Non-
membrane associated proteins remain in the load at the bottom of the gradient. The COPI-vesicle cargo 
protein Emp47p peaks in fractions 4 – 7, whereas both Bud7p and Bch2p peak in fractions 3 – 5. For 
comparison, Golgi membranes derived from wild-type and a strain in which the whole Bud7-Chs6 family is 
deleted was also loaded on the gel. 
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3.4.2 Discussion 
The finding that Chs5p and Bch1p both interacted with the activated form of Arf1p was the 
starting point for a series of experiments investigating the function of the Bud7-Chs6 
family both on a genetic as well as a biochemical level. We showed that ARF1 genetically 
interacts with members of the Bud7-Chs6 family and also with CHS5. CHS5 acts as an 
upstream regulator or a downstream converging point of the Bud7-Chs6 family as 
determined by genetics. We had proposed that the Bud7-Chs6 family proteins are involved 
in Arf1p-dependent post-Golgi transport steps of fungi-specific cargo molecules like the 
chitin synthase Chs3p to the mother-bud neck (Chapter 3.3). In this chapter, we tried to 
corroborate the notion that the Bud7-Chs6 family proteins act as cargo receptors . 
To study the Bud7-Chs6 family proteins biochemically we decided to construct a set of 
strains in which the Bud7-Chs6 family members are chromosomally tagged. This was 
necessary because raising antisera against individual members of the Bud7-Chs6 family 
were unsuccessful since the antisera cross-reacted due to the high similarity of these 
proteins (unpublished observation). We paid particular attention not to interfere with the 
physiological function of the proteins. Therefore, all protein fusions were tagged at the C-
terminus on the chromosome in order to keep endogenous protein expression levels. 
Moreover, all protein fusions strains were tested intensively for functionality and compared 
to wild-type and deletion strains.  
In the course of these experiments we realized that a short deletion at the C-terminus of the 
proteins renders the Bud7-Chs6 family proteins non-functional. This was of particular 
interest since the proteins were still present at wild-type levels (except for Bch2p∆c). The 
strains exhibited the same phenotype as the complete deletion independent of an additional 
epitope tag. This implies that a short sequence at the C-terminus is required for protein 
function (and in the case of Bch2p∆c also for protein stability).  
We were able to show a physical interaction of all Bud7-Chs6 family members with Arf1p 
by co-immunoprecipitation experiments. At least for Bch1p, it was shown that it 
predominantly interacts with Arf1p-GTP. Based on this fact, it is a reasonable assumption 
that also the other members of the Bud7-Chs6 family might interact with activated Arf1p, 
which is localizes to the Golgi apparatus (Stearns et al., 1990b). This is consistent with the 
observation that all Bud7-Chs6 family members are at least partially localized to the TGN. 
The interaction of one specific member of the Bud7-Chs6 family with Arf1p was 
independent on the presence of Chs5p or the any other family members. In addition, the C-
terminal sequence was not required for binding to Arf1p. On the contrary, the interaction 
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with Arf1p was even more pronounced in this case. These results would point to a 
regulatory function of the C-terminal sequence. Alternatively, the amount of precipitable 
protein might have been increased because some other protein-protein interaction was 
abolished.  
All Bud7-Chs6 family members interacted physically with Chs5p. The interaction of one 
specific Bud7-Chs6 family member was again not dependent on the presence of any other 
member. Most importantly, the C-terminuis was required for binding to Chs5p, which was 
clearly evident for at least Chs6p and Bch1p. The fact that strains with short deletions of 
the C-terminus behaved like the complete deletion can now be related to the inability to 
interact with Chs5p. A CHS5 deletion combines all the phenotypes so far described for the 
single deletion of the Bud7-Chs6 family. This means that Chs5p binding is essential for 
mediating the function of each single Bud7-Chs6 family member. 
We already realized during the genetic analysis of the Bud7-Chs6 family that some genes 
are more tightly linked than others. For instance, Bud7p and Bch1p were able to substitute 
for each other under overexpression conditions whereas this was not the case for Chs6p 
and Bch2p. In addition, a CHS6 deletion was calcofluor white resistant, a phenotype we 
did not observe for the single deletions of BUD7 and BCH1. Unexpectedly, the double 
deletion of BUD7 BCH1 was also calcofluor resistant. We therefore considered the 
possibility that the Bud7-Chs6 family proteins would act in (facultative) pairs: Bud7p-
Bch1p would be one pair and Chs6p-Bch2p would be the other pair. These two pairs 
correspond to the two sub-branches of the Bud7-Chs6 family. Hence, we tested for a 
physical interaction of the Bud7-Chs6 family proteins which each other. Co-
immunoprecipiation experiments suggested that all four members are able to physically 
interact with each other. These results are consistent with data obtained by Blue Native 
PAGE analysis which showed that the Bud7-Chs6 family proteins exist in high molecular 
weight complexes. Whether in all cases all four proteins are involved remains unclear. One 
possibility might be that a complex is formed containing at least one member of each sub-
family. This would mean that not in all complexes all members of the Bud7-Chs6 family 
are taking part. Rather, the precise constitution of the complex could be adjusted to the 
cell’s needs.  
Arf1p and Chs5p have been shown to localize to the Golgi-apparatus. We were able to 
show by immunofluorescence that Chs5p is still localized to the TGN in the absence of the 
whole Bud7-Chs6 family. This was not unexpected since Chs5p is also involved in other 
trafficking events apart from Bud7-Chs6 family related pathways: for instance, the 
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polarized localization of the cell fusion factor Fus1p during mating (Chapter 3.3; Santos 
and Snyder, 2003). Based on the results from the co-immunoprecipitation, one could 
expect that the Bud7-Chs6 family proteins would localize to the TGN. However, this was 
not the case. Bch2p was the only member with an exclusive TGN localization and, in 
contrast, Bch1p showed a very diffuse staining. Chs6p and Bud7p localized to the TGN but 
additionally displayed a punctate staining. This punctate staining might correspond to e.g. 
chitosomes, a specialized endosomal compartment, through which the chitin synthase 
Chs3p is traveling in a Chs6p dependent manner. This might be an indication that Chs6p 
and Bud7p are also needed for a second transport step at this site of the cell or that the 
Bch1p and Bch2p have a faster dynamics. However, all four Bud7-Chs6 family members 
exhibited at least partial TGN localization. Upon deletion of CHS5 or deletion of the C-
terminus required for binding to Chs5p, the Bud7-Chs6 family proteins lost their 
localization at the TGN (although not evident for Bch1p). This demonstrates that Chs5p is 
required for recruitment and/or stabilization of the Bud7-Chs6 family proteins at the TGN. 
These results are consistent with the analysis of protein complexes by Blue Native PAGE. 
In wild-type cells, the Chs6p, Bud7p and Bch2p are present in low- and high molecular 
weight forms. The high molecular weight form might correspond to a “priming complex” 
forming at the TGN. Deletion of CHS5 converts the high-molecular weight species to low-
molecular weight species. This would indicate that Chs5p is needed for the formation or 
stability of this priming complex. Deletion of the C-terminus results in preservation or a 
slight shift in the high-molecular weight species (Bud7p and Chs6p). Although the ability 
to interact with Chs5p is lost, other members interacting with the C-terminal deleted form 
might help to stabilize the priming complex.  
Bch1p seems to be an exception - every family has its black sheep. Whereas Chs6p, Bud7p 
and Bch2p are expressed to about the same level, Bch1p is expressed to much higher 
extent. The intracellular distribution also differs; it is the only member of the Bud7-Chs6 
family showing a very diffuse staining. Also, most of Bch1p is not part of a “priming 
complex” as determined by Blue Native PAGE but is present as low-molecular weight 
form. Surprisingly, this changes upon deletion of CHS5 or the C-terminus of Bch1p. This 
could mean that Bch1p is for the most part under the conditions tested not involved in 
generating vesicles but only included according to the cell’s needs. A deletion of CHS5 
might provoke compensation of the cell and the distribution and interaction of the Bud7-
Chs6 family proteins might be changed accordingly. Alternatively, Chs5p might have a 
negatively regulatory role for the incorporation of Bch1p into complexes. 
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We also tested if the Bud7-Chs6 family proteins would become part of vesicles derived 
from the Golgi-apparatus. We were able to show a vesicle association for at least Bud7p 
and Bch2p. The corresponding vesicles have a lower density than COPI-coated vesicles, 
which were visualized by the cargo molecule Emp47p. We did not detect Bch1p or Chs6p 
on these vesicles. However, this might be a detection problem and does not exclude that 
these proteins are also vesicle-associated. Alternatively, they could associate with other 
kinds of vesicles that were not revealed in this specific experiment. Further experiments 
are required to resolve this issue. 
We speculate that activated Arf1p is recruiting Chs5p and the Bud7-Chs6 family members 
to the TGN. There, Chs5p is needed for stabilization of the Bud7-Chs6 family proteins. 
Such a complex would be consistent with the priming complex model proposed by 
Springer et al. (1999), in which coat proteins and cargo receptors are together in one 
complex. It has already been proposed that Chs5p might act as a coat protein (Santos and 
Snyder, 1997). This would happen for Bud7-Chs6 family-dependent (like Chs3p) and -
independent vesicular traffic (like Fus1p). In case Chs5p is the coat protein, a deletion of 
CHS5 would result in no vesicle production. The Bud7-Chs6 family proteins might serve 
as cargo receptors. Thus, in the absence of one specific member of the Bud7-Chs6 family 
vesicles would be formed but certain cargo molecules like the chitin synthase Chs3p would 
not be incorporated. These cargo receptors complexes could be of a modular nature. 
Depending on the cell’s needs, different amounts of cargo receptors would be recruited for 
vesicle formation. It is conceivable that one protein of the Bud7-Chs6 family is not 
sufficient but it might require the assistance of other members of the Bud7-Chs6 family 
members to efficiently recruit cargo molecules. This is of course speculative and other 
modes of actions of the Bud7-Chs6 family proteins are also conceivable.  
We proposed that the Bud7-Chs6 family proteins act as cargo receptors. This notion is 
corroborated by the following observations: (i) the Bud7-Chs6 family proteins interact 
with Arf1p. In case of Bch1p, it was shown that it predominantly interacts with activated 
Arf1p. Arf1p is itself required for the formation of different post-Golgi vesicles. (ii) the 
Bud7-Chs6 family proteins interact with Chs5p which has been suggested to reside on the 
outside of vesicles. The interaction with Chs5p is required for protein funtion. Chs5p also 
interacts with activated Arf1p. (iii) the Bud7-Chs6 family proteins at least partially localize 
to the TGN. At least Bud7p and Bch2p become associated with vesicles derived from 
Golgi membranes. (iv) the Bud7-Chs6 family proteins interact with each other. They are 
able to form higher molecular weight complexes, a feature which is also observed for the 
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p24 family of cargo receptors (v) the Bud7-Chs6 family proteins seem to be required for 
trafficking of specific cargo molecules. It has been shown that Chs6p is required for 
trafficking of Chs3p but not of the closely related Chs1p (Ziman et al., 1998). (vi) the 
Bud7-Chs6 family proteins exist in membrane-bound and soluble pools. A “cycling” as 
cargo receptors could be achieved by membrane association and dissociation events. The 
coatomer complex (recruited by Arf1p) as well as Sec24p (recruited by Sar1p) are 
examples of soluble cargo receptors for COPI and COPII vesicles, respectively (vii) the 
knockout of the whole Bud7-Chs6 family does not display a deleterious phenotype. 
Similarly, the complete knockout of the whole p24 family in yeast displays a rather subtle 
phenotype (Springer et al., 2000). 
 
This work described here implicates the members of the Bud7-Chs6 family as vesicluar 
cargo receptors. Valuable tools have been generated that will facilitate more extensive 
exploration of the molecular involvement of Chs5p and the Bud7-Chs6 family proteins in 
vesicle generation and cargo-recruitment in the future.  
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4 Summary 
The small GTPase Arf1 is a crucial regulator of vesicle formation at many steps of the 
secretory pathway in the yeast Saccharomyces cerevisiae as well as in higher eukaryotes. 
Currently best understood is the role of Arf1 in the formation of COPI-coated vesicles at 
different levels of the Golgi apparatus. In addition, there is growing evidence of Arf1 being 
involved in actin cytoskeleton rearrangements as well as in lipid metabolism. The variety 
of already known regulators and effectors of Arf1 is, however, still insufficient to explain 
the multiple functions of the same molecule at different cellular locations. Furthermore, it 
is likely that new Arf1-dependent pathways await discovery in both yeast and mammals. 
In this study, a differential affinity chromatography approach was used to identify new 
interactors of Arf1p from Saccharomyces cerevisiae cytosol. One of the new interactors of 
activated Arf1p that was identified was the polyA-binding protein Pab1p, which binds to 
the polyA-tail of mRNA. Pab1p was found to associate with purified COPI-coated vesicles 
generated from Golgi membranes in vitro. The stability of the Arf1p-Pab1p complex 
depends on the presence of mRNA. Both symmetrically distributed mRNAs as well as the 
asymmetrically distributed ASH1 mRNA are found in association with Arf1p. 
Remarkably, Arf1p and Pab1p are both required to restrict ASH1 mRNA to the bud tip. 
Arf1p and coatomer play an unexpected role in localizing mRNA independent and 
downstream of the SHE machinery. Hereby acts the SHE machinery in long-range mRNA 
transport while COPI vesicles could act as short-range localization vehicles. The ER-Golgi 
shuttle might be involved in concentrating mRNA at the ER. 
Other interactors of activated Arf1p identified were Chs5p and Bch1p, a member of the 
Bud7-Chs6 family. In this study, I showed that all members of this new and previously 
uncharacterized fungi-specific protein family physically interact with Arf1p and Chs5p. 
Moreover, the Bud7-Chs6 family proteins interact with one another and form higher 
molecular weight complexes. In addition, they are all at least partially localized to the 
trans-Golgi network. Most importantly, at least Bud7p and Bch2p are found on vesicles 
generated from Golgi membranes in vitro. The Bud7-Chs6 family is required for 
trafficking of specific cargo molecules like the chitin synthase Chs3p from the trans-Golgi-
network to the mother-bud neck and plays a role in bud-site selection. These functions of 
the Bud7-Chs6 family proteins converge in Chs5p. Finally, I propose that the Bud7-Chs6 
family proteins act as cargo receptors and are involved in Arf1p-dependent post-Golgi 
transport steps of fungi-specific cargo molecules directed to the mother-bud neck.  
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5 Zusammenfassung 
Die kleine GTPase Arf1 ist ein entscheidender Regulator bei der Vesikelbildung an vielen 
Stellen des sekretorischen Wegs in der Hefe S. cerevisiae und ebenso in höheren 
Eukaryoten. Momentan ist die Funktion von Arf1 bei der Bildung von COPI-Vesikeln am 
besten charakterisiert. Es gibt aber auch immer mehr Hinweise darauf, dass Arf1 an der 
Umbildung des Actin-Cytoskeletts beteiligt ist und ebenso den Lipid-Metabolismus 
beeinflusst. Die große Vielfalt an schon bekannten Interaktoren von Arf1 ist jedoch immer 
noch nicht ausreichend, um die multiplen Funktionen ein und desselben Moleküls an 
verschiedenen zellulären Orten zu erklären. Es ist außerdem wahrscheinlich, dass weitere 
Arf1-abhängige Wege in Hefen und höheren Eukaryoten noch gar nicht entdeckt wurden.  
In dieser Arbeit wurde eine differenzielle Affinitätschromatographie durchgeführt, um 
neue cytosolische Interaktoren von Arf1p aus S. cerevsiae zu identifizieren. Einer der neu 
gefundenen Interaktoren von aktiviertem Arf1p war das PolyA-bindende Protein Pab1p. Es 
wurde gefunden, dass Pab1p mit aufgereinigten COPI-Vesikeln assoziiert ist, die aus Golgi 
Membranen in vitro hergestellt wurden. Die Stabilität des Arf1p-Pab1p Komplexes war ab 
hängig von mRNA. Sowohl symmetrische mRNAs als auch die asymmetrisch verteilte 
ASH1 mRNA waren mit Arf1p assoziiert. Bemerkenswerterweise waren sowohl Arf1p als 
auch Pab1p nötig, um ASH1 mRNA auf die Knospungspitze zu beschränken. Arf1p und 
Coatomer spielen eine unerwartete Rolle in der Lokalisierung von mRNA. Diese ist 
unabhängig von der SHE Maschinerie und ihr nachgeschaltet. Die SHE Maschinerie agiert 
hier als Langstrecken-Transportsystem, während COPI-Vesikel kurze Strecken 
überbrücken könnten. Der ER-Golgi Pendelverkehr könnte daran beteiligt sein, mRNA am 
ER zu konzentrieren.  
Weitere neue Interaktoren waren Chs5p und Bch1p, ein Mitglied der Bud7-Chs6 Familie. 
In dieser Arbeit wurde gezeigt, dass alle Mitglieder dieser pilzspezifischen Proteinfamilie 
physikalisch mit Arf1p und Chs5p wechselwirken. Darüber hinaus interagieren die 
Proteine der Bud7-Chs6 Familie miteinander und bilden höhermolekulare Komplexe. Alle 
sind zumindest teilweise am trans-Golgi Netzwerk lokalisiert und außerdem sind Bud7p 
und Bch2p auf Vesikeln zu finden. Die Bud7-Chs6 Familie ist nötig für den Transport von 
spezieller Proteinfracht wie etwa der Chitin Synthase Chs3p vom trans-Golgi-Netzwerk 
zum Knospungshals und spielt eine Rolle bei der Auswahl der Knospungsstellen. Diese 
Funktionen der Bud7-Chs6 Familie konvergieren in Chs5p. Es wird vorgeschlagen, dass 
die Mitglieder der Bud7-Chs6 Familie als neuartige Fracht-Rezeptoren fungieren und 
beteiligt sind an Arf1p-abhängigen post-Golgi Transportschritten hin zum Knospungshals. 
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Ac Acetate 
AP Adaptor protein 
AP Alkaline phosphatase 
ATP Adenosine-5’-triphosphate 
BNP Blue Native PAGE 
bp Base pairs 
BSA Bovine serum albumine 
CFP Cyan fluorescent protein 
COP Coat protein 
DAPI 4',6-Diamidino-2-phenylindole dihydrochloride 
DEAE Diethylaminoethane 
DMF N,N-Dimethyleformamide 
DMP Dimethylpimelimidate 
DMPC L-α-Dimyristoylphosphatidylcholine 
DMSO Dimethylsulfoxide 
DNA Deoxyribose nucleic acid 
DNase Deoxyribonuclease 
dNTPs Deoxyribonucleotides 
DTT DL-Dithiothreitol 
E. coli Escherichia coli 
ECL Enhanced chemoluminesence 
EDTA Ethylenediaminetetraacetic acid 
ER Endoplasmic Reticulum 
EtOH Ethanol 
FITC Fluoresceine-isothiocyanate 
5-FOA 5-Fluoro orotic acid 
GAP GTPase activating protein 
GDP Guanosine-5‘-diphosphate 
GEF Guanine nucleotide exchange factor 
GFP Green fluorescent protein 
GMP-PNP Guanosine-5'-(β,γ-imido)triphosphate 
GPI Glycosylphosphatidylinositol 
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GTP Guanosine-5‘-triphosphate 
GTPase GTP hydrolase 
GTPγS Guanosine-5’-O-(3-thiotriphosphate) 
HEPES N-[2-Hydroxyethyl]piperazine-N‘-[2-ethanesulfonic 
acid] 
HRP Horseradish peroxidase 
IPTG Isopropyl-β-D-thiogalactopyranoside 
K. lactis Kluyveromyces lactis 
KPi Potassium phosphate buffer 
LB Luria-Bertani 
LDL Low-density lipoprotein 
MALDI Matrix-assisted Laserionization/Desorption 
MetOH Methanol 
MHC Major Histocompatibility Complex 
MIIC MHC class II compartment 
MOPS 3-(N-Morpholino)propanesulfonic acid 
mRNA Messenger RNA 
MS Mass spectrometry 
MVB Multi-vesicular body 
NEM N-Ethylmaleimide 
NHS N-Hydroxysuccinimide 
Ni-NTA Nickel-Nitrilotetraessigsäure 
NSF NEM-sensitive fusion factor 
OD Optical density 
ORF Open reading frame 
PA Phosphatidic acid 
PAGE Polyacrylamide-Gel-Electrophoresis 
PBS Phosphate-buffered saline 
PCR Polymerase Chain Reaction 
PEG Polyethylene glycol 
PIP2 Phosphatidylinositol-bisphosphate 
PLD Phospholipase D 
PMSF Phenylmethylsulfonylfluoride 
PVDF Polyvinylidenfluoride 
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RNA Ribonucleic acid 
RNase Ribonuclease 
RT Room temperature 
RT-PCR Reverse Transcription Polymerase Chain Reaction 
S. cerevisiae Saccharomyces cerevisiae 
S. pombe Saccharomyces pombe 
SDS Sodium Dodecylsulfate 
SNARE soluble NSF attachment receptor 
TBS Tris-buffered saline 
TCA Trichloro acetic acid 
TEMED N,N,N‘,N‘-Tetramethylethylenediamin 
TGN trans-Golgi-network 
Tris Tris(hydroxymethylaminomethane) 
tRNA transfer RNA 
t-SNARE target-SNARE 
UTP Uridine-5'-Triphosphate 
v-SNARE vesicle-SNARE 
YFP Yellow fluorescent protein 
 
According to the suggestions of the IUPAC-IUB-commission for biological nomeclature 
(1984), the One-Letter- or Three-Letter code was used for amino acids . 
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